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ABSTRACT 
 
MicroRNAs (miRNAs) are short non-coding RNAs that play key roles during 
metazoan development, and are frequently misregulated in human disease. MiRNAs 
regulate gene output by targeting degenerate elements primarily in the 3´ untranslated 
regions of mRNAs. MiRNAs are often deeply conserved, but have undergone drastic 
expansions in higher metazoans, leading to families of miRNAs with highly similar 
sequences. The evolutionary advantage of maintaining multiple copies of duplicated 
miRNAs is not well understood, nor has the distinct functions of miRNA family members 
been systematically studied. Furthermore, the unbiased and high-throughput discovery of 
targets remains a major challenge, yet is required to understand the biological function of 
a given miRNA. 
I hypothesize that duplication events grant miRNA families with enhanced 
regulatory capabilities, specifically through distinct targeting preferences by family 
members. This has relevance for our understanding of vertebrate evolution, as well 
disease detection and personalized medicine. To test this hypothesis, I apply a 
conjunction of bioinformatic and experimental approaches, and design a novel high-
throughput screening platform to identify human miRNA targets. Combined with 
conventional approaches, this tool allows systematic testing for functional targets of 
human miRNAs, and the identification of novel target genes on an unprecedented scale. 
In this dissertation, I explore evolutionary signatures of 62 deeply conserved 
metazoan miRNA families, as well as the targeting preferences for several human 
miRNAs. I find that constraints on miRNA processing impact sequence evolution, 
creating evolutionary hotspots within families that guide distinct target preferences. I 
ii 
apply our novel screening platform to two cancer-relevant miRNAs, and identify 
hundreds of previously undescribed targets. I also analyze critical features of functional 
miRNA target sites, finding that each miRNA recognizes surprisingly distinct features of 
targets. To further explore the functional distinction between family members, I analyze 
miRNA expression patterns in multiple contexts, including mouse embryogenesis, RNA-
seq data from human tissues, and cancer cell lines. Together, my results inform a model 
that describes the evolution of metazoan miRNAs, and suggests that highly similar 
miRNA family members possess distinct functions. These findings broaden our 
understanding of miRNA function in vertebrate evolution and development, and how 
their misexpression contributes to human disease. 
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PROLOGUE 
Over the past several decades, RNA research has yielded many surprising 
discoveries and fascinating insights into this multifaceted molecule. The central dogma of 
molecular biology, which was admittedly simplistic at it’s inception, described RNA as a 
simple messenger, carrying information from the heritable material of life - DNA - to the 
molecular machines of the cell - proteins. However, in the years between then and now, 
our understanding of RNA has expanded far beyond the limits of a simple message. For 
example, RNA molecules are at the core of protein synthesis, RNA splicing provides a 
means of generating the staggering protein diversity required for complex life forms, and 
catalytic RNAs provide strong evidence that RNA is the heritable molecule that preceded 
life on Earth.  
Suggestive of the preeminent role of RNA in establishing and maintaining life, 
recent reports find that more than 80% of the human genome is transcribed into RNA, 
while only 2% encodes for proteins. Originally termed ‘junk’ DNA, the transcription of 
these vast protein-barren expanses suggests that this ‘junk’ may be anything but. While 
the function of the majority of this non-coding RNA remains unknown and somewhat 
controversial, many surprising discoveries have come from this pool. The subject of my 
thesis was born from one such discovery in an unlikely creature, the small nematode 
worm, C. elegans. This discovery preceded an explosion of RNA research, the result of 
which is what my mentor affectionately refers to as ‘the zoo of non-coding RNAs’.  
Our ever-evolving understanding of RNA, and the rapidly growing field that 
surrounds it, continuously prods and challenges my imagination. As such, the central 
theme of this thesis is expansion, which is illustrated with examples ranging from the 
xvi 
historical rise of microRNA research, to the evolutionary expansion of microRNA 
families in vertebrates. This theme is fitting, as the majority of the work in this thesis 
grew from a simple control experiment that yielded unexpected results. This ‘failed’ 
experiment hinted at an answer to a basic question, illustrated by the graph below, which 
has so intrigued me these past years.  
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Introduction 
An organism’s genome is the complete set of genetic material containing all of 
the information required for development, survival, and reproduction. In multicellular 
organisms, each cell houses a complete copy of the genome, which can be reduced to 
functional units called genes. Not all cells utilize the genome in the same way; each cell 
faithfully employs only a subset of genes, which collectively grants the cell unique 
features and capabilities. It is the differential use of the genome that establishes different 
cell types, which ultimately function in concert to form the entire organism. In this light, 
it is not the ownership of genes, but how they are used, that creates diversity of cell types, 
and ultimately the staggering complexity of multicellular life. To achieve this feat of 
multicellularity from a single uniform genome, cells employ a variety of mechanisms that 
collectively fall under the term gene regulation. Thus, understanding the mechanisms and 
consequences of gene regulation is a major goal of molecular biology.  
One form of regulation, broadly referred to as post-transcriptional gene 
regulation, involves a variety of mechanisms that operate on RNA. Evidenced by the 
pervasive transcription of the human genome [1], these mechanisms are key regulators of 
nearly all biological processes. A subset of these mechanisms operates on the 
messengerRNA (mRNA) molecule, ultimately affecting the fate of each mRNA. These 
mechanisms include chemical alterations of mRNA, such as the addition of m6A methyl 
groups [2], adenosine-to-inosine editing [3], and cytoplasmic polyadenylation [4] and 
deadenylation [5]. mRNA is also regulated by a diverse range of factors which associate 
with the mRNA and influence it’s behavior, and ultimately, it’s fate in the cell. These 
trans-acting factors primarily include RNA binding proteins and non-coding RNAs.  
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RNA-binding proteins recognize individual mRNAs in several ways, including 
sequence elements, either specific or degenerate, or structural motifs in the mRNA [6]. 
These interactions have many wide ranging effects on the mRNA, including export from 
the nucleus [7], localization to specific cytoplasmic compartments [8], mRNA 
stabilization/destabilization [9], and can impact protein translation efficiency [10].  
In recent years, the pace of discovery of novel classes of non-coding RNAs has 
been accelerated by the emergence of high-throughput sequencing technologies [11]. 
These technologies enable the unbiased probing of the transcriptome with incredible 
sensitivity. As such, diverse non-coding RNAs have been discovered ubiquitously 
throughout the genomes of organisms in all realms of life [12]. These transcripts are 
defined by their lack of protein coding potential, and are typically categorized as either 
long (>200 nucleotides) or short (<200 nucleotides) [13]. Current estimates place the 
number of distinct long non-coding RNAs (lncRNA) in the human genome at 
approximately 10,000 [13]. The expression of lncRNA is typically low compared to that 
of mRNAs, and the nucleus is especially enriched for lncRNA compared to the cytoplasm 
[14]. Several well-studied examples illustrate the diversity of mechanisms by which 
lncRNAs contribute to, and in some cases solely direct, important biological processes. 
These include, but are not limited to, catalytic RNAs that function in transferRNA 
(tRNA) processing [15], self splicing introns [16], X-chromosome inactivation [17], long 
range chromatin interactions impacting gene expression in cis [18] and in trans [19], 
transcripts that run in antisense orientation to mRNAs and silences their transcription [20, 
21], enhancer RNAs that promote transcription via chromatin looping [22], and circular 
RNAs that function as molecular decoys for microRNAs [23] or RNA binding proteins 
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[24]. However, functional characterization for the vast majority of lncRNAs has proven 
difficult, and it remains controversial what fraction is indeed functional, as opposed to 
transcriptional noise [12].  
Short non-coding RNAs also illustrate the diverse capabilities of RNAs as key 
regulators of a variety of biological processes. Small RNAs were originally studied in the 
context of translation and splicing, where tRNAs bridge the gap between the triplet codon 
on mRNA and the nascent polypeptide chain, and where many key components of the 
spliceosome are U-rich small nuclear RNAs. Subsequent discoveries have placed small 
RNAs at the center of ribosome biogenesis [25] and silencing mobile genetic elements in 
the germline [26]. Recent advances in the understanding of the prokaryotic CRISPR-Cas 
systems led to the development of incredibly specific genome editing tools in eukaryotes, 
which are driven by ~24-48 nucleotide guideRNAs [27]. 
However, at the base of the explosion of non-coding RNA research was the 
discovery of a small RNA species that marked precise developmental transitions in the 
nematode C. elegans [28, 29]. These RNAs, ~21-24 nucleotides in length, repress the 
translation of endogenous mRNAs, and function as essential developmental switches 
during worm embryonic development. The name of these small RNAs, ‘microRNA’ 
(miRNA), first appeared in the literature in 2001, in three papers released simultaneously 
by the Ambros, Tuschl, and Bartel labs [30-33]. These papers built on the initial 
identification of a single miRNA in the human genome [34], and explored the deep 
conservation of additional miRNAs in plants [35, 36], worms, and humans. In the 
following years, the field of miRNA research has expanded enormously (Figure 1.1). The 
introduction of this thesis begins with the historical discovery of miRNAs, which 
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highlights four points critical to my own research on miRNA evolution and gene 
targeting.  
 
The discovery of microRNAs  
The discovery of miRNA was preceded by advances throughout the 1960s and 
1970s in the lab of Sydney Brenner. Among Brenner’s research interests was the genetic 
control of development, specifically on how cells of the early embryo differentiate into 
neurons, and eventually form the complex structures of the nervous system [37]. At the 
time, Drosophila was a prominent model for nervous system development, but Brenner 
decided that the fly, with nearly 105 neurons, was too complicated to gain fundamental 
insights into basic neural function [37]. So, in the early 1970’s, Brenner began work to 
establish the small nematode worm, C. elegans, as a model for nervous system 
 
Figure 1.1. The explosion of miRNA research. I extracted all publications from 
PubMed that contain the terms “miRNA”, “microRNA”, or “microRNAs” in their 
abstract, and plotted the number based on year of publication. For comparison, the 
black line marks all papers with “mRNA” in the abstract. This highlights both the 
rapid pace of discovery and the broad interest in miRNA research.  	
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development [38, 39]. Worms provided an attractive developmental model because of 
several intrinsic features: they are completely transparent, have a relatively short life 
cycle (~3 days), and are morphologically simpler than flies, while still maintaining all 
relevant tissue types (muscle and neurons).  
In the early 1970s, John Sulston and Robert Horvitz, both working in Brenner’s 
lab, optimized methods to track individual cell divisions in live worms. Sulston and 
Horvitz used these methods to precisely track worm development beginning from a single 
fertilized egg, and concluding with all 959 somatic cells of the adult worm [40]. These 
experiments revealed that worm development proceeds through an invariant pattern of 
cell division and cell death. The combination of the worm’s unvarying development with 
the exhaustive cell lineage map generated in Brenner’s lab made C. elegans an ideal 
organism for identifying genes that control development processes. Indeed, Brenner, 
Sulston, and Horvitz first identified genes that control cell death, and in 2002 were 
awarded the Nobel Prize for this work [38-41]. 
Subsequently, throughout the 1980’s, two post-doctoral fellows from the Horvitz 
lab, Victor Ambros and Gary Ruvkun, began studying the genetic pathways controlling 
developmental timing in C. elegans. The work in Ambros and Ruvkun’s own labs 
focused on classifying genes that control the timing of transitions between larval stages 
of the worm [42-47]. These genes were termed heterochronic, in that mutations of these 
genes altered the timing of specific developmental stages (Figure 1.2A).  Their elegant 
genetic studies revealed that heterochronic genes exist in a hierarchy, with some genes 
ushering in the next development stage by silencing other genes. While all the genes 
investigated changed their expression levels throughout development, genes differed in   
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Figure 1.2. miRNAs control developmental timing and the heterochronic gene 
pathway in C. elegans. (A) The heterochronic hierarchy across worm development as 
established by genetic studies. Blue bars mark protein coding genes that define certain 
larval stages. Maroon bars are miRNAs that repress the genes associated with earlier 
developmental stages. (B) lin-4 mutant worms reiterate early developmental stages 
because of abnormal expression of the lin-4 target lin-14 . Conversely, lin-14 mutants 
skip the L1 stage, proceeding to L2 like cell lineages, resulting in lethality. (C) Let-7 
mutants frequently display a burst vulva phenotype, which is the consequence of 
abnormally high rates of cell division, causing tissue rupture out of the vulval opening. 
(Adapted from [51-53]) 
7 
their level of control and range of expression. For example, lin-4 negatively regulated lin-
14, which was associated with the first larval stage (L1), and activated genes important 
for L2 development. Similarly, at the transition of the L3 stage, let-7 negatively regulated 
lin-41, which was a negative regulator of lin-29, a key effector of genes critical for 
development of the hypodermis in L4 and adult worms. By randomly mutating the 
genome of C. elegans, these labs were able to place these genes in a hierarchy of 
regulatory interactions (Figure 1.2A). Genes operating at the top of the hierarchy, i.e. lin-
4 and lin-14, act as genetic switches that repress previous genetic programs, and activate 
those responsible for the subsequent developmental stage. Genes lower in the regulatory 
network, i.e. lin-29, are responsible for creating a specific cellular phenotype, but are 
under the control of the upstream regulators.  
Based on previous studies, it was known that early larval development in C. 
elegans depended on the temporal interaction between lin-14 and lin-4 (Figure 1.2B). 
Despite the absence of the LIN-14 protein after the L1 stage of development (see Figure 
1.2A), the mRNA levels of the lin-14 gene remained constant throughout development. 
This key insight suggested that lin-14 is regulated post-transcriptionally at the mRNA 
level [42, 44-46]. However, the sequence of these genes and the mechanism of action of 
their assumed proteins was unknown until 1993, when it was discovered that lin-4 was a 
22 nucleotide RNA which did not code for a protein [28, 29]. Importantly, Ruvkun and 
Ambros found that the sequence of lin-4 had partial complementarity to a portion of the 
3´ untranslated region (3´UTR) of lin-14, indicating that the mRNA molecules of these 
two genes could hybridize via Watson-Crick base pairing. Thus, they hypothesized that 
lin-14 was regulated by lin-4 via anti-sense hybridization in the 3´UTR of the lin-14 
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mRNA transcript. Despite lacking a mechanistic explanation of how this regulation 
occurred, all data indicated a novel form of post-transcriptional regulation [28, 29]. 
While examples of post-transcriptional regulation mediated by the 3´UTR were 
observed in various organisms such as flies, frogs [48], and mice [49], the discovery of a 
small RNA with anti-sense complementarity to a 3´UTR was unique. Furthermore, no 
small RNAs homologous to lin-4 could be found outside of nematodes, and as such these 
findings were widely regarded as an anomaly confined to worms [50]. Yet over the next 
several years, additional mutagenesis screens identified additional genes in the 
heterochronic hierarchy. One of these genes, let-7, functioned as developmental switch 
similar to lin-4 (Figure 1.2A,C) [51, 52], and in 2000 the Ruvkun lab discovered that the 
let-7 gene coded for a 22 nucleotide RNA with complementarity to target sites in the 
3´UTR s of lin-14, lin-28, and lin-41 [53]. The temporal expression pattern of let-7 was 
non-overlapping with several of it’s target genes, suggesting that one function of let-7 is 
to protect against the expression of genes associated with earlier developmental stages 
[53]. Fortuitously, the discovery of let-7 occurred in parallel with advances in whole-
genome sequencing, which facilitated the search for this small RNA in the genomes of 
other species [54, 55]. Thus, shortly after the discovery of let-7 in C. elegans, it was 
found expressed from the genomes of every animal species from worms to humans [34]. 
This deep conservation of let-7 ignited incredible interest in the world of miRNAs, which 
continues to expand to this day (Figure 1.1) [50]. 
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These pioneering studies highlight four points that are of central importance to the 
thesis presented here. First, miRNAs primarily recognize target sites in the 3´UTR of 
mRNAs (Figure 1.3). The 3´UTR is the region of the mRNA between the stop codon and 
the polyA tail, and by definition possesses no protein coding potential. Recently, 3´UTRs 
have been the focus of much attention because of their regulatory roles in post-
transcriptional gene regulation: 3´UTRs frequently contain binding sites for a wide array 
of trans-acting factors that regulate the fate of the mRNA molecule, including RNA-
binding proteins, lncRNAs, and miRNAs (Figure 1.3). Second, as evidenced by the lin-
4/lin-14 interaction, the functional interaction between a miRNA and mRNA typically 
results in decreased protein production. It is important to note that this interaction does 
not necessarily mean that the mRNA levels are affected [42, 56, 57], although this is 
certainly a frequent result of miRNA targeting (see below section on mechanisms of 
miRNA repression) [58]. Third, the lin-4 and let-7 mutants demonstrate that miRNAs are 
key regulators of development, and subsequently, we now know are deregulated in nearly 
all disease contexts examined to date (see below sections on development and human 
 Figure 1.3. The 3´ untranslated region of mRNA plays a central role in post-
transcriptional gene regulation. The 3´ untranslated region (3´UTR) is defined as the 
region between the stop codon and the polyA tail of eukaryotic mRNAs. The exact 
location of the polyA tail is marked by polyadenylation sequence elements (PAS), which 
signal cotranscriptional cleavage and polyadenylation. 3´UTRs are frequently targeted by 
numerous trans-acting factors, such as non-coding RNAs, RNA binding proteins, and 
miRNAs.  
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miRNAs in disease). And lastly, the let-7 example highlights that miRNAs are a deeply 
conserved form of post-transcriptional gene regulation. In fact, the miRNA processing 
machinery is conserved in all animals [59], plants [60], archaea [61], and even viruses 
[62]. Together, these four points are the central themes of the research presented in this 
thesis, and are expanded upon below. 
  
miRNA biogenesis: Transcription, processing, and Argonaute loading 
As the effectors of a potent mechanism of post-transcriptional gene regulation, it 
is not surprising that miRNAs themselves are subject to complex forms of regulation 
[63]. This regulation begins with miRNA transcription, which proceeds from several 
genomic contexts. miRNAs are typically found in three roughly equally sized pools in the 
human genome [64]: single miRNA transcripts, polycistronic miRNA clusters that 
contain multiple miRNAs in tandem [65, 66], or within introns (or other excised RNA 
fragments [67]) of host genes. Both the single and clustered miRNAs possess their own 
promoters capable of driving miRNA expression [68]. While miRNAs within introns also 
may have their own promoters [69], they typically rely on expression of the host gene. 
The majority of metazoan miRNAs are transcribed by RNA-polymerase II, and share 
features with mRNAs such as the 5´ cap and polyA tail (Figure 1.4) [70, 71]. However, 
several miRNAs have also been found in RNA polymerase-III transcripts, such as Alu 
repeats [72] and ribosomal RNA [67]. Following transcription, the nascent miRNAs, 
termed primary miRNA (pri-miRNA) are of variable size [73]. Historically, identifying 
the transcription start site for pri-miRNAs was difficult because of their transient nature, 
and until recently it was unclear where exactly the 5´ end of many pri-miRNAs start [73]. 
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Thus, relatively little is known about the promoter architecture of miRNAs in general 
[74].  
 A defining feature of pri-miRNAs is the hairpin structure formed by extensive 
base pairing between ~70-100 consecutive nucleotides (Figure 1.4). The two arms of the 
hairpin are 30-40 nucleotides in length, possess various mismatches, loops, and bulges 
 
 
Figure 1.4. miRNA biogenesis and processing. (A) Primary miRNAs are typically 
transcribed from the genome by RNA Pol-II, and a possess 5 cap and polyA tail.  A 
defining feature of the pri-miRNA is the hairpin secondary structure. Sequence 
elements direct the co-transcriptional cleavage of the unstructured nucleotides 
surrounding the hairpin by the endonuclease Drosha, creating the pre-miRNA. The 
pre-miRNA is then exported out of nucleus by Exportin5 (XPO5). (B) Once in the 
cytoplasm, the pre-miRNA is recognized by a second endonuclease, Dicer, which 
removes the hairpin loop, leaving two ~22 nucleotide molecules that interact via 
Watson-Crick base pairing.  This is called the miRNA duplex (C).  One of these 
strands will be selectively incorporated into the RNA-induced silencing complex 
(RISC), where it will guide the RISC to target mRNAs based on complementarity.		
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[75], and are separated by a loop of varying size [76]. Flanking the miRNA hairpin is 
unstructured single stranded RNA (ssRNA), typically several hundred to a few thousand 
nucleotides in length. This single stranded region of the pri-miRNA is removed almost 
immediately following transcription, which explains the scarcity of pri-miRNAs in 
transcriptome sequencing. The processing of pri-miRNAs was originally confirmed using 
biochemical approaches [68], and the nuclease responsible for this cleavage, Drosha, was 
identified based on homology to other type-III ribonucleases [77]. Drosha, so named 
because of its initial discovery in Drosophila [78], recognizes and cleaves double-
stranded RNA (dsRNA). Subsequently, it was found that Drosha and Pasha form a 
complex that was named the microprocessor [79]. The mammalian homologue of Pasha, 
DGCR8, is an essential component of the microprocessor, as it is capable of binding to 
single stranded regions of the pri-miRNA such as the hairpin loop [80], and stabilizes the 
interaction between Drosha and the miRNA [81]. Collectively, the microprocessor is a 
heterotrimeric complex containing one Drosha and two DGCR8 proteins [81], which 
recognizes both the secondary structure and specific sequence elements in the pri-miRNA 
(Figure 1.4) [82, 83]. Interestingly, transcription and efficient processing of the pri-
miRNA are intimately coupled, with the pri-miRNA being retained at the site of 
transcription prior to cleavage by the microprocessor [84]. The recent crystal structure 
revealed that Drosha functions as a molecular ruler, measuring and cleaving 11 
nucleotides from the junction where the single-stranded pri-miRNA becomes the double 
stranded hairpin structure [85].  
Cleavage by the microprocessor leaves a ~70-100 nucleotide hairpin structure 
termed the pre-miRNA. The formation of the pre-miRNA is a critical step in miRNA 
13 
biogenesis, and as such it was originally assumed that all pre-miRNAs must be processed 
to the appropriate size by the microprocessor. However, several conserved mechanisms 
that circumvent the microprocessor have been described [86]. The best-characterized 
example is the miRtron pathway, which combines splicing with pre-miRNA processing. 
MiRtrons are formed from small introns that possess a hairpin secondary structure, and 
following splicing, are ideally sized to be recognized by the cytoplasmic pre-miRNA 
processing enzyme Dicer [87]. While miRtrons represent only a small fraction of the total 
miRNAs in animal genomes, they are often conserved [88], underscoring the flexibility 
and complexity of miRNA processing. 
Pre-miRNA export from the nucleus is facilitated by the dsRNA binding protein 
Exportin5 (XPO5). miRNA binding by XPO5 is facilitated via it’s interaction with the 
small GTPase Ran, which is enriched in the nucleus [89]. The XPO5/RanGTP/pre-
miRNA complex then associates with the nuclear pore complex to shuttle the complex 
out of the nucleus [90, 91]. Following nuclear export, the low levels of RanGTP in the 
cytoplasm cause the complex to dissociate, releasing the miRNA into the cytoplasm 
where it will be further processed [89]. Exportin5 binds to the two-nucleotide overhang 
generated by Drosha cleavage, and does not have any reported sequence specificity [92]. 
However, XPO5 does not efficiently bind improperly processed pre-miRNAs, suggesting 
that XPO5 binding is a key checkpoint that ensures pre-miRNA integrity [91].  
Once in the cytoplasm, the pre-miRNA is released by Exportin5 and bound by the 
type-III ribonuclease Dicer. Dicer was initially discovered in the processing of small 
interfering RNAs (siRNA) during RNA interference (RNAi) in C. elegans [93, 94]. Dicer 
was later connected to miRNA processing due to the phenotypic similarities of worms 
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and flies that possess mutations to let-7 or Dicer [95, 96]. It is now recognized that Dicer 
is the convergence point of the siRNA and miRNA pathways in animals. While Dicer 
processes both siRNA and miRNA, the major distinction between these pathways is that 
siRNAs are typically formed from larger, double-stranded foreign genetic elements (i.e. 
viruses and transposons), while miRNAs are endogenous transcripts formed from 
hairpins [97].  
Dicer and Drosha posses structural and functional similarities [85], which is 
surprising given that sequence based comparisons have yielded no clear evolutionary 
relationship between the two [98]. Dicer recognizes and cleaves dsRNA similar to 
Drosha, yet in contrast to Drosha, has no sequence specificity [99]. Instead, Dicer 
recognizes structural features of the dsRNA, such as the 2-nucleotide 3´ overhang left by 
Drosha cleavage [100] and the 5´ exposed phosphate of the miRNA backbone [101], and 
cleaves the dsRNA into ~22 nucleotide fragments [100, 102]. Thus, Dicer has been 
described as a molecular ruler, relying on distance to dictate the cleavage site [102]. The 
cleavage product, termed the miRNA duplex, is composed of two RNA molecules that 
interact via extensive base pairing, and possess two nucleotide 3´ overhangs (Figure 1.4).  
While in vitro experiments demonstrate Dicer alone is capable of recognition and 
cleavage of pre-miRNAs, two closely related proteins, TRBP and PACT, can modulate 
Dicer’s catalytic activity [103]. Dicer is capable of generating dsRNA duplexes of 
varying lengths (~21-25 nucleotides), and this flexibility may be moderated by TRBP and 
PACT [104, 105]. The subtle flexibility in the precise cleavage site is responsible for the 
production of isomiRs, which are miRNAs with 1-2 nucleotide shifts in the 5´ or 3´ 
position of the mature miRNA. In theory, these shifts can greatly impact target 
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recognition by miRNAs [106], but beyond a few examples little is known about the 
general contribution of isomiRs to global miRNA function [107].  
A critical function of TRBP and PACT is facilitating the handoff of the miRNA 
duplex from Dicer to Argonaute [108, 109], the central effector of miRNA regulation. 
Together, Dicer, TRBP, and Argonaute are known as the minimal RISC-loading complex 
(RLC) [110, 111]. Once the handoff is complete, the RLC may remain intact [112], and it 
is currently unclear if Dicer and TRBP play a role in subsequent miRNA processing or 
target recognition and repression. In either case, the Argonaute protein selects one of the 
two strands to function as the guide RNA (also termed the miRNA strand), and degrades 
or discards the other (termed the passenger or miRNA* strand). 
Strand selection is a critical step in miRNA biogenesis, as the sequence of the 
miRNA will dictate target identification. The key features of the miRNA duplex that 
direct proper strand selection are structural asymmetry, and sequence specificity [113]. 
Structural asymmetry is created by mismatches in the secondary structure on one side of 
the duplex [114]. Mismatches at the 5´ end of the miRNA strand leave the first nucleotide 
of the miRNA unpaired, and free to interact with the MID domain of the Argonaute 
protein [115]. Unpaired nucleotides in the central region of the miRNA may also 
facilitate Argonaute loading [116]. Crystal structures have revealed the amino acids in 
Argonaute that specifically interact with the first nucleotide in the miRNA [115, 117, 
118], and provide structural evidence for the observed uracil bias in the first position of 
the miRNA [119]. In cases where one strand of the miRNA duplex is preferentially 
incorporated over the other, there is a strong bias for uracil in the first position of the 
miRNA, and a cytosine bias in the first position of the miRNA* [120].  
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Despite these well-characterized features, many miRNAs demonstrate surprising 
flexibility in strand selection. There are examples where one strand is preferentially 
incorporated in certain tissues, while this preference is reversed in others [121]. It is 
currently unclear if any trans-acting factors control this preference, and this is an 
interesting hypothesis that warrants further exploration. Regardless, the result is that a 
single miRNA duplex can produce two miRNAs that have distinct roles, acting in either 
concert [122] or in opposition [123] to each other.  
Once incorporated, the miRNA is used as a guide by Argonaute to recognize 
specific target sites on mRNAs largely by Watson-Crick base pairing.  The interaction 
between the mRNA and Argonaute typically results in a decrease in protein output for the 
targeted mRNA. Despite the amount of interest in the functional outcome of miRNA 
targeting, the exact mechanisms of repression, whether mRNA decay or translational 
repression, remain controversial. Because the mechanism of silencing is of central 
importance to the research presented in this thesis, I review the current understanding of 
these mechanisms below. 
   
The mechanisms of miRNA target repression 
Based on early studies in C. elegans, the effect of miRNA targeting seemed to be 
translational repression without changing the level of target mRNAs [42], a pattern that 
has been observed with miRNAs in multiple species [56, 57]. However, emerging high-
throughput sequencing technologies seemed to contradict this mechanism, demonstrating 
instead that mRNA levels of most miRNA targets decrease upon miRNA overexpression 
[124-126]. While this decade-old conflict remains incompletely resolved [127], recent 
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biochemical studies have shed light on the order and mechanisms of miRNA targeting 
[128]. These mechanisms are best described in terms of the proteins that the miRNA 
guides to target sites, which is a large and dynamic complex called the RNA induced 
silencing complex (RISC) [129]. 
At the core of the RISC is the Argonaute protein, which binds the miRNA, 
 
  
Figure 1.5. Human Argonaute2 complexed with miR-20a.  Complete crystal structure 
of human Argonaute2 complexed with miR-20a (PDB: 4W5N, structure from [118]. The 
miRNA backbone is the black line, miRNA nucleotides are in red (seed region), or blue. 
Green: MID domain. Maroon: PIWI domain. Orange: PAZ. The seed nucleotides (2-7) 
extend into a central cleft in the protein, and are arranged in a helical structure. The 
uncolored region of the protein plays a role in interactions with RISC proteins such as 
GW182. 
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granting the RISC with target specificity (Figure 1.5). Argonaute proteins are deeply 
conserved from plants to humans, and all utilize small RNAs that guide the protein to 
target sites. Argonautes have undergone duplication and functional divergence in many 
species. The  most prominent of these is C. elegans, which has 27 Argonaute proteins 
with diverse functions, including RNA interference, silencing transposable elements, and 
transcriptional silencing [130]. Humans possess four Argonaute proteins that function in 
the miRNA pathway [131]. While the majority of evidence currently supports functional 
overlap between these proteins [132], there are some unique features that suggest 
functional divergence. For example, Ago2 is the only human Argonaute with the ability 
to cleave target mRNAs, which is the so-called ‘slicing’ mechanism [133]. Individual 
Argonautes also exhibit tissue specific expression patterns [134], as well as some 
preference for specific miRNAs [135]. While the high degree of conservation and 
functional overlap in human Argonautes implies general mechanisms of miRNA 
targeting, the number of human Argonautes and their distinct differences suggests a 
subtle complexity that has yet to be fully understood. 
While miRNA loaded Argonautes function to guide the RISC to target sites on 
mRNAs, it is the accessory RISC proteins that perform the biochemical function of 
translational repression followed by mRNA decay. Recent studies have clarified the 
historically elusive mechanism of translational repression. Several studies from diverse 
species show that reduction of target mRNAs in polysome fractions precedes mRNA 
decay [136-138]. Furthermore, translational repression does not necessitate removal of 
the polyA tail or mRNA destabilization [136, 138], which is intriguing, as these results 
suggest the possibility of conditionally reversing target repression [139]. Mechanistically, 
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the RISC seems to repress translation primarily at the initiation step, by blocking proteins 
that interact with the 5´ cap of the mRNA. The first evidence for this was that miRNAs 
are incapable of repressing transcripts that are translated from an internal ribosome entry 
site (IRES) [140, 141]. Translation initiation normally requires recruitment of ribosomal 
subunits by the eIF4F cap-binding proteins, and IRES do not rely on the 5´ cap for this. 
One study elegantly demonstrated that adding the eIF4F complex to cell extracts could 
reverse translational repression by let-7, and that this step definitively preceded mRNA 
decay [142]. A subsequent screen identified eIF4A2 as the only member of the eIF4F 
complex that was required for miRNA mediated translational repression [143]. eIF4A2 is 
an RNA helicase that is a component of the eIF4F complex, and co-purification 
experiments demonstrate that eIF4A2 preferentially binds components of the RISC over 
other cap binding proteins [143]. While the precise details of this interaction are still 
unclear, evidence suggests that mRNA conformational changes and competitive binding 
for the 5´ cap structure are the primary mechanism by which the RISC prevents ribosome 
entry [128]. 
miRNA mediated translational repression is frequently followed by mRNA 
destabilization, and compared to translational repression, the mechanism of mRNA 
destabilization is more clearly understood. An essential component of the RISC is the 
protein GW182 [144]. GW182 functions as a molecular scaffold for the effector proteins 
of the RISC [145]; the GW182 N-terminus binds to Argonaute proteins, while its C-
terminus binds to the cytoplasmic polyA binding protein (PABP) and deadenylase 
complexes such as CCR4/NOT [146]. Binding of CCR4/NOT and PABP to the polyA 
tail directs deadenylation, and subsequent destabilization of the transcript [147]. One 
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frequent feature of functional miRNA target sites is that they tend occur close the to 3´ 
end of the mRNA [148]. Given that deadenylation is a critical step in mRNA 
destabilization, the distance between the RISC and the polyA tail may influence 
deadenylation efficiency and have a quantifiable effect on miRNA repression [148]. 
PolyA tail length also plays an important role in this process, with longer tails being more 
susceptible to miRNA based silencing [149]. GW182 was initially discovered because of 
its localization to p-bodies, which are cytoplasmic foci that function as mRNA storage 
and decay centers [150, 151]. P-bodies are enriched in decapping enzymes that 
specifically associate with the RISC [152, 153]. P-bodies are typically the terminal 
destination for the mRNA, and as well as the miRNA, as evidence suggests that both 
mRNA and miRNAs are degraded in P-bodies [154]. 
Despite intense research into the mechanisms of miRNA-based silencing, there is 
a significant body of literature that illustrates exceptions to these general principles, 
underscoring the flexibility and complexity of miRNA-based silencing [128]. Yet 
regardless of the exact mechanism, the biological consequence of miRNA targeting is the 
reduction of the protein expression of target genes. Thus, the identification of miRNA 
targets is the perhaps the most relevant, yet surprisingly difficult, aspect of studies 
investigating miRNA function. Below is a review of relevant targeting principles and 
experimental techniques for identifying and validating miRNA target sites in mRNAs.  
 
General principles of miRNA target site identification 
The mechanism of target site recognition for miRNAs is largely based on the 
interaction between the miRNA and the Argonaute protein. While general targeting 
21 
principles were initially identified based on target site alignments and biochemical data, 
the recently solved crystal structures of Argonaute proteins with guide RNAs nicely 
illustrate the physical basis of these principles [115, 117, 118, 155]. Members of the 
Argonaute family of proteins are defined by the presence of three domains: MID, PAZ, 
and PIWI (Figure 1.5). The MID domain (Figure 1.5-1.7, green domain) binds the first 
nucleotide of the miRNA, and plays a role in miRNA strand selection and incorporation 
[117]. The human Ago2 crystal structure shows that the first nucleotide is twisted away 
from the central cleft of the protein, and has been suggested to play a minimal role in 
  
 
Figure 1.6.  The structure of the miRNA seed region. The 5´ nucleotide of the 
miRNA (orange) physically associates with the MID domain (green), and is twisted 
away from nucleotides 2-7 (see black backbone). Nucleotides 2-7 (blue) have a helical 
conformation that extends into a cleft in the protein where target mRNAs enter. The 
conformation of the seed is what results in the requirement for seed pairing in the 
majority of miRNA targets.  (PDB: 4W5N) 
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interactions with the target mRNA (Figure 1.6).  
The PIWI domain (Figure 1.5-1.7, maroon domain) possesses catalytic abilities in 
some Argonautes, including human Ago2 [111] and all plant Argonautes [156], and is 
able to cleave target mRNAs in cases of perfect complementarity. However, only one 
human miRNA, miR-196, is known to possess perfect target recognition and direct 
mRNA cleavage [157]. The overwhelming majority of human miRNAs utilize imperfect 
complementarity with their target mRNAs, and utilize the repression mechanisms 
described above. However, perfect complementarity with nucleotides 2-7, termed the 
‘seed’ region, is considered crucial for target site recognition [158]. These seed based 
  
Figure 1.7. The central region of the miRNA does not associate with human 
Argonaute2. The only nucleotides of the miRNA that provide no density in the crystal 
structure are positions 8-11. This region is suggested not to play a critical role in target 
site identification or stabilizing the interaction between the miRNA and mRNA.  
(PDB: 4W5N) 
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target sites are frequently called canonical target sites. The requirement for seed pairing 
was discovered observationally based on the sequence of the of lin-4 and let-7 target 
sites, but the recent Ago2 crystal structures revealed the physical basis for this specificity 
[115, 117, 118, 155]. The PIWI domain interacts with the phosphate backbone of 
nucleotides 2-7 of the miRNA, and the nucleotide bases extend into a central cleft in the 
protein, adopting a helical conformation (Figure 1.5-1.7). In this particular structure 
[118], nucleotides 8-11 are not stably associated with the protein (Figure 1.7), 
presumably due to a constriction in the protein [115, 118]. This evidence, along with 
binding affinity experiments [159] and analysis of target sites from RNA-seq experiments 
[160], has the led to the suggestion that the central region does not play a substantial role 
in either target identification, functional repression, or stabilization between the miRNA 
and the target site [161].  
The PAZ domain (Figure 1.5,1.8, orange domain) contains a binding pocket that 
stabilizes the 3´ end of the miRNA primarily via hydrogen bonds with the phosphate 
backbone of the miRNA [118]. The nucleotide bases are highly disordered compared to 
those of the seed region, and as such do not necessarily play a substantial role in target 
site identification. However, in cases of perfect complementarity in the seed region, the 
3´ end of the miRNA is necessary to stabilize the interaction between the miRNA and 
target mRNA [161]. As such, target sites that possess only seed pairing typically do not 
lead to productive repression [161]. 
This evidence supports the current model of canonical miRNA target site 
identification (Figure 1.9). To summarize, the first nucleotide is most frequently a uracil, 
and does not play a substantial role in target recognition. Nucleotides 2-7 are termed the 
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seed region, which is the critical region for targeting specificity. The central region may 
not play a substantial role in target identification or stabilization based on previous 
reports, while the 3´ end stabilizes canonical target interactions. This model is frequently 
used to bioinformatically predict miRNA targets (see below), and such predictions are 
widely utilized by the field to identify potential targets for miRNAs of interest.  
Bioinformatic predictions have been instrumental in discovering the targets of 
miRNAs in different cellular contexts, yet their widespread use biases the discovery 
toward targets that utilize canonical sites. As such, non-canonical targets, defined as 
  
Figure 1.8. The 3´ end of miRNA is stabilized by the PAZ domain. The 3´ end of 
the miRNA is stabilized by the PAZ domain (orange).  The nucleotides in this region 
extend outward from the protein in different directions, and are suggested to not play a 
role in target identification.  However, these nucleotides are crucial for stabilizing the 
interaction between the miRNA and mRNA, as seed targets alone typically do not 
grant functional repression. (PDB: 4W5N) 
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those that do not utilize perfect seed pairing, are relatively rare in the literature, in 
practice much more difficult to identify. Yet there is a substantial body of evidence that 
suggests non-canonical targeting is widespread, and may even be more prevalent than 
canonical targeting. This prevalence was evident early in the field; the first experiments 
that identified target sites for lin-4 and let-7 reported substantial non-canonical targeting 
[53, 162, 163]. Importantly, the lin-4 and let-7 targets were identified using genetic 
approaches that are not as frequent in more complex metazoans. As such, the 
overwhelming majority of experimentally validated interactions in vertebrates utilize 
canonical target sites. However, the emergence of high-throughput sequencing 
technologies has facilitated the discovery of miRNA targets in a more unbiased manner 
(see below sections for descriptions of these approaches). Estimates vary, yet most 
reports suggest that non-canonical target sites may account for 25-60% of all functional 
  
Figure 1.9. A model for miRNA target identification. This model describes the 
current mechanism of target identification, and is based on the structural, biochemical, 
and conservation data (see text). The 5´ nucleotide of the miRNA is most frequently a 
uracil, is thought to play no substantial role in target recognition. The seed region 
(nucleotides 2-7) is thought to be critical to target site identification, and strict base 
pairing in the seed is the most frequently utilized indicator of canonical target sites. 
The central region is proposed to play no substantial role in the interaction, while the 
3´end stabilizes the interaction, allowing various mismatches and wobble base pairing. 
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target sites [164-167]. However, in contrast to seed based targeting, a conserved motif for 
non-canonical binding has not been identified. There is one notable exception to this, 
although this has only been corroborated with one miRNA [165]. Instead, evidence is 
beginning to emerge that individual miRNAs may utilize distinct features of target sites, 
suggesting surprising complexity of targeting mechanisms by otherwise similar miRNA 
molecules [168].  
While features of the target site are critical in initial miRNA recognition, there are 
additional factors that influence the accessibility of the target site to the RISC. Perhaps 
the most wide reaching, but least understood mechanism of avoiding (or enabling) 
miRNA targeting is alternative polyadenylation (APA). There are specific sequence 
elements within 3´UTRs that signal transcription termination, mRNA cleavage, and 
additional of the polyA tail [169]. APA occurs when 3´UTRs contain multiple such 
elements that are used either in different contexts or within the same cell [170]. General 
mechanisms governing the choice of polyA site remain elusive, apart from a few isolated 
examples [170]. However, the choice between polyA sites dictates the presence or 
absence of the cis-regulatory elements that influence the fate of the mRNA, such as 
miRNA target sites. Numerous studies have shown that APA is a pervasive feature of 
eukaryotic mRNAs [171, 172], and it is estimated that >60% of human mRNAs are 
subject to alternative polyadenylation [173]. Strong evidence suggests that avoiding 
miRNA targeting may be a major consequence of APA, and several specific examples 
have been documented [173-175]. In addition, global shortening of 3´UTRs has been 
suggested to be a key feature of proliferating cells, [176], and has been connected to 
oncogenic transformation [177, 178].  Interestingly, there is emerging evidence that 
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3´UTR shortening via APA can also activate functional repression by a miRNA, 
presumably by bringing the target site closer to the polyA tail [Blazie et al., unpublished]. 
In addition to APA, trans-acting factors also influence miRNA targeting. For 
example, functional repression can require cooperative repression by multiple miRNAs 
on the same 3´UTR [179], typically within 30-40 nucleotides of each other [160]. RNA-
binding proteins can also compete with the RISC for miRNA target site occupancy, 
preventing repression by a miRNA [180]. These examples illustrate that even given a 
likely miRNA target site based on sequence, multiple factors influence whether a target 
site actually leads to productive repression. Therefore, experimental validation of 
functional miRNA targeting is an important step in characterizing the biochemical 
function of a miRNA. There are a variety of methods that can validate direct miRNA 
targeting, each with their own strengths and inherent limitations. The next section 
discusses several widely used techniques, and place emphasis on high-throughput 
methods analogous to the techniques developed in this thesis. 
 
Methods to identify and validate miRNA targets 
In contrast to proteins, miRNAs have no catalytic ability on their own. Instead, 
they rely on the RISC to repress the translation of specific target genes. Thus, miRNA 
target identification is a critical component of understanding the function of a miRNA. 
Because miRNA target site recognition is guided by antisense complementarity, 
identifying putative miRNA target sites bioinformatically is relatively straightforward. As 
such, shortly after the discovery of human miRNAs, multiple groups developed 
algorithms that could predict functional binding sites throughout the genomes of many 
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species [158, 181-184]. At their core, all these algorithms search for sequences with 
sufficient complementarity to each miRNA of interest, typically using Watson-Crick and 
G:U wobble base pairing [185]. Many algorithms place emphasis on perfect 
complementarity in the seed region [158, 181, 183], while some utilize thermodynamic 
measurements of the entire mRNA/miRNA interaction [186]. Without further filtering, 
most algorithms predict thousands of putative target genes for each miRNA, due to the 
small size and degenerate nature of target sites. To refine these predictions to only high-
confidence targets, algorithms frequently utilize additional features of target sites such as 
conservation, free energy, features of the surrounding context, and target site accessibility 
[187]. Site conservation is the most relevant of these features for the research presented 
in this thesis, and is briefly described below.  
Conservation refers to the presence of a specific target site within multiple 
species. This relies on the assumption that evolutionary pressure will maintain functional 
target sites, while non-functional targets will be lost to genetic drift. Because the 
phylogenetic relationship of the species being compared will impact conservation 
measurements, it is common to calculate multiple conservation scores based on the 
miRNA and species of interest. For example, predictions in C. elegans frequently use 
either three or five nematode species for comparison [188]. For human predictions it is 
common to calculate conservation within specific clades, such as mammals or 
vertebrates, as specific miRNAs may be relevant only to a subgroup of species [189]. 
Using conservation drastically reduces the number of predicted targets to those that are 
maintained across evolutionary time, and presumably, those that are evolutionarily 
important. However, this filter will remove species-specific targets as well as those that 
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recently emerged in evolutionary history, which is problematic due to substantial 
evidence that many non-conserved target sites are indeed functional [190]. Using 
conservation filters is also complicated by the generally poor conservation of 3´UTRs 
relative to coding sequences, even among closely related species [191, 192]. As such, 
some algorithms allow the user to choose what level of conservation best fits their needs 
[193]. 
Strikingly, there is generally little overlap in the predictions between the now 
dozens of miRNA target prediction algorithms [194]. This is presumably due to the wide 
range of potential factors that influence miRNA targeting, and the relative weighting of 
each criteria in each algorithm. It is controversial whether quantifying error rates for 
these algorithms is appropriate, especially because miRNA targeting is often dependent 
on the cellular context, and which ‘unbiased’ experimental technique is used for 
comparison will certainly affect the calculation of error rates. Furthermore, the literature 
is certainly biased by the widespread use of specific algorithms (i.e. TargetScan [193]). 
Despite the biases, the analysis of the predictive performance of several of the most 
prominent algorithms estimates  ~50-60% false negative [124, 166, 195] and false 
positive rates [126, 165]. It is difficult to precisely account for high false positive rates, 
but context specific factors, such as cooperative miRNA function, alternative 
polyadenylation, or trans-acting competitors certainly contribute. Conversely, the high 
false negative rates may largely be due to non-canonical targets, which recent evidence 
suggests may be widespread [165, 166, 196-201]. These algorithms are indispensible 
tools for candidate gene approaches to initially identify putative miRNA targets, yet the 
high error rates require experimental validation on a gene-by-gene basis. Furthermore, 
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because miRNAs are predicted to target such a large portion of the transcriptome, 
systematic high-throughput target detection holds much promise, yet remains a major 
challenge in the field. 
The emergence of technologies to probe the transcriptome and proteome has 
facilitated the unbiased, high-throughput discovery of miRNA targets. Generally, these 
methods rely on overexpression or inhibition of a miRNA of interest, followed by 
transcriptome sequencing or quantitative proteomics. These experiments have been useful 
in characterizing the repression strength of different kinds of target sites [126], and 
quantifying the relative contribution of translational repression and mRNA decay during 
miRNA targeting [57]. However, difficulties in analyzing such data have complicated 
specific conclusions drawn using such approaches, and some controversy remains [202]. 
One highly specific method to identify miRNA target sites combines the cross-
linking and immunoprecipitation of an Argonaute protein with next generation 
sequencing (AGO-HITS-CLIP). By sequencing the mRNA population bound to 
Argonaute, it is possible to map the sequence footprints occupied by the RISC to specific 
genes [203]. However, AGO-HITS-CLIP only detects binding of the miRNA to the 
target, and does not measure the functional impact of miRNA targeting on the level of 
protein synthesis. It is currently unclear if stable binding by the RISC necessarily leads to 
functional repression measured at the protein level, especially given the multiple 
mechanisms by which the RISC represses target mRNAs.  
One major caveat of AGO-HITS-CLIP is that it does not provide information 
about which miRNA led the RISC to the target site, which is instead predicted based on 
the miRNA expression profile of the context of interest [204]. To overcome this, a recent 
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adaption of AGO-HITS-CLIP adds a ligation step, which produces a miRNA/mRNA 
chimera that definitively connects the miRNA with the target [168, 205-207]. This 
method, called CLASH (cross-linking and sequencing of hybrids) has yielded several 
interesting findings that highlight the complexity of miRNA targeting principles. First, 
the majority of miRNA targets identified with these methods are non-canonical, utilizing 
imperfect seed pairing [168, 206]. Second, different miRNAs seem to recognize distinct 
features of target sites, including preferentially utilizing different nucleotides for target 
interactions [168]. And lastly, highly similar miRNA family members, which differ by 
only one or two non-seed nucleotides, seem to target non-overlapping sets of genes (see 
below for discussion about miRNA families) [168]. While these findings are incredibly 
intriguing, the efficiency of the ligation step is typically <1%, and even with high-
throughput sequencing the number of total chimeric reads available for analysis is low. In 
addition, the lack of a functional measure of repression limits the conclusions drawn from 
these approaches, and it is unclear if these findings will be corroborated using functional 
methods of miRNA target identification.  
While high-throughput approaches inform general trends on miRNA function, an 
important goal of many miRNA studies is the experimental validation of targets for the 
miRNA of interest. Early experiments validated target sites by Northern and Western 
blotting for the mRNA and protein of interest, respectively, and concluded that the 
protein is the functionally relevant molecule to measure miRNA repression [29]. As such, 
Western blots are widely used to measure changes in the protein level of endogenous 
genes. However, Western blotting requires an antibody for the protein of interest, is semi-
quantitative at best, and is difficult to perform at a scale conducive to the discovery of 
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networks of target genes. Reporter constructs overcome many of these issues, by fusing 
the 3´UTR of interest to a gene product that is easily quantifiable. While several different 
kinds of reporters have been used (fluorescent proteins, beta-galactosidase, etc.), the most 
widely utilized reporter is the luciferase gene from the firefly Photinus pyralis. 
Luciferase reporters were originally developed to test transcriptional activity [208, 209], 
but were quickly adapted for use in post-transcriptional studies [210]. The luciferase 
protein produces bioluminescent light in favorable pH conditions when a specific 
substrate (luciferin) is present. Importantly, luciferase does not require light excitation, so 
there is little background noise, allowing for highly sensitive quantification of protein 
levels [211]. This system has been adapted for use in cell lysates, live cell imaging, and 
even live whole-animal imaging [212].  
As applied to miRNAs, luciferase assays allow researchers to test the functional 
output of the interaction between a miRNA and 3´UTR of interest. Furthermore, 
mutagenesis experiments can reveal the exact site in the 3´UTR that is responsible for 
this interaction. Thus, luciferase assays are the most commonly utilized technique to 
validate direct targeting of individual target sites in a 3´UTR of interest. However 
powerful, this technique requires the generation of reporter constructs, and consumable 
reagents are typically costly. While luciferase assays are the gold standard method to 
validate individual miRNA targets, these limitations prevent the use of luciferase assays 
for high-throughput target discovery. 
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The function of miRNAs in metazoan development  
The miRNAs lin-4 and let-7 were first discovered as key regulators of 
developmental timing in C. elegans, where they were expressed late in larval 
development. When let-7 was found to be deeply conserved in metazoans, researchers 
also observed conservation of the expression pattern of let-7 in the late development of 
diverse species such as fly, zebrafish, and human [34]. The conservation of both sequence 
and expression implied that let-7 was a key regulator of development across the metazoan 
kingdom. Today, miRNAs are known to play key roles in the development of tissues in 
nearly all metazoans investigated to date. The body of literature on miRNAs in metazoan 
development is substantial, so this section will focus on the miRNAs that are relevant to 
the research presented in this thesis. 
Knockouts of individual components of the miRNA biogenesis machinery 
(Drosha, Pasha, and Dicer) result in embryonic lethality in mice, consistent with the 
pleiotropic function of miRNAs during development [213-215]. Tissue specific 
knockouts of these genes also frequently result in deficits in viability and differentiation 
[216, 217]. Knockouts of individual Argonaute proteins typically have few phenotypic 
effects, suggesting functional overlap [119]. However, combinatorial knockouts of 
Argonautes in C. elegans and mice are typically not viable [132, 218]. 
Given that disruption of the miRNA biogenesis machinery is so penetrant, and 
that lin-4 and let-7 deletion exhibit such striking developmental defects, it was originally 
assumed that the roles of individual miRNAs could be explored via genetic disruption 
[219]. Early efforts to systematically delete all miRNAs in the C. elegans genome 
revealed surprisingly that of the 89 miRNAs deleted, only four had obvious phenotypic 
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consequences [220]. A recent report that assessed the phenotypic effects of 130 
Drosophila miRNA knockouts found at least one phenotypic abnormality in 80% of the 
mutants [221]. However, the phenotypes were typically subtle, and not comparable to the 
severe phenotypes frequently obtained with knockouts of protein coding genes [222]. 
These observations also hold true in vertebrates [223]. This trend has complicated the 
study of many individual miRNAs, yet may be suggestive of the bona fide biological 
function of miRNAs in general. It has been suggested that miRNAs may function to 
provide robustness to regulatory networks by reinforcing transcriptional programs [224]. 
In this view, the phenotypic consequences of miRNA knockout should be more obvious 
in stressful environmental conditions or variable genetic backgrounds. There are several 
examples of this in worms [225] and mice [226]. In addition, many miRNAs exist in 
multiple copies throughout the genomes of metazoans, and this is especially true in 
vertebrates [59]. Thus, analogous to the redundancy in Argonaute proteins, members of 
miRNA families may need to be deleted simultaneously to see a striking phenotypic 
effect.  
Despite these difficulties, there is a growing body of literature that describes the 
phenotypic consequences of individual miRNAs in development. There are several 
studies worthy of emphasis that discuss the miRNAs that are relevant to the content of 
this thesis. First, the let-7 miRNAs are deeply conserved, and generally function 
simultaneously to promote differentiation while inhibiting cell proliferation [227]. While 
let-7 mutants have obvious phenotypic in C. elegans that results from abnormal cell 
proliferation, let-7 is more difficult to study in vertebrates because it has undergone 
several duplications in the genomes of higher metazoans [228]. Assigning specific 
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functions to each family member has been challenging, yet some general trends have 
emerged. Several of the interactions between let-7 and the heterochronic genes in C. 
elegans (lin-41, lin-28, let-60) are conserved in humans (Trim71, Lin-28, RAS) [229] and 
Drosophila [230] . Similar to worms, mature let-7 is expressed in differentiating tissues 
in vertebrates, but typically not in stem or progenitor cells [231]. This expression profile 
is achieved largely by post-transcriptional blockage of let-7 processing by Lin-28 [232]. 
However, examples of specific developmental processes regulated by let-7 are generally 
lacking outside of C. elegans [229].  
Let-7 frequently occurs in clusters with miR-125, and miR-99/miR-100 in the 
genomes of higher metazoans.  Mir-125 is homologous to lin-4 in C. elegans, and exists 
in three copies in mammalian genomes. While lin-4 and let-7 function cooperatively in 
heterochronic pathway in worms, they are not clustered in the worm genome, and the 
genomic rearrangement that led to the formation of let-7/miR-125 clusters occurred in the 
last common ancestor of arthropods and vertebrates [233]. miR-125 functions in 
developmental timing in Drosophila and mouse, and knockouts have reduced survival 
[221]. Similar to let-7, miR-125 is a positive regulator of neural stem cell differentiation 
[234] and hematopoiesis [235]. 
Relatively little is known about the miR-99/miR-100 family in development, with 
the exception of a few examples. Worms have several copies of miR-99/miR-100 (miR-
51-56), and while deletions of individual members of the family have no phenotypic 
effect, deletion of all six is lethal [236]. In mouse, the miR-99a/let-7c cluster plays a role 
in wound healing [237], and cardiomyogenesis via regulation of chromatin modifiers 
[238]. 
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Interestingly, the miR-99 family also includes a group of miRNAs that differ in 
sequence from miR-99 primarily by a single nucleotide insertion in the seed region. This 
family of miRNAs, called miR-10, is expressed from the Hox clusters in most species, 
and has undergone genomic duplications in vertebrates [239]. Interestingly, the first 
identified targets of miR-10 were Hox genes [240], and subsequent studies found 
additional miR-10 targets in the Hox clusters of diverse species [241-243]. Surprisingly, 
the miR-10/miR-99 family has also been suggested to play a role in ribosome biogenesis 
by enhancing the translation of ribosomal proteins by binding to the 5´UTR of ribosomal 
mRNAs [244].  
While each of these miRNAs has received some attention in the context of 
development, the vast majority of targets of these miRNAs have been described in the 
context of cancer. Below is a review the discovery of miRNAs in cancer, and the function 
of these specific miRNA families in the course of tumorigenesis.  
 
miRNAs are powerful regulators of tumorigenesis 
There are intriguing connections between the genetic pathways that control early 
development, and those that are frequently mutated in cancer [245]. In this light, perhaps 
it is not surprising that miRNAs are frequently misexpressed in cancer, and in many cases 
play a causal role [246]. Similar to the discovery of miRNAs in C. elegans, genetic 
evidence revealed the first miRNAs that play a role in tumorigenesis. Chronic 
lymphocytic leukemia is the most common form of adult leukemia, and the majority of 
cases contain a specific deletion on chromosome 13 [247]. All of the known protein 
coding genes in the region were tested for potential tumor suppressive capabilities, but 
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none of them demonstrated consistent involvement in the initiation or progression of the 
disease [248]. The initial discovery of multiple human miRNAs revealed a miRNA 
cluster in this region [30], and these miRNAs, miR-15/16, were subsequently found to be 
the tumor suppressors in question [65]. The predominant role these miRNAs played in 
the pathogenesis of the disease was highlighted over subsequent years by the 
identification of dozens of direct targets which cooperatively function to control 
proliferation and apoptosis [249]. 
		
Figure 1.10. MiRNAs play a role in tumorigenesis. High-throughput sequencing 
approaches greatly facilitate the identification of miRNAs in various biological contexts. 
In the case of cancers, miRNAs have been found to be misexpressed in nearly every 
tumor type investigated to date.  They also play specific roles in each of the classic 
hallmarks of cancer based on the genes they target.  Listed are examples of specific 
miRNAs that function either as tumor suppressors (red) or oncomiRs (green), based 
largely on the genes they target. (Adapted from [250]) 
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This discovery thrust miRNAs into the realm of human health, where they have 
been prominent residents ever since. Now miRNAs are known to play direct roles in 
nearly every aspect of tumorigenesis, where they can function either as tumor suppressors 
or oncogenes, based solely on the mRNAs that they regulate (Figure 1.10) [250, 251]. As 
such, the discovery of targets of misexpressed miRNAs is of critical importance to 
understand the role these miRNAs play in cancer initiation, progression, and metastasis 
[252].  
As a regulator of differentiation during development, let-7 is also potent tumor 
suppressor, largely by regulating multiple genes in the cell-cycle and RAS signaling 
pathways [253]. let-7 family members are frequently deleted or down-regulated in 
cancers of diverse origin, and let-7 loss correlates with poor survival outcomes [254-256]. 
As one of the clearest examples of a miRNA with potent tumor suppressive capabilities, 
let-7 has been the focus of intense research, especially in the realm of miRNA-based 
therapeutics [257, 258]. Because reintroduction of let-7 into tumor cells drastically 
reduces tumor growth, let-7 based therapeutics are currently in development for a variety 
of solid tumors [259]. In addition, miR-34, which is a transcriptional target of p53 [260] 
and is epigenetically silenced in many tumors [261], is currently in phase-II clinical trials 
[262]. However, delivery is a major challenge of miRNA-based therapeutics, and 
significant efforts are being made to chemically modify the backbone of the miRNA for 
improved stability, uptake, and targeted delivery [263]. 
The miRNAs that are clustered with let-7 family members, miR-99/miR-100 and 
miR-125, are also implicated in tumorigenesis. miR-99/miR-100 function as tumor 
suppressors in breast tumors [264], glioblastoma [265], and endometrial carcinomas 
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[266], by directly targeting the oncogenes mTOR and FGFR [267, 268]. Interestingly, 
while miR-125 also is frequently misexpressed in multiple tumor types, its net effect on 
tumorigenesis seems to be context dependent [269]. For example, mir-125 behaves as an 
oncomiR in multiple leukemia subtypes [270, 271], yet acts as a tumor suppressor in 
breast tumorigenesis [272]. This context dependent effect highlights a key aspect of 
miRNA biology: the function of a miRNA depends solely on the target genes that it 
regulates.  
 
The deep conservation of miRNAs and miRNA processing machinery 
 In evolutionary biology, the conservation of a gene across evolutionary time 
provides evidence of the importance of that gene to an organism’s survival and 
reproduction. The discovery of the deep conservation of let-7 established the miRNA 
field in a wide range of organisms, and initiated the exploration into the evolutionary 
origin of these small RNAs. It is now appreciated that miRNAs have a unique 
evolutionary history that reveals much about the emergence of complex life forms, both 
plant and animal. Below is a brief review of this fascinating topic as it pertains to the 
research presented in this thesis.  
The miRNA processing machinery is conserved between plants and animals, 
suggesting that post-transcriptional gene regulation is an ancient mechanism, established 
prior to the emergence of multicellular life. Argonaute proteins have multiple 
homologues in both bacteria and archaea [273], while Dicer emerged later in the last 
common ancestor of plants and animals [274]. While plant and animal miRNAs are often 
deeply conserved within these groups, there are no identifiable common miRNAs 
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between them [87]. This suggests that the shared miRNA processing machinery preceded 
the emergence of genomically encoded miRNAs, and supports the hypothesis that 
miRNAs were born of an RNAi-like mechanism that initially existed to silence foreign 
genetic elements. The differences in miRNA biogenesis and targeting between plants and 
animals further support this hypothesis. Plant miRNA biogenesis is performed mostly by 
Dicer, not Drosha, as is the case with siRNAs in animals [275]. Plant miRNAs also 
typically target genes via perfectly complementarity, leading to cleavage of the target 
mRNA by Argonaute [276], which is more similar to siRNAs than animal miRNAs. The 
high degree of complementarity along the entirety of the miRNA aids bioinformatic 
target prediction in plants, and has been highly effective compared to animal predictions 
[277]. Furthermore, the extensive base pairing required in plant miRNAs make it less 
likely that targets will evolve de novo, and therefore plant miRNAs are predicted to target 
10-fold fewer mRNAs than animals [161].  
MiRNAs are often deeply conserved in animals, and as the transcriptomes of non-
model organisms began to be explored, an interesting trend emerged: the number of 
genomic miRNAs correlates with organismal complexity [278-281]. Furthermore, the 
emergence of novel miRNAs tends to fall at major evolutionary transitions, providing 
anecdotal evidence that miRNAs may contribute directly to evolving organismal 
complexity. For example, there are major miRNA expansions at the base of the 
bilaterians [282, 283] and vertebrates [284]. Intriguingly, evidence suggests that once a 
miRNA is established in a particular lineage, it is rarely lost [279], suggesting that 
miRNAs are an evolutionarily potent class of genes. Novel miRNAs emerge from two 
sources; de novo evolution of a miRNA-like gene, or duplication of existing miRNAs. 
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Both sources substantially contribute to these evolutionary expansions, yet each has 
unique features and evolutionary relevance. 
Conceptually, the functional consequence of de novo miRNA evolution is 
straightforward. These miRNAs have no homologues in the genome, and thus possess a 
unique sequence, establishing the post-transcriptional regulation of a novel set of target 
genes. However, de novo evolution requires the defining features of miRNAs to form 
anew. These features include elements important for transcription such as a promoter, 
enhancers to drive tissue specific expression, and polyadenylation sequence elements. 
Furthermore, to enter into the miRNA processing pathway the novel transcript must 
possess the hairpin loop structure, as well as the sequence elements that are recognized 
by the microprocessor. There are many transcripts that contain secondary hairpin 
structure, yet relatively few are processed as miRNAs, so it has been suggested that 
evolution of the sequence elements recognized by Drosha is a rate-limiting step in the 
evolution of novel miRNAs [285]. Perhaps not surprisingly, most recently emerged 
miRNAs are either weakly transcribed or not efficiently processed, due to the 
simultaneous requirement of these multiple factors [286]. Furthermore, it is unlikely by 
chance alone that novel miRNAs will target a gene in a specific context that has a 
beneficial effect on the fitness of the organism. Therefore, while the emergence of de 
novo miRNAs is a common feature of miRNA expansions, their direct functional 
relevance to the evolution of complexity is not always clear. 
The second source of a novel miRNA is the duplication of an existing miRNA, in 
many cases from whole genome duplication events [278, 284, 287]. Gene duplication 
typically results in one of two outcomes; either one or both genes gain new function 
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through mutation and are maintained, or one copy is lost due to a lack of selective 
pressure to maintain two redundant genes. In the overwhelming majority of protein 
coding gene duplications, one copy is typically lost due to genetic drift [288].  Thus, 
these genes do not tend to accumulate over evolutionary time, despite many whole 
genome duplication events [288]. However, miRNAs do not follow this trend, as the 
numbers of miRNAs in genomes seems to correlate directly with whole genome 
duplications [284].  
In contrast to miRNAs evolved de novo, duplicated miRNAs may already possess 
the structural and sequence elements required for efficient transcription and processing, 
and as such are typically highly expressed compared to species specific miRNAs [286]. 
However, these duplicated miRNAs frequently mutate at individual positions in the 
mature miRNA, creating families of miRNAs with highly similar, albeit subtly different, 
sequences. The ensuing question is, why do duplicated miRNAs frequently persist, while 
duplicated protein-coding genes typically do not? The evolutionary advantage of 
maintaining multiple copies of highly similar miRNAs is not entirely clear. It has been 
suggested that paralogous miRNAs add robustness to regulatory networks, fortifying 
transcriptional programs and protecting against aberrant transcription [224]. There is 
ample evidence for this, especially from the miRNA knockout experiments discussed 
above. Owing to their sequence similarity, it is commonly assumed that miRNA family 
members target largely, if not completely, overlapping sets of genes [183]. However, the 
extent to which this is true has not been systematically tested, and it is unclear what effect 
sequence evolution in miRNA families has on gene targeting. This question has clear 
relevance for our basic understanding of the role of miRNAs in the evolution of complex 
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life forms. Furthermore, as miRNAs are continuously found misexpressed in a variety of 
diseases, any functional differences between miRNA family members may have 
implications for disease treatment and patient outcome. 
 
Hypothesis and Specific Aims 
 MiRNAs have a powerful impact on cell fate, yet despite intense research efforts, 
there are still substantial questions about the functional targets of miRNAs. First, given 
the rapid expansion of animal miRNAs, how does evolutionary pressure on processing 
and targeting shape evolutionary patterns of animal miRNAs? Second, each miRNA is 
predicted to target hundreds to thousands of mRNAs, yet the vast majority of these 
interactions have not been tested. What insights into miRNA function can be gained with 
novel approaches to identify miRNA targets? And third, is there functional distinction 
between highly similar miRNA family members?  
I hypothesize that miRNA family members have distinct functions in humans. To 
test this idea, we have combined a comprehensive analysis of metazoan miRNA 
evolution, a novel miRNA target screening platform, and diverse experimental and 
bioinformatic approaches. Each of these questions and techniques are addressed in the 
specific aims of this thesis, outlined below. 
 
Aim #1: Explore signatures of metazoan miRNA evolution that are influenced miRNA 
processing and targeting (Chapter 2) 
 The first aim utilizes the wealth of information about miRNAs in the genomes of 
diverse animal species to explore evolutionary signatures in conserved miRNA families. 
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We performed a comprehensive analysis of sequence evolution in 62 of the most deeply 
conserved miRNA families, revealing evolutionary demonstrating p10-11  hotspots and 
functional signatures that reflect miRNA processing and targeting principles. This data 
suggests selective pressure for the emergence of miRNA sequence changes, and provides 
a conceptual foundation from which to experimentally test the function of human miRNA 
family members. 
  
Aim #2: Develop and implement a novel assay to identify functional human miRNA 
targets in high-throughput (Chapters 3 and 4) 
 A major challenge in the miRNA field is the identification of functional target 
sites. The goal of this aim is to develop and implement a novel assay designed to 
systematically test thousands of functional miRNA target interactions at a scale not 
possible with current methodologies. This is applied using two deeply conserved and 
cancer relevant human miRNAs, and identifies hundreds of previously uncharacterized 
regulatory interactions. This screen also revealed that miRNA targets tend to function 
cooperatively within regulatory networks, that each miRNA preferentially recognizes 
distinct features of target sites, and that context is a critical factor in determining the 
functionality of a miRNA target. 
 
Aim #3: Systematically examine the targeting specificity and expression profiles of highly 
similar miRNA family members (Chapter 5) 
 The distinct functions of highly similar miRNA family members is unclear, yet 
has significant relevance to metazoan evolution and development, and human disease. In 
45 
this aim we apply a combination of approaches to assess the targeting specificity of 
miRNA family members, and explore the expression of these miRNAs in the context of 
embryogenesis, normal adult tissues, and tumor cell lines. Together with the previous two 
aims, the data presented in this thesis informs a model for the function of miRNA 
duplications, in which processing constraints direct evolutionary hotspots, leading to 
specific targeting preferences, and the emergence of novel tissue specific expression 
patterns.  
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CHAPTER 2 
EXPLORATION OF THE EXPANSION OF  
METAZOAN MICRORNAS REVEALS  
EVOLUTIONARY HOTSPOTS 
Publication Note 
The research reported in this chapter is in press in Genome Research by Justin M. 
Wolter, Hoai Huang Thi Le, Alexander Linse, Victoria A. Godlove, Thuy-Duyen 
Nguyen, Kasuen Kotagama, Alissa Lynch, Alan Rawls, and Marco Mangone. 
Evolutionary Principles of Metazoan microRNAs Reveal Targeting Principles in the 
Human let-7 and miR-10 families. Genome Research. 2016 (in press). All co-authors 
have granted permission for this work to be included in this dissertation. 
 
Overview  
MicroRNAs (miRNAs) are ~22 nucleotide non-coding RNAs that regulate a 
multitude of biological processes in metazoans, and have been implicated in various 
diseases. MiRNAs recognize target elements primarily in 3´UTRs of mRNA, by Watson-
Crick and G:U wobble pairing. These elements are short, degenerate, and are driven 
largely by perfect complementarity in nucleotides 2-7 of the miRNA, which is termed the 
‘seed’ region [289]. However, the presence of a perfect seed does not always confer 
regulation by complementary miRNAs [160, 167], and there are several alternative 
modes of miRNA target recognition that do not utilize canonical seed pairing [53, 162, 
163, 165, 167, 200, 201, 290, 291]. The result of miRNA targeting is typically a modest 
reduction in protein output for a given mRNA [126] by deadenylation and subsequent 
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degradation of the mRNA transcript [58]. However, translation inhibition without a 
reduction of mRNA levels is frequently observed [56, 57].  
MiRNAs have undergone several pronounced expansions in metazoan genomes 
[59, 278]. These expansions coincide with evolving organismal complexity, yet seldom 
correspond with increases in the number of protein coding genes [59]. While expansions 
are driven in part by the de novo evolution of novel miRNAs, the majority arise from 
duplications of existing miRNAs. These miRNAs are rarely lost following duplication 
events, suggesting selective pressure to acquire and maintain new miRNAs [292]. 
Following duplication, the primary sequence of miRNAs frequently evolves at positions 
outside the seed region, creating families of miRNAs that have distinct sequence 
variations. The advantage of the expanded miRNA repertoire of higher metazoans is 
unclear, but it has been suggested that copies of highly similar miRNAs provide 
robustness to gene regulatory networks [224]. This has led to the assumption that miRNA 
family members target largely, if not completely, overlapping gene sets. However, the 
extent to which nucleotide changes impart novel targeting specificity to miRNA family 
members has not been systematically studied, and it is unclear what unique functions, if 
any, individual miRNA family members possess.  
We hypothesize that aspects of miRNA biogenesis, processing, and targeting 
shape patterns of miRNA evolution. To test this idea, we perform a comprehensive 
analysis of sequence evolution in 62 deeply conserved metazoan miRNA families. 
Specifically, we explore patterns of miRNA expansions, when in the phylogenetic tree 
sequence changes occur, and how sequence changes effect the secondary structure of 
miRNA duplexes. We find that expansions of these deeply conserved miRNA families 
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frequently occurs at phylogenetic boundaries that correlate with increases in organismal 
complexity. These miRNA duplication events are almost invariantly followed by changes 
in the sequence of at least one member of the miRNA family, and it is rare that sequence 
 
miRNA Family 
Number of 
metazoan miRNA 
family members 
miR-183-5p 40 
miR-184-3p 70 
miR-19-3p 76 
miR-193-3p 62 
miR-194-5p 37 
miR-196-5p 65 
miR-199-5p 31 
miR-20-5p 58 
mir-200-3p 84 
mir-203-3p 29 
mir-205-5p 39 
mir-208-3p 27 
miR-21-5p 36 
mir-210-3p 56 
mir-212-3p 15 
mir-216-5p 59 
mir-219-5p 72 
miR-22-3p 49 
mir-222-3p 35 
miR-23-3p 72 
miR-25-3p 30 
miR-26-5p 56 
miR-27-3p 76 
miR-29-3p 117 
mir-301-3p 47 
miR-31-5p 75 
mir-329-3p 15 
miR-33-5p 56 
miR-34-5p 115 
miR-92-3p 151 
mir-99-5p 44 
 
Table 2.1. Number of deeply conserved metazoan miRNAs 
 
miRNA Family 
Number of 
metazoan miRNA 
family members 
let-7-5p 298 
miR-1-3p 99 
miR-10-5p 127 
miR-100-5p 76 
miR-101-3p 46 
miR-103-3p 38 
miR-106-5p 41 
miR-107-3p 36 
miR-122-5p 29 
miR-124-3p 105 
miR-126-3p 32 
miR-1271-5p 11 
miR-128-3p 37 
miR-129-5p 38 
miR-130-3p 72 
miR-133-3p 112 
miR-135-5p 62 
miR-137-3p 56 
miR-139-5p 25 
miR-142-5p 29 
miR-146-5p 52 
miR-147-3p 27 
miR-148-3p 47 
miR-15-5p 79 
miR-152-3p 23 
miR-153-3p 50 
miR-155-5p 26 
miR-16-5p 55 
miR-17-5p 36 
miR-18-5p 59 
miR-181-5p 104 
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changes occur without duplication. Lastly, we find that these nucleotide changes reflect 
targeting specificity of the functional miRNA, and that the position of evolutionary 
hotspots is influenced by miRNA duplex secondary structure.  
 
 
 
Figure 2.1. microRNAs have expanded in the genomes of higher metazoans. We 
downloaded all metazoan pre- and mature miRNAs from miRbase, and filtered to 
maintain 62 deeply conserved miRNA families that contain at least one human 
homologue. Plotted are the raw numbers of pre-miRNAs in each species, with each 
colored bar representing a single miRNA family. Images represent the prominent 
model organism in each major phylogenetic grouping. Numbers on each image 
represent approximate number of protein coding genes, demonstrating that while the 
numbers of miRNAs have expanded, the number of protein coding genes is relatively 
constant. 
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Results 
MiRNAs have expanded in the genomes of higher metazoans 
We hypothesized that evolutionary patterns may reveal information about the 
function of miRNA family members in higher metazoans. To test this idea we analyzed 
the sequence of miRNAs belonging to 62 of the most deeply conserved miRNA families 
in 117 metazoan species (n=3,265 distinct miRNAs), with the sole criteria being that each 
family must possess at least one homologue in the human genome [293] (Table 2.1). The 
raw number of miRNAs showed that these families have undergone a drastic expansion 
 
 
 
Figure 2.2. The percentage of miRNAs that exist in multicopy families. miRNAs 
were grouped based on the number of members in each family, and normalized to the 
total number of highly conserved miRNAs in each species.  Data shows that the 
percentage of miRNAs that belong to multicopy families is >80% in the majority of 
vertebrate species.  
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at the base of the vertebrate lineage, and outside of freshwater teleosts miRNAs have not 
changed dramatically in number since the expansion (Figure 2.1). When correcting for 
the number of miRNAs per species, we observed that the number of miRNAs that exist in 
multi-copy families has increased ~4 fold in vertebrates, with 85% of deeply conserved 
human miRNAs belonging to families that contain at least two members (Figure 2.2). 
  
 
 
Figure 2.3. The expansion of 3´UTRs in higher metazoans. (A) The distribution of 
3´UTR lengths of all known protein coding genes in C. elegans (adapted from 
Mangone, et. al, 2010). (B) The distribution of 3´UTR lengths of all known protein 
coding genes in H. sapiens. (C) The median size of the all open reading frames (ORF) 
and 3´UTRs from C. elegans and H. sapiens. This data suggests that the size (base 
pairs) and number of protein coding genes in the genomes of these organisms has 
stayed the same, the number of miRNAs and the size of 3´UTRs has drastically 
expanded.  Together, this highlights the expanded potential of post-transcriptional 
gene regulation in higher metazoans.   
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Along with the whole genome expansions that led to the expansion of miRNA 
families, there is an increase in the size of the genomes of complex metazoans [294]. This 
expansion in genome size does not correlate with the number of protein coding genes 
(Figure 2.1), but instead correlates with the increased size of intergenic regions, introns, 
and other regulatory elements such as promoters [295]. As 3´UTRs are the predominant 
target sites in metazoan miRNAs, we wondered if 3´UTRs would show similar patterns 
between C. elegans and human. To test this, we extracted the size (base pairs) of all 
annotated protein coding genes and 3´UTRs from the C. elegans and human genomes 
(from [172, 296, 297]), and plotted them based on size distribution (Figure 2.3A-B). The 
distribution of 3´UTR size was very similar between C. elegans and human, however the 
median 3´UTR size was ~9 fold high in humans (Figure 2.3C). In comparison, we did not 
see an increase in size in the protein coding genes between C. elegans and human (Figure 
2.3C). This suggests that while the number and size of protein coding genes is relatively 
 
 
Figure 2.4. Arm preference and nucleotide content of miRNA duplexes. (A) In the 
62 miRNA familes we analyzed, we found no preference for which arm is selectively 
used for miRNA based mRNA targeting, suggested sequence or structural elements 
may be responsible for strand discrimination. (B) Nucleotide content of miRNA and 
miRNA* strands shows the expected complementarity between the two strands. 
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stable, the potential for post-transcriptional regulation of the genes is significantly 
expanded in higher metazoans via expansion of the regulators (miRNAs), and the amount 
of space available for regulation (3´UTRs). 
 
Patterns of sequence changes reveal position specific functional signatures 
We then looked at several features of the 62 deeply conserved miRNA families. 
Collectively, these families showed no bias towards either the 5p or 3p arms in 
determining which is selectively used for miRNA regulation (Figure 2.4A). The 
nucleotide content of each arm contained the expected complementarity between the 
 
Figure 2.5. Nucleotide preference by position miRNA and miRNA* strands. We 
measured the frequency of each nucleotide at each position of the miRNA (top) and 
miRNA* (bottom) strands (n=3,685 miRNA duplexes in62 families) Seed region is 
marked with grey box. The p1 displays a striking preference for uracil in the miRNA 
strand, and a depletion in the miRNA*. We also found urical is enriched in p9, and a 
general preference for G/U in the 3´ end of the miRNA strand.   
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miRNA and miRNA* strands (Figure 2.4B). When we looked at individual positions 
within the miRNA, we observed an enrichment of U residues in the first position in the 
miRNA strand, which is known to play a role in Argonaute incorporation [119] (Figure 
2.5, top). There is a preference for A residues in the 2nd position and U residues in the 9th 
position, as well as an overall enrichment of G/U nucleotides in the 3´ end. Conversely, 
the miRNA* strand showed no positional nucleotide bias beyond a depletion for U 
residues in the first position (Figure 2.5, bottom).  
Next, we explored if each position favored specific point mutations, reasoning 
that this measure would independently assess the biases in each position regardless of the 
 
 
Figure 2.6. Individual positions of the miRNA demonstrate distinct biases for 
specific nucleotide changes: We measured the specific mutation frequency of specific 
nucleotides from the conserved base in the family, toward either A/C or G/U. We 
observed that the majority of positions in the seed region prefer sequence changes 
towards A/C, while the 3´ end favors G/U. We hypothesize that these preferences may 
reflect specificity in the seed by not allowing G:U wobble pairing, and the function of 
the 3´end in stabilizing seed-based pairing by expanding the likelihood of base pairing 
via G:U wobbles. 
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identity of the conserved nucleotide. When we grouped nucleotide changes based on 
ability to form wobble base pairs (G/U, and A/C), we noticed that mutations towards A/C 
were generally favored in the seed region, neutral in the central region, and depleted in  
the 3´ end (Figure 2.6). To assess the tolerance of wobbles during miRNA repression, we 
tested the ability of human miR-10b to repress a minimal 3´UTR fused to a luciferase 
reporter (Figure 2.7). In agreement with the evolutionary trends (Figure 2.6), G:U wobble  
  
Figure 2.7. The tolerance of G:U wobble base pairing depends on position in the 
miRNA. To test our hypothesis on the effect of G:U wobble pairing in specific 
positions, we cloned various permutations of the miR-10a target site into the SV40 
3´UTR (top). Gold boxes mark wobble nucleotides tested. Each target was tested for 
repression by miR-10b in dual luciferase assay in HEK293T cells (bottom). 
Repression is measured as the change in relative luciferase ratio in response to 
miRNA cotransfection. Values normalized to a negative miRNA control (dashed 
line) (n=3). All error bars are S.E.M. unless otherwise noted. 
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Figure 2.8. miRNAs evolve at specific hotspots. Sequence logos for 10 
representative miRNA families from all metazoan species. Colored nucleotides 
represent highly variable positions across species (hotspots). Number of 
miRNAs in each family and the number of copies in the human genome are 
noted. Black bars represent the positions that are variable within the human 
families.  This analysis suggests that miRNA families evolve at specific hotspots 
that are highly conserved. 
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pairing had no impact at position 6 (p6), or in p18-20, but was not well tolerated in p7 
(Figure 2.7). Previous experiments found that wobble base pairing in the seed negatively 
impacts the affinity and translational repression between a miRNA and target mRNA 
[159, 298]. However, in neither of these experiments was p6 tested alone. Our results are 
consistent with the idea that specificity in the majority of the seed region via Watson-
Crick base pairing is a conserved feature of miRNA:mRNA interactions, but expands 
upon the details of positional specificity. Furthermore, wobble pairing in the 3´  
end of the miRNA may be advantageous by increasing the frequency of base pairing in 
canonical miRNA targets. Together, this data suggests that the positional biases along the 
length of the miRNA may impact miRNA processing and target sequence preference 
across these deeply conserved miRNA families. 
 
miRNA families evolve at specific hotspots  
Next, we investigated the position of sequence variation within miRNA families. 
Alignments of family members revealed conserved nucleotide changes at specific 
positions, which we refer to as evolutionary ‘hotspots’ (Figure 2.8). We observed that in 
humans, the majority of deeply conserved miRNAs belonging to multi-member families 
have experienced at least one nucleotide change, which are frequently conserved among 
metazoans (Figure 2.8, black bars). When we investigate where in the metazoan 
phylogeny these hotspots evolved, we find that in the absence of duplication events there 
is rarely sequence evolution (Figure 2.9-2.10). Conversely, duplications are almost 
invariably followed by the emergence of novel hotspots within miRNA families.  
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Combining the conservation scores of these miRNA families revealed that the 
evolutionary hotspots center on nucleotides 9-12 of the mature miRNA (Figure 2.11). 
Outside the seed, conservation is highest at positions 13-15, and decreases until the 3´ 
end of the miRNA (Figure 2.11). Conversely, the miRNA* strand is uniformly conserved 
at positions 1-8 and 13-18, and is poorly conserved in positions 9-13 (Figure 2.12). The 
mirrored conservation between the miRNA and miRNA* strands suggests that the 
secondary structure of the miRNA duplex may influence sequence evolution. To 
investigate this, we measured the frequency of mismatches, wobbles, and gaps between  
the miRNA and miRNA* strands (Figure 2.13), and observed a relatively low frequency 
of base pairing at the 5´ end of the miRNA duplex, and a high frequency at 3´ end of the  
 
 
Figure 2.9. miRNA duplications and sequence divergence are closely connected. 
We analyzed the number family members of let-7 (top) and miR-10b (bottom) in all 
metazoan species, and investigated where in the phylogeny sequence changes occur. 
Arrows and numbers specify the position(s) of nucleotide changes within the mature 
miRNA relative to the nearest species. The numbers represent changes unique to that 
species, not cumulative changes. Red bars denote species with sequence changes. This 
data suggests that sequence divergence is rare in the absence of miRNA duplications. 
Conversely, sequence almost invariantly follows miRNA duplications, suggested 
evolutionary pressure for novel sequence changes in duplicated miRNAs.   
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Figure 2.10. History of sequence evolution in several deeply conserved metazoan 
miRNA families. These families were chosen based of their use our experiments, or 
because of unique features. For example, miR-1 is unique in that there has been a 
duplication without sequence divergence, and miR-31 typically has more copies in 
insects than in vertebrates. Regardless of the differences, the general trend is that 
sequence divergence most frequently occurs following duplication, and without 
duplication sequence changes are rare.  The one consistent exception to this is the 
freshwater teleosts (zebrafish, catfish, and salmon). (arm=arm switching, ins=insertion, 
del=deletion, tand. dup.=tandem duplication). 
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miRNA (Figure 2.14A). We also observed a bias in the position of single nucleotide 
bulges in the 5´ end of the miRNA strand and the 3´ end of the miRNA* strand (Figure 
2.14B). These results highlight the asymmetry of the miRNA duplex, which plays a role 
in strand selection during Argonaute incorporation [114]. We also observed that p10-12 
are unpaired as frequently as p1-2. This data suggests that base pairing at specific 
positions is selectively conserved in the miRNA duplex, and that relaxed base pairing 
constraints may contribute to the high frequency of nucleotide changes observed in the 
central region of duplicated miRNAs. 
 
 
 
Figure 2.11. miRNAs evolve most rapidly in the central region. We calculated the 
conservation score (entropy) of each position in all 62 families, and combined them 
to reveal general trends in sequence evolution. Conservation score normalized to 
most conserved position (p3). This demonstrates that the seed is invariant in most 
miRNA families, and that the central region evolves relatively rapidly. 
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Discussion 
Evolutionary duplications may provide miRNA families with novel functions 
 The evolution of miRNAs has been explored in many contexts across the animal 
kingdom, and it is now well established that increases in the number of genomic miRNAs 
correlates with major evolutionary transitions, including at the base of the bilaterians 
[283] and vertebrates [278]. Strikingly, the acquisition of novel miRNAs is one of the 
 
 
Figure 2.12. Conservation of the miRNA and miRNA* duplex suggests 
constraints on secondary structure. Raw entropy scores were calculated  for the 
miRNA or miRNA* strands for 62 miRNA families, and averaged by position. The 
least conserved in both strands nucleotides are also those that have the lowest 
frequency of base pairing, or are overhangs left from dicer processing (the two 3´-
most nucleotides). The miRNA strand is most conserved in the seed region, and has 
drop in conservation in the central region.  Surprisingly, the miRNA* strand mirrors 
this pattern of conservation in the central region, while there is no increase in 
conservation in the seed region. This evidence suggests that the secondary structure of 
the miRNA duplex impacts conservation and sequence changes in the mature miRNA.   
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most prominent genomic events at the base of the vertebrate lineage [284], and we also 
find that miRNA families significantly grew at this transition. Together, this suggests that 
two evolutionary forces, de novo miRNA evolution and miRNA duplication events, both 
contribute to the large numbers of miRNAs observed in vertebrate genomes. We also 
observe an increase in the size of 3´UTRs in diverse animal species, connecting the 
expansion of miRNAs with an increase in the amount of sequence space available for 
them to target.    
 In our analysis of when in the phylogenic tree sequence changes emerge, we find 
that sequence evolution and miRNA duplications are closely linked. This provides 
evidence against the theory that the 
emergence of miRNA families 
function simply to provide robustness 
to transcription profiles. If this were 
the case, a duplication event alone 
would be sufficient, and no sequence 
changes would be required. While it is 
currently assumed that miRNA family 
members target largely overlapping 
sets of genes, our evidence suggests 
that sequence changes are not random, 
and may provide targeting specificity 
to highly similar miRNAs.   
 
Figure 2.13. Schematic of features 
analyzed within miRNA duplexes. 1: 
mismatched bases, 2: bulge in miRNA 
strand, 3: bulge in miRNA* strand. Species 
used in this analysis were C. elegans, D. 
melanogaster, S. purpuratus,  C. intestinalis, 
P. marinus, D. rerio, M. musculus, and H. 
sapiens.  Data represents 590 miRNAs from 
62 families.  
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Figure 2.14: Asymmetric base pairing is a conserved feature of miRNA 
duplexes. (A) Frequency of base pairing between miRNA/miRNA* strands miRNA 
duplex. We observe a high frequency of unpaired nucleotides at the 5´ position, and 
in the central unpaired first position is known to play a role in Argonaute strand 
selection. (B) Distribution of bulges along miRNA duplexes. Values represent mean 
frequency of bulge possession in 62 miRNA families. Asymmetry in bulges suggests 
helical structure may play a role in strand discrimination.  
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Evolutionary signatures of miRNAs suggest distinct function at specific positions 
In our analysis of miRNA evolution, we specifically focused on the deeply 
conserved miRNAs. We assumed that this pool would contain signatures that are 
maintained across evolutionary time, which enable efficient miRNA processing and 
effective targeting. By analyzing the identity of sequence changes in individual positions, 
we found that there is a trend away from G:U wobble pairing in the seed, and a trend 
toward G:U wobble pairing in the 3´end of the miRNA. This is in general agreement with 
the concept that the seed region provides specificity of targeting, while the 3´end 
functions primarily to stabilize the interaction. Our evolutionary analysis suggested that 
the sixth position alone may tolerate wobble pairing, and our targeting experiments 
confirmed this. Previous experiments had shown that wobble pairing in the seed was not 
tolerated, however, the sixth position was not specifically tested in these experiments.  As 
non-canonical targeting is frequent, yet poorly understood, our evidence from 
evolutionary and experimental approaches of a conserved, non-canonical targeting motif 
is certainly intriguing. However, it is important to test this non-canonical targeting motif 
in endogenous 3´UTRs and with multiple miRNAs. 
 
Evolutionary hotspots frequently occur in the central region of the miRNA 
Our study found that deeply conserved metazoan miRNAs evolve at specific 
hotspots. It interesting that these hotspots most frequently occur in positions 10-12, as 
there are conflicting reports as to whether this region plays a role in targeting. A 
prominent study relying on miRNA overexpression observed decreases in mRNA levels 
of target genes with strong seed pairing (7mer or 8mer), with p9-11 being the most 
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mismatched nucleotides in these targets [160]. This study also found that the nucleotides 
in 3´UTRs that align to the middle portion of the targeting miRNAs are poorly conserved 
[160], concluding that this poor conservation implies a lack of function. In vitro 
biochemical approaches converge on similar findings, suggesting p10-11 play a relatively 
minimal role in stabilizing the interaction between the miRNA and mRNA [159]. In 
addition, the recent crystal structures of human Argonaute2, complexed with a guide 
RNA and target, finds that the central nucleotides of the miRNA are disordered, and not 
stably associated with this Argonaute [118]. Taken together, this evidence suggests that 
the central region of the miRNA may not play a major role in modulating targeting 
specificity. 
In contrast, there are several pieces of evidence that suggest the central region is 
indeed functional. Complementarity at p10-11 is critical for the slicing activity of deeply 
conserved Argonaute proteins including Ago1 in budding yeast [155], Drosophila [299], 
and mouse and human AGO2 [300]. A recent study analyzing miRNA/mRNA chimeras 
found target motif preferences between miRNA families, with motifs spanning the 
entirety of the miRNA [168]. Given our findings indicating that the central region of the 
miRNA is under relaxed secondary structure constraints, we speculate that poor 
conservation in this region may be mirrored in target sites, and may not be an indication 
of a lack of function per se. Furthermore, the above studies do not directly detect changes 
in protein expression due to miRNA activity, which is the ultimate effect of productive 
miRNA targeting. Therefore, experiments that measure the effect of miRNA targeting on 
translational output will be informative in revealing the relevance of the central region of 
the miRNA to target recognition and repression. 
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In conclusion, this data suggests that the expansion of miRNA families is 
correlated with emerging organismal complexity. Strikingly, we find a strong connection 
between duplication events and subsequent sequence changes, which frequently occur in 
the central region of the miRNA. Because miRNAs function by guiding the RISC to 
target mRNAs via anti-sense complementarity, we hypothesize that these sequence 
changes may contribute to targeting differences between miRNA family members. To 
test this, we employed a novel high-throughput assay to systematically identify targets of 
two miRNAs relevant in development and tumor progression. The proof-of-principle 
experiments for this assay are presented in the following chapter. 
 
Experimental 
miRbase Data analysis 
Pre-miRNA and mature miRNA sequences were downloaded from miRbase 
release 21 [293]. Conserved metazoan miRNAs were defined as those that have at least 
20 annotated homologues across all species, and at least one copy in H. sapiens. Family 
alignments were performed using ClustalO [301], and output files were used in Weblogo 
[302] to calculate positional nucleotide contents and entropy values. Internal and external 
insertions and deletions were omitted from analysis if they were present in less than 10% 
of miRNAs. The phylogenetic position of sequence changes in each miRNA family was 
identified by ordering the miRNA sequences based on phylogeny, and manually looking 
for sequence changes. 
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3´UTR length analysis 
 We downloaded the Refseq gene annotations for all C. elegans and human protein 
coding genes from the UCSC genome browser.  We then calculated the distance from the 
stop codon to the end of the transcript for the longest annotated isoform of each gene 
using previously developed PERL scripts [172].  
 
Synthetic 3´UTR construction and luciferase assays: 
 To insert custom target sites within the 3´UTR of SV40, we adapted a previously 
described simultaneous restriction digest and ligation cloning strategy [303]. In brief, we 
inserted two restriction sites in opposite orientation for the enzyme BbsI, which cuts two 
nucleotides 3´ of the sequence GAAGAC.  These two cut sites leave four nucleotide 
overhangs, AATG on the 5´ end, and TAAC on the 3´ end.  We then design two primers 
which are the complement and reverse complement of the target site of interest, that 
contain an additional four nucleotides corresponding to the overhangs left by BbsI. These 
primers are annealed by incubating them at 95˚C in a thermalcycler, then reducing the 
temperature 5˚C per minute until they are at room temperature. The annealed primers (~2 
ng) plasmid containing the SV40 3´UTR with BbsI cut sites (~100 ng), are combined 
with the BbsI restriction enzyme, T4 DNA ligase, NEB buffer 2.1, 10 uM DTT, 10 mM 
ATP, and water to 20 uL. The reaction is then treated incubated at 37˚C for five minutes, 
then 20˚C for 5 minutes, repeating these steps six times.  1 uL of the reaction is then 
transformed into competent bacteria, and colonies are screened by colony PCR. 
Successful clones are the shuttled into the pLIFE-3´UTR plasmid (see chapter 3) using 
Gateway cloning.  
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 ~80,000 HEK293T cells per well in a 96-well were transiently transfected with 
pLIFE-3´UTR (100 ng) and miRNA expression plasmid (500 ng) using a modified 
nucleofection protocol optimized in our lab (see chapter 3). Cells were incubated in 
DMEM for ~72 hours, then cell lysate was used in dual luciferase reaction. The ratio 
between the Firefly luciferase::SV40 3´UTR containing the target site of interest, and 
Renilla fused with a non-specific 3´UTR was used to measure the strength of repression 
for each target by miR-10b.  Results were normalized to a negative miRNA control 
plasmid, and were performed in triplicate.   
 
Secondary structure analysis 
 To assess trends in secondary structure, we manually investigated the alignments 
of all the 62 miRNA family members miRNAs from 8 model organisms with the best 
annotated miRNAs in miRbase, specifically looking for sequencing evidence of which 
arm is selectively incorporated into Argonaute (C. elegans, D. melanogaster, S. 
purpuratus, P. marinus, D. rerio, M. musculus, H. sapiens). At each position we then 
noted mismatches, wobbles, and gaps. 
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CHAPTER 3 
3´LIFE: A NOVEL ASSAY TO  
IDENTIFY MICRORNA TARGETS  
IN HIGH-THROUGHPUT 
 
Publication Note 
The research reported in this chapter is in press in Nucleic Acids Research by 
Justin M. Wolter, Kasuen Kotagama, Alexandra Pierre-Bez, Mari Firago, and Marco 
Mangone. 3´LIFE: a functional assay to detect miRNA targets in high-throughput. 
Nucleic Acids Research. 2015;42(17). All co-authors have granted permission for this 
work to be included in this dissertation. 
 
Overview 
MicroRNAs (miRNAs) are short non-coding RNAs that bind to sequence 
elements primarily in the 3´ untranslated regions (3´UTRs) of messenger RNAs 
(mRNAs) and repress their translation [185]. MiRNAs are expressed in nearly every 
eukaryotic cell type investigated to date, where they regulate fundamental biological 
processes such as development and morphogenesis [28]. Furthermore, miRNA 
misregulation has also been observed in a wide range of cancers [252], where they can 
function as tumor suppressors or oncogenic miRNAs (oncomiRs) [304], based solely on 
the function of target genes. The misexpression of miRNAs can have substantial 
consequences in development and disease, highlighting the powerful roles miRNAs play 
in influencing cell behavior. In human, each miRNA is predicted to target hundreds to 
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thousands of genes based on complementarity with messenger RNA (mRNA) sequence 
[183], thus identifying and experimentally validating gene targets is central to 
understanding a miRNAs function. To analyze the large number of putative 
miRNA/mRNA interactions, bioinformatic and next-gen sequencing approaches are 
commonly used to predict and identify miRNA target sites throughout the genome. Each 
approach has inherent strengths and shortfalls. 
Many algorithms have been developed to predict miRNA target sites throughout 
the transcriptome by searching for regions of complementarity with mRNAs by Watson-
Crick and G:U wobble base pairing [185]. These interactions may utilize as little as six 
consecutive nucleotides near the 5´ end, or seed region, of the mature miRNA [158, 161, 
183]. Perfect complementarity with the seed region is considered the canonical indicator 
of a miRNA target site, but can be strengthened by additional pairing with the 3´ end of 
the miRNA. Due to the small size and degenerate nature of target sequence elements, 
most algorithms predict hundreds to thousands of putative target genes for each miRNA. 
These algorithms typically apply parameters such as stringent seed pairing, cross-species 
conservation, and thermodynamic stability to identify high-confidence targets [181, 183]. 
However, the analysis of the predictive performance of several of the most prominent 
algorithms reports extremely high false negative [124, 166, 195], and false positive rates 
(~66%) [126, 165]. These error rates reflect that these algorithms typically do not predict 
poorly conserved species specific interactions, or non-canonical targets not reliant on 
perfect seed complementarity, which recent evidence suggests may be widespread [165, 
166, 196-201, 305]. These algorithms are useful for candidate gene approaches to 
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identify putative miRNA targets, but the high error rates make systematic target detection 
challenging. 
Several recently developed techniques allow the experimental detection of 
miRNA targets on a transcriptome wide level, bypassing target prediction software. One 
of the most used methods combines the cross-link and immunoprecipitation of Argonaute 
(AGO) family members with Next Generation sequencing (AGO-HITS-CLIP). AGO 
proteins directly bind mature miRNAs, and guide the large multi-protein complex called 
the RNA induced silencing complex (RISC) to target mRNAs. By sequencing the mRNA 
population bound to AGO, it is possible to map the sequence footprints occupied by the 
RISC to specific genes [203]. However, the physical immunoprecipitation of AGO from 
cell lysates is often challenging to execute, and may add unwanted noise, impacting 
reproducibility and complicating downstream analysis. Importantly, while this approach 
produces hundreds of targets, it does not provide information about which miRNA led the 
RISC to that location, which has to be extracted using bioinformatic approaches [204]. 
Furthermore, AGO-HITS-CLIP fails to measure the functional impact of miRNA 
targeting on the level of protein synthesis. The result of targeting by the RISC can range 
from translational repression to mRNA degradation [126], and it is not currently clear if 
these alternative mechanisms bias the results of AGO-HITS-CLIP towards target sites 
that are held in translational repression. While AGO-HITS-CLIP is an excellent high-
throughput method to detect miRNA target sites in a specific biological context, the 
limitations with assigning a miRNA and the lack of a functional measure of targeting 
limits this approach.  
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To address these gaps, we have developed a high-throughput assay to directly 
probe for interactions between miRNAs and their targets in 3´UTRs. This assay, named 
Luminescent Identification of Functional Elements in 3´UTRs (3´LIFE), measures direct 
interactions and translational repression of the test 3´UTR  by a query miRNA using a 
dual luciferase approach. Luciferase assays rely on the fusion of the 3´UTR of a gene of 
interest to a luciferase reporter gene. The reporter is cotransfected with a query miRNA 
in cell culture. Targeting is measured as a relative change between the test 3´UTR 
reporter and a second, non-targeted luciferase reporter. Luciferase assays offer several 
advantages over other methods to identify miRNA targets such as mRNA sequencing and 
protein quantification approaches. Luciferase assays detect interactions at the RNA level, 
but measure these interactions at the protein level, bypassing differences in mRNA 
degradation/translational repression, and changes in protein abundance independent of 
3´UTR based regulation. Luciferase assays are sensitive and scalable, yet use in high-
throughput screens is greatly limited by 1) high costs associated with consumable 
reagents, 2) lack of publically available 3´UTR reporter libraries, and 3) absence of 
standardized dual luciferase protocols to perform large scale screens, leading to 
difficulties in comparing functional repression across multiple datasets. 
The 3´LIFE assay enhances the dual luciferase assay by placing emphasis on the 
rapid, sensitive, standardized, and high-throughput screening for miRNA targets. These 
advances include the development of a test 3´UTR library, Gateway™ compatible 
miRNA expression and 3´UTR reporter plasmids, non-consumable transfection reagents, 
and non-commercial dual-luciferase assay reagents [306]. Importantly, the scalability of 
the 3´LIFE assay allows screens of individual miRNAs against a large 3´UTR library 
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without biasing the screen towards candidate genes identified bioinformatically [307]. 
This unbiased approach facilitates the identification of genes targeted via non-canonical 
and poorly conserved interactions. Importantly, the sensitivity of the luciferase reporters 
combined with the inherently large number of negative miRNA/mRNA interactions in 
3´LIFE, allows for detection of the subtle effects of miRNA targeting, a benefit not 
possible with low-throughput, candidate gene [307], or other selection based reporter 
assays [308]. 
To test the ability of the 3´LIFE assay to detect biologically relevant target genes, 
we studied the targeting of two cancer relevant miRNAs, let-7c and miR-10b. The let-7 
family members are broadly characterized as tumor suppressors; reduction in the 
expression of multiple family members is observed in many cancers, and correlates with 
poor survival outcomes [254, 309-311]. let-7 miRNAs target genes that promote cell 
proliferation (RAS [253], HMGA2 [309], E2F5 [312] [313] and invasion and metastasis 
(MMP11, PBX3 [314]). Each let-7 miRNA is bioinformatically predicted to target over 
1,000 genes [183], with completely overlapping target sets. miR-10b was initially 
described in the context of late stage breast cancer, where overexpression initiated 
malignancy in vivo [243]. Subsequently, miR-10b overexpression has been observed in 
over a dozen late stage tumor types [291, 315-317]. There are several validated targets of 
miR-10b including tumor suppressors HOXD10, KLF4, and NCOR2 [243, 318-320]. 
Despite the significant body of research on these miRNAs, it is striking the number of 
targets with direct experimental validation equates to less than 3% of bioinformatically 
predicted targets [183, 319].  
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We tested the feasibility of the 3´LIFE assay by querying let-7c and miR-10b 
against 275 test human 3´UTRs. Our results confirmed 80% of previously validated 
targets, and identified many novel targets for these two miRNAs. However, In comparing 
the 3´LIFE assay to TargetScan, a widely utilized target prediction software, we identify 
that 63% of predicted targets have some degree of repression in the 3´LIFE screen, yet 
69% of targets were not predicted, and approximately 27% did not contain a canonical 
seed target. We also observed that many miRNA target genes contain unpredicted 
canonical seed elements, and demonstrate this is likely due to poor conservation within 
3´UTRs of unpredicted genes, and not at miRNA target sites per se. Taken together, our 
results suggest that the 3´LIFE assay is a powerful tool to rapidly and systematically 
identify miRNA targets in high-throughput, validate bioinformatic predictions, identify 
novel non-canonical targets, and highlights the complexity of miRNA targeting 
mechanisms. 
 
Results 
MiRNA target predictions have high false negative rates 
Several algorithms have been developed to predict miRNA/mRNA interactions in 
3´UTRs corresponding to each gene in the genome [161]. Predictions for miRNA targets 
are generally based on the characteristics of previously validated miRNA target elements 
and utilize additional parameters, such as site conservation, to refine putative target lists. 
These algorithms generate hundreds to thousands of predicted interactions for each 
miRNA, and thus can be used to analyze miRNA targets on a systems level. However,  
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several groups have reported high false positive [126, 165] and false negative rates [124, 
195]. We measured the efficacy of three widely utilized algorithms, TargetScan [183], 
Diana-microT [321] and PicTar [181] to identify the most predictive algorithm to 
compare against results from the 3´LIFE assay. We selected five miRNAs based on their 
significant presence in the literature and relevance to cancer, and compared the predicted 
targets with experimentally validated targets from the literature (Figure 3.1). Despite the 
wide body of literature on these miRNAs (thousands in PubMed), there are only 64 
validated targets, representing ~2% of all bioinformatic predictions. TargetScan correctly 
predicted 57% of experimentally validated targets, while Diana-microT and PicTar 
predicted 53% and 47% of validated targets, respectively (Figure 3.2). However, 
TargetScan predicted 3,236 targets, compared to 2,001 by PicTar, which may account for 
differences in false negative rates. We compared all hits from the 3´LIFE assay against 
predictions from TargetScan because it contained the lowest false negative rate. 
Figure 3.1 (next page). Analysis of target prediction softwares. We have 
superimposed all the experimentally validated miRNA targets of five cancer-related 
miRNAs (x-axis, black dots) to target predictions produced by a panel of widely 
utilized prediction algorithms, (A)TargetScan [184], (B) DIANA microT-CDS [320], 
and (C) PicTar  [182]. The Y-axis represents the normalized targeting score assigned 
to each prediction, with the black horizontal line representing the normalized mean. 
We show the same five representative miRNAs in each panel. These miRNAs were 
selected for this analysis based on 1) their significant presence in the literature, 2) 
their correlation with oncogenic pathways, and 3) their uncharacteristic high number 
of validated gene targets when compared to other less studied miRNAs.  
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3´LIFE is a scalable method to rapidly detect miRNAs targets in high-throughput  
Luciferase-based assays are widely used to directly detect miRNA targeting due 
to their high sensitivity. Commercial high-throughput luciferase reagents are also 
available, but are cost prohibitive for large-scale approaches. To overcome these 
limitations, we have developed a cost-effective high-throughput assay that systematically 
screens miRNA/mRNA interactions in an unbiased and standardized fashion. 3´LIFE is 
an adaptation of the dual luciferase reporter assay performed in high-throughput (Figure 
3.3). The dual luciferase assay relies on the fusion of a test 3´UTR to a luminescent 
reporter gene. Targeting and translational repression of the test 3´UTR by a probe 
miRNA is identified by a decrease in the luciferase::3´UTR signal (Firefly luciferase) 
relative to a second normalization signal (Renilla luciferase) (Figure 3.3, red spots). To 
account for endogenous miRNAs which may target the luciferase reporter, we include a 
no miRNA negative control, which provides a baseline from which to detect targeting by  
 
 
Figure 3.2. Error rates of target prediction softwares. Among 67 experimentally 
validated targets for these five miRNAs, 34% were not predicted by TargetScan, 47% 
were not predicted by DIANA-microT-CDS, and 52% were not predicted by PicTar. 
Of note, these algorithms produce thousands of predictions that are yet to be tested, 
representing >98% of predicted targets. This comprehensive list was compiled 
utilizing miRTarbase [319] and by our own manual literature review of up-to-date 
resources. 
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the exogenous test miRNAs. 3´LIFE is designed to rapidly identify functional targets of a 
given miRNA in a panel of hundreds of test 3´UTRs in co-transfection experiments. 
 
 
  
Figure 3.3. Schematic of the 3´LIFE assay. A reporter library of luciferase::3´UTR 
fusion genes is cotransfected in HEK293T cells with miRNAs of interest and a 
negative control in 96-well format. Following transfection cell lysate is used in a 
dual luciferase assay, and target genes are identified by a significant repression of 
the luciferase gene compared to the negative control. 
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Figure 3.4. 3´LIFE Vector Design. Top: Gateway compatible dual luciferase 
expression vector. The 3´UTR of interest is cloned downstream of Firefly luciferase 
using Gateway cloning. Both luciferase genes are located on the same plasmid to 
prevent fluctuations in the luciferase ratio across experiments. Bottom: Gateway 
compatible miRNA expression plasmid. The miRNA of interest is cloned within an 
intron in the 3´UTR of RFP using Gateway cloning. This approach functions dually as 
a visual marker for transfection efficiency and miRNA expression. 
 
 
 
  
Figure 3.5. 3´LIFE assay plasmid maps (A) pLIFE-3´UTR (B) pLIFE-miRNA. 
Positions of restriction sites used to clone various elements are noted. Plasmids are 
available through DNASU Plasmid Repository (www.DNASU.org, clone 
IDs:EvNO00601503 and EvNO00601504). 
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Figure 3.6. Expression and splicing of miRNA from pLIFE-miRNA vector (A) 
Top: Total RNA from HEK293T cells transfected with pLIFE-miRNA plasmid was 
extracted, and cDNA was synthesized using a polydT reverse primer. The second 
strand PCR reaction was performed using a forward primer that anneals in the open 
reading frame of RFP, and a reverse primer that anneals downstream of the 3´ splice 
site in the 3´UTR. Middle: Gel electrophoresis depicts PCR of plasmid DNA and 
cDNA, with a shift of the expected size given proper intron/miRNA splicing. Bottom: 
Sequencing of the PCR products confirmed that the miRNA is properly spliced out of 
the RFP mRNA transcript (B) Bright field (left) and fluorescent (right) images of 
HEK293T cells used in the above experiment. RFP expression functions both as a 
marker for transfection efficiency, and signals transcription of the primary miRNA 
transcript.   
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3´LIFE uses two specially designed vectors to express the test 3´UTRs (pLIFE-
3´UTR) and the miRNA (pLIFE-miRNA) (Figure 3.4). In the pLIFE-3´UTR vector, the 
two luciferase genes were cloned into the same plasmid to prevent fluctuations in their 
molar ratios across separate transfections. We have also included a Gateway-compatible 
recombination cassette (GW) cloned downstream of the Firefly luciferase gene to 
efficiently shuttle test 3´UTRs into the pLIFE-3´UTR vector (Figure 3.4 (top), Figure 
3.5A). In the pLIFE-miRNA vector, the miRNA is cloned within an intron in the 3´UTR 
of the red fluorescent protein [322] (Figure 3.4 (bottom), Figures 3.5B, 3.6A), dually 
 
Figure 3.7. Positive controls for let-7c and miR-10b expression. The SV40 3´UTR 
containing a scrambled miR-10b target site (blank), or let-7c and miR-10b targets, 
were cloned into the pLIFE-3´UTR and tested in quadruplicate using a dual luciferase 
assay. Results are normalized to the Blank condition of each 3´UTR. Y-axis measures 
the percentage of repression compared to the Blank condition. Error bars are standard 
error unless otherwise noted. * denotes statistical significance (Student’s t-test, * 
p<0.05, ** p<0.01, *** p<0.001) 
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functioning as a marker for transfection efficiency and miRNA expression (Figure 3.6B).  
To test the processing and functional activity of the miRNA expression vectors, 
we introduced perfect target sites for each miRNA into the SV40 3´UTR, and co-
transfected the pLIFE-SV40 vectors with a negative miRNA control, let-7c, or miR-10b. 
Each miRNA strongly repressed only the 3´UTR containing its target site, confirming the 
processing of the miRNA, and demonstrating the specificity of the targeting (Figure 3.7, 
panels 4-9).  
 
 
 
Figure 3.8. Strong and weak promoters driving miRNA expression. PGK promoter 
is 80% weaker than CMV Promoter. (A) We have compared the strength of the CMV 
promoter related to the PGK promoter in co-transfection experiments using 
fluorescence microscopy. While the expression of GFP driven by a CMV promoter is 
constant in both experiments (compare panel 1 with 3), the expression of dsRed2 
included in the pLIFE is much weaker using the PGK promoter (compare panel 2 with 
panel 4). (B) Quantification of fluorescence produced by these two promoters shows 
that CMV promoter is at least five times stronger than the PGK promoter, results 
comparable to those  obtained by Qin, et al. 2010 [323]. 
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Figure 3.9. Optimization of nucleofection transfection buffers. We tested 11 
electroporation buffers against 8 different pulse codes. 100k HEK293T cells were 
transfected with 50 ng pmaxGFP plasmid (Lonza) and compared against the SF cell 
line solution (Lonza) (data not shown). (A) The highest performing buffers were each 
retested with various permutations of pH and buffer composition to determine optimal 
transfection conditions. Based on fluorescence and cell survival PBS 1.5% HEPES pH 
7.0 and pulse code FF120 (red box) was chosen for the 3´LIFE assay. (B) HEK293T 
cells transfected with GFP in PBS 1.5% HEPES pH 7.0 buffer and pulse code FF120 
performed in 6 replicates. Cells were cultured for 48 hours following transfection, and 
fluorescence was analyzed using flow cytometer. Light blue line is negative 
transfection control without GFP. The percentage of transfected cells is consistent 
between experiments. (C) Transfection efficiency of previous experiment (b). 
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Overexpression of exogenous miRNAs may cause nonspecific or dosage-
dependent effects. To test this hypothesis we replaced the CMV promoter present in the 
pLIFE-miRNA vector with the weaker PGK promoter (pLIFE-PGK). In HEK293T cells 
the CMV promoter was previously 
reported to be approximately five 
times stronger than PGK [323], a 
result echoed by our own analysis 
of fluorescence expression (Figure 
3.8). Importantly, the PGK 
promoter is also used to drive 
expression of the Firefly 
luciferase::3´UTR reporter, thus 
expression levels of these two 
genes should be equivalent in the 
pmiRNA-PGK experiment.  
Repeating the miRNA 
targeting experiments with the 
pLIFE-PGK miRNA expression 
vector yielded decreased 
translational repression (Figure 3.7, 
panels 10-15), although not to the 
extent expected by decreasing 
 
 
Figure 3.10. 3´LIFE cloning pipeline. This 
cloning pipeline was used to clone the 384 
3´UTRs, and miRNAs used in the 3´LIFE assay. 
1. Primers used to amplify 3´UTRs from the 
human the genome anneal in the terminal exon 
of each gene and 150 nt downstream of the 
longest 3´UTR annotation in Refseq HG19. 
miRNAs were amplified using primers that 
anneal ~200 nucleotides upstream and 
downstream from the pre-miRNA. All primers 
contain 5´ Gateway elements to clone into the 
pLIFE Gateway compatible plasmids.  2. 
3´UTRs were amplified using touchdown PCR in 
96-well plates. BP reactions were transformed in 
DH5α cells and plated in 48 well culture plates. 
Screens for successful clones were performed 
using colony PCR and size based selection for 
one colony. If first colony was not positive, up to 
eight additional colonies were picked. 3. 
Successful 3´UTR clones are re-arrayed into 96-
well plates and tested for targeting by each 
miRNA in the 3´LIFE assay. 
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expression levels 80% (Figure 3.7, compare panel 5 with panel 11, and panel 9 with panel 
15).  
The feasibility of high-throughput dual luciferase assays is limited by high costs 
associated with transfection and luciferase assay reagents, and the lack of a publicly 
available human 3´UTR library. Furthermore, genome-wide screens for miRNA targets 
are challenged by the need for appropriate high-throughput technologies and pipelines. 
3´LIFE assay utilizes low cost non-proprietary transfection and dual-luciferase reagents 
[306] (Figure 3.9). We have designed each step of the 3´UTR cloning pipeline and the 
3´LIFE assay to be highly automated (Figure 3.10). PCR, cloning, plasmid DNA 
preparation, cell culture, transfection, and luciferase assays are performed in 96-well 
format using multi-channel micropipettes, dedicated liquid handling robots, and other 
high-throughput instrumentation.  
To test the 3´LIFE 
assay, we chose a pilot library 
of 384 human 3´UTRs 
containing experimentally 
validated targets (n=10) and 
bioinformatically predicted 
targets (n=42) of let-7c and 
miR-10b, as well as genes that 
play regulatory roles in 
tumorigenesis (Figure 3.11). 
 
 
Figure 3.11.The pilot human 3´UTR clone library. 
Gel electrophoresis of 384 3´UTRs amplified from 
human genomic DNA using touchdown PCR for use 
in the 3´LIFE assay. 
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This human 3´UTR clone collection is publically available through the DNASU plasmid 
repository (http://dnasu.org) [324]. More clones are periodically added to the library, with 
the goal of covering the entire human 3´UTRome. 
Here, we screened 275 of these 3´UTRs for potential targeting by each miRNA, 
performing four replicates of each experiment using the pLIFE-miRNA vector (totaling 
~3,500 transfection reactions and luciferase assays). To detect miRNA targeting, each 
 
 
Figure 3.12. Hits in the 3´LIFE assay are enriched for predicted and previously 
validated targets.  275 3´UTRs were probed for targeting by let-7c (left), or miR-10b 
(right). Repression index values (see Experimental) represent the average of four 
replicates. 3´UTRs were considered putative hits if the repression index falls below the 
standard error for each miRNA (dashed line). Bioinformatically predicted genes are 
extracted and ranked (right of each panel), demonstrating an enrichment for predicted 
targets among putative hits. Previously validated targets are marked with black arrows. 
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3´UTR was co-transfected with the miRNA, and the luciferase ratio was compared to a 
negative control. Putative hits are defined as those that have a Repression Index (RI) 
below the mean standard error of the assay (0.15 for let-7c, and 0.16 for miR-10b). These 
putative hits were enriched with bioinformatically predicted targets, and previously 
validated targets for both let-7c (E2F5, RTCA, PBX3, TRIM71), and miR-10b (SDC1, 
NCOR2, HOXD10) (Figure 3.12, arrows). Surprisingly, we detected repression in only 
62% of genes predicted by TargetScan. 
To further refine our putative hits to only high confidence targets, we set a cutoff 
for genes with a repression index <0.80, and p-value <0.05. Using this criteria we 
obtained 37 high- confidence hits for let-7c, and 26 for miR-10b (Figure 3.13). To 
identify putative miRNA target sites within these top hits, we scanned each 3´UTR for 
elements highly complementary to the miRNA (Appendix A). While 63% of these 
3´UTRs contained perfect seed elements, only 32% were predicted by TargetScan, 
presumably because they contain either poorly conserved canonical seeds or non-
canonical target sites.  
 
 
Figure 3.13. Target sites in top hits of the 3´LIFE assay. Top hits obtained are 
defined as those with RI < 0.80 and p < 0.05. let-7c had 37, and miR-10b had 26 top 
hits, the majority of which contain canonical target sites.  
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Strong miRNA and weak miRNA overexpression yield comparable results 
We were then interested in studying the extent of non-specific or dosage 
dependent targeting caused by miRNA overexpression. We rescreened one plate of 
 Figure 3.14. miRNA delivered using both weak and strong promoters identify 
comparable targets. (A) Comparison of 87 genes screened in the 3´LIFE assay using 
pLIFE (strong promoter) and pLIFE-PGK (weak promoter) for targeting by let-7c and 
miR10b. The yellow panel highlights the repression from both miRNA delivery 
methods. (B) Top hits produced with pLIFE compared with hits produced with pLIFE-
PGK. Of the top hits produced using pLIFE-miRNA, 77% of them were also repressed 
using a weaker promoter, but to a lesser extent. (C) Venn diagram showing the 
overlap between hits produced using both miRNA delivery vectors. 97% of genes 
were either repressed or not repressed using both vectors. (D) We studied the seed 
region in three statistically significant hits detected using the pLIFE-PGK for miR-10b 
that were not targted by pLIFE (middle panel in C).  Two of three have a perfect seed 
element in their 3´UTRs, suggesting that although at a low frequency (1.7%), some 
genes may exhibit dosage-dependent targeting. 
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3´UTRs (n=87) using the pLIFE-PGK miRNA expression vector, repeating the assay in 
quadruplicate (total of 1,152 transfection reactions and luciferase assays) (Figure 3.14). 
The repression index of each gene tested against varying extents of miRNA 
overexpression yielded largely comparable results, with the majority of genes having 
some degree of repression in both, or neither (Figure 3.14A). Among the top hits 
obtained in with pLIFE-miRNA vectors, 77% of targets were also repressed with the  
 
pLIFE-PGK vectors, albeit generally to a lesser degree (Figure 3.14B-C). We 
obtained three genes not repressed with the pLIFE-miRNA screen that show significant 
repression (RI<0.80, p<0.05) by miR-10b in the pLIFE-PGK experiment (AATK, 
HOXA1, KRT1). HOXA1 and KRT1 contain perfect seed matches for miR-10b, while 
AATK contains a highly complementary non-canonical target (Figure 3.14D). In 
conclusion, this data suggests that while there may be a dosage effect for a small portion 
miRNA targets, the majority of targets show consistent repression regardless of the 
degree of miRNA overexpression.  
 
Putative miRNA target genes have functions consistent with known role of each miRNA in 
cancer 
We next sought to identify potential correlations between the functional role of 
each miRNA in tumorigenesis and the novel targets identified by our pilot 3´LIFE assay. 
We performed a literature review for the top gene targets to determine if our bona-fide 
targets were previously recognized to have positive or negative contributions to 
tumorigenesis (Figure 3.15, Table 3.1). let-7c targets identified by the 3´LIFE assay are 
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generally overexpressed in tumors, and have positive roles in tumorigenesis, which is 
consistent with the tumor suppressor function of let-7c. Conversely, miR-10b target genes 
are typically down-regulated in late stage tumors and inhibit cancer progression and 
metastasis, which is also consistent with miR-10b as an indicator of late stage, aggressive 
tumors (Figure 3.15).  
 
 
Figure 3.15: Top hits in the 3´LIFE assay are enriched for genes implicated in 
tumorigenesis. Putative seed target site is listed as defined in Friedman, et al. (2009). 
Each gene was identified as having a positive role (green), negative role, conflicting 
roles (red/green), or no identifiable or established role in tumorigenesis based on a 
manual literature review (see Materials and Methods and Supplemental Table 3). 
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  Table 3.1. Literature review of miRNA target roles in tumorigenesis 
 
let-7c Targets: 
 
Gene References: 
E2F5 [313, 325] 
CREM [326, 327]  
RHOB [328-331]  
HOXD1 [332, 333] 
XBP1 [334, 335] 
SETDB1 [336, 337] 
SREBF1 [338, 339]  
PBX3 [314, 340] 
ID1 [341-343] 
NRM [344] 
BCCIP [345-347]  
RFX6 [348, 349] 
MICB [350-352] 
HSF1 [353-356] 
DLX4 [357-359] 
RHOV [360-362] 
USF2 [363, 364] 
RARB [365, 366] 
OLFM4 [367-369] 
CRK [370, 371] 
DNMT1 [372-374] 
SMAD6 [375, 376] 
ARID3A [377, 378] 
EZH2 [379, 380] 
STAT2 [381] 
HHAT [382, 383] 
MYCL1 [384-386] 
TRIM71 [387] 
SPDEF [388-392] 
EN2 [393, 394] 
TTF1 [395] 
HES5 [396-398]  
RNF7 [399-401] 	
miR-10b Targets:  
 
ZMYND11 [402]  
SDC1 [403-405] 
RARG [406-410] 
LYL1 [411, 412] 
NCOR2 [413-415] 
CRK [370, 371] 
USP6 [416, 417] 
SREBF1 [338, 339] 
ANXA7 [418-420] 
HOXD11 [421, 422] 
NCOA6 [423] 
HOXD10 [243, 424, 425] 
HHAT [382, 383] 
NUAK2 [426, 427] 
HOXD1 [332, 333] 
STAT6 [428, 429] 
ASCL2 [430-432] 
HIVEP2 [433, 434] 
GATA3 [435-437] 	
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Each miRNA exhibits a unique binding footprint 
Analysis for enriched nucleotides in these putative miRNA target sites revealed 
that the seed was the least variant region within the target element of both miRNAs 
(Figure 3.16). The 3´ end of the miRNA also showed consistent interaction with the 
mRNA compared to the central nucleotides. let-7c also possesses a more even 
distribution of interacting nucleotides compared to miR-10b, which has two distinct 
regions at the terminal ends. The mean bit score gives a measure of the extent to which 
that each nucleotide interacts with the target mRNA, and in let-7c is slightly higher that 
in miR-10b (1.03 compared to 0.86), suggesting that let-7c interacts with more 
 
 
 
Figure 3.16. Target signature motif of putative miRNA target sites within top hits 
identified using ClustalW alignments. Black box represents the miRNA seed region. 
Black horizontal lines indicate nucleotides within the mRNA with a bit-score > 0.8.  
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nucleotides in each target mRNA than miR-10b. As G:U base pairing expands the 
flexibility of these nucleotides to interact with more than one base, we compared the bit 
score of G/U and A/C nucleotides. G/U’s outside the seed region were twice as likely to 
interact with corresponding mRNA nucleotides than A/C (0.85 compared to 0.43), which 
is expected given that the number of nucleotides that G/U can pair with is double that of 
A/C. The five 3´-most nucleotides of both miRNAs are G/U’s, which may account for the 
targeting peaks in this region. Of note is the high percentage of G/U nucleotides in let-7c 
(82%) compared to miR-10b (52%), which may contribute to the overall higher bit score, 
the increased number of bioinformatically predicted targets (Figure 3.1), and the larger 
number miRNA targets detected by the 3´LIFE screen (Figure 3.13) for let-7c compared 
to miR-10b. 
 
Seed elements are conserved compared to surrounding 3´UTR sequence 
30% of 3´UTRs in the target library contain canonical seed elements. Within this 
group, more than half were among 3´LIFE top hits, suggesting that 3´LIFE hits are 
enriched with genes containing canonical seeds. Among the 3´LIFE top hits, 73% contain 
a canonical seed (46 out of 63), yet only 32% were predicted bioinformatically (20 out of 
63). We reasoned that most of these canonical targets escaped prediction because the seed 
element is poorly conserved. To address this discrepancy we measured the sequence 
conservation among vertebrates for both predicted and unpredicted canonical seed 
elements within our 3´LIFE top hits. We then compared the results to the conservation 
levels in the open reading frames and in the 3´UTRs of the same genes (Figure 3.17). Not 
surprisingly, the seed region in predicted targets was four times more conserved than  
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in non-predicted targets. However, in both the terminal exon and in the 3´UTR of non-
predicted targets we observed far less conservation compared to the same regions in 
predicted targets. This suggests that when comparing conservation of genes as a whole, 
the degree of conservation of unpredicted genes may automatically exclude any canonical 
targets from prediction by algorithms using conservation criteria. Furthermore, the seed 
region in unpredicted targets is twice as conserved as the surrounding 3´UTR, a jump 
similar in magnitude to that of predicted seed targets. This suggests that despite the 
relatively poor conservation of unpredicted targets, these elements are possibly functional 
and there is indeed some selective pressure to maintain them. Taking together, these 
results suggest that the lack of conservation in the seed region per se is not solely 
responsible for the failure of TargetScan to predict the bona fide miRNA targets that are 
  
Figure 3.17. Conservation of target sites in canonical target sites. Conservation 
scores of the terminal exon, miRNA target site, and flanking 3´UTR of genes 
possessing perfect seed matches. Scores are plotted log(2) scale. 3´UTRs are separated 
based on the prediction status of each gene based on TargetScan. Conservation score is 
obtained using the PhyloP vertebrate conservation track on UCSC genome browser.  
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detected by the 3´LIFE assay, but that other factors such as the lack of conservation in the 
3´UTR itself plays a role in increasing false negative rates of prediction softwares.  
To further validate non-canonical targets sites among the top hits of 3´LIFE, we 
selected two genes, RhoB and HOXD11, and deleted the putative target sites for let-7c 
and miR-10b, respectively (Figure 3.18). Deleting these elements completely rescued 
 
 
Figure 3.18. 3´LIFE identifies non-canonical miRNA target sites. Deletion analysis 
of two top non-canonical miRNA target sites identified in 3´LIFE assay. Map showing 
the relation of the miRNA target site within the 3´UTR relative to polyadenylation 
sequences (AAUAAA). Red boxes indicate canonical seed nucleotides. Each 3´UTR 
containing either the wild-type or deleted miRNA target site is cotransfected with 
Blank miRNA control, let-7c, or miR-10b.  
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each 3´UTR from repression by their respective miRNAs, demonstrating that the 3´LIFE 
assay is capable of identifying non-canonical miRNA/mRNA interactions (Figure 3.18). 
 
Discussion 
3´LIFE is a highly sensitive method to detect miRNA targets in high-throughput 
In this study we present a novel, scalable, and sensitive method to identify 
miRNA targets in high-throughput, which addresses a critical need in miRNA biology. 
Currently, bioinformatic and RISC-IP approaches are the only tools to investigate 
miRNA targets in a high-throughput manner.  
Bioinformatic approaches utilize a suite of parameters to predict highly likely 
targets, such as target composition (i.e. miRNA seed regions), site conservation, and 
thermodynamic stability, and benefit from the ability to identify sites throughout the 
entire genome. While these algorithms are indispensable tools to identify candidate genes  
for experimental validation, their high false-positive and false-negative rates suggest that 
the parameters upon which these algorithms are built do not yet account for all the 
mechanisms miRNAs use to recognize target sites. Genome wide bioinformatic 
predictions are only useful in the absence of experimental tools that deliver results at a 
comparable scale. AGO-HITS-CLIP provides a high-throughput experimental approach 
to identify miRNA targets in a specific context, i.e. cell line or tissue. When we compare 
our results with data obtained from similar approaches, we note that IP-based assays limit 
the findings to the set of abundantly expressed transcripts, and that occupancy of a 
miRNA at a specific target site may not necessarily result in translational repression  
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Figure 3.19. Comparative analysis of 3´LIFE with AGO-HITS-CLIP. (A) 
Recently, a technique termed cross-linking and sequencing of hybrids (CLASH) was 
applied to the AGO protein and miRNA:mRNA interactions (Helwak, et al, 2012) The 
CLASH dataset was conducted in HEK293T cells, which provided a complementary 
approach to cross validate hits obtained from 3´LIFE. We compared our results with 
this dataset. Unfortunately, of the 272 chimeric reads obtained for let-7c and miR-10b, 
only one gene was present in the 3´LIFE library (EIF3A), and the target footprint 
mapped to the open reading, thus was not comparable to 3´LIFE. However, CLASH 
did identify 21 genes which were targeted by a family member of let-7c or miR-10b 
which were included in the 3´LIFE library. (B) Alignments of let-7 family members 
shows that these miRNAs share identical seed regions (red box), and diverge by 1-2 
nucleotides in the 3´ end of the miRNA (yellow boxes). Of these 21 genes, 12 mapped 
to coding sequences, while 9 mapped to 3´UTRs. Of the 9 overlapping 3´UTRs in the 
two datasets, 3 of them were significantly repressed in the 3´LIFE (p<0.05). Of these 
3, the gene with the highest repression in 3´LIFE, EZH2, was the only gene with a 
canonical seed target identified by CLASH and had the highest number of reads 
sequenced by CLASH. The remaining eight genes had either non-canonical, or 
unidentifiable target sites. The only gene with canonical seed was the top hit in both 
3´LIFE and CLASH, and 7 out of 9 CLASH hits have some degree of repression in 
3´LIFE, although only 3 significantly. While there may be subtle differences in 
miRNA targets by closely related miRNA family members, this comparison suggests 
that binding (as shown by CLASH) is not an accurate proxy for functional repression 
(as shown by 3´LIFE). 
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(Figure 3.19). Dual luciferase reporter assays are rapid, sensitive, quantitative, and 
measure the functional output of miRNA interactions at the protein level. Despite the 
widespread use of dual luciferase assays to validate miRNA targets, the notable lack of 
use in initial high-throughput screens speaks to the substantial technical and 
methodological barriers to such applications. These barriers include the lack of a high-
quality publicly available 3´UTR reporter library, the high costs associated with 
transfection and luciferase assay reagents, and the absence of standardized high-
throughput protocols and data analysis pipelines. 
The 3´LIFE assay overcomes the above challenges by 1) measuring the effect of 
miRNA targeting at the protein level, 2) utilizing a reporter assay that is quantitative and 
highly sensitive to subtle fluctuations in protein concentration, 3) does not rely on prior 
assumptions about miRNA targets to generate candidate gene libraries [307], and 4) by 
using a high-throughput screening approach it becomes possible to detect subtle 
repression in a large number of genes due to the large number of negative interactions 
built into the assay. This last point is of critical importance, in that evidence suggests that 
miRNAs exert significant influence on the transcriptome not by strongly repressing 
individual genes, but by subtly repressing many targets (see Discussion below).  
In this proof-of-principle screen we tested 275 3´UTRs for targeting by let-7c and 
miR-10b, and observed repression in a large number of novel putative targets, eight of ten 
previously validated targets, and 62% of the bioinformatically predicted genes included 
in this 3´UTR library (Figure 3.12). Among the top hits in the 3´LIFE assay were genes 
targeted by non-canonical target sites (27%) (Figure 3.15), poorly conserved canonical 
seeds (Figure 3.17), and genes frequently utilizing G:U wobble pairing (Figure 3.16, 
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Appendix A). These degenerate targeting principles expand the repertoire of potential 
miRNA target sites, contribute to the observation that only 32% of the top 3´LIFE hits 
were bioinformatically predicted, and support the use of unbiased high-throughput 
experimental approaches to identify miRNA targets. 
Surprisingly, 20% of previously validated targets and 38% of bioinformatically 
predicted targets showed no detectable degree of repression. Previous groups have 
reported similar false positive rates for prediction algorithms [126, 165], suggesting that 
algorithm error rates may account for the lack of targeting in this screen. However, false 
negatives could also be explained by several biological factors. First, sequence elements 
flanking putative canonical target sites that possess high degrees of secondary structure 
may have a critical impact on target recognition by restricting the access of the miRNA 
silencing machinery to the target site [160, 190]. Second, cooperative repression by 
multiple miRNA target sites [179] or interactions with trans-acting factors such as RNA-
binding proteins [180] can contribute to miRNA target recognition that requires multiple 
trans-acting factors, resulting in targeting only in specific contexts. Third, recent studies 
indicate that a large portion of eukaryotic mRNAs are reversibly methylated, 
preferentially within non-coding regulatory regions, and potentially contributing to the 
evasion of miRNA targeting [438]. Lastly, alternative polyadenylation may increase the 
false negative rate in the 3´LIFE assay. 50% of human genes contain multiple 
polyadenylation signals (PAS) within 3´UTRs that signal transcription termination, 
cleavage, and polyadenylation [439, 440]. Rapidly proliferating and tumor cells were 
shown to possess, on average, shorter 3´UTR isoforms, a mechanism resulting in the 
evasion of miRNA regulation [176-178]
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the exclusion of miRNA target sites in a context dependent manner, by producing short 
3´UTR isoforms only in certain cell lines or tissues. Thus, context specific targeting 
mechanisms, including interactions with trans-acting factors and alternative 
polyadenylation, may contribute to false negatives in the 3´LIFE assay.  
Conversely, overexpression of regulatory factors, such as miRNAs, may yield 
false positive results due to non-specific repression of the reporter gene, or 
supraphysiological expression levels driving specific, yet biologically irrelevant 
repression. The first scenario results from cascades of regulatory interactions that may 
alter the expression levels of other regulatory genes, which in turn target the reporter. 
Such false positives are a major caveat to overexpression experiments, and in general are 
difficult to detect. Non-specific effects are particularly pronounced in experiments 
utilizing RNA-Seq or proteomics approaches to identify miRNA targets among 
endogenous genes, in that the repression can occur both pre- and post-transcriptionally, 
and be driven by sequence elements at any region of the mRNA. Because 3´LIFE utilizes 
only the 3´UTR in the reporter genes, non-specific effects are minimized to downstream 
factors that regulate elements within the 3´UTR, such as miRNAs and RNA-binding 
proteins. 3´LIFE minimizes these effects by performing the luciferase assay shortly (48-
72 hrs) following transfection, reducing the time in which any changes may occur. Any 
non-specific targeting effects would have to occur following a chain of events, including 
transcription and processing of the exogenous miRNA, miRNA targeting, and any 
subsequent downstream events (i.e. transcription and translation/miRNA processing). 
Finally, these changes would need to result in the down-regulation of the reporter 3´UTR 
to an extent comparable with the strongly expressed exogenous miRNA. Several pieces 
101 
of evidence suggest that the top hits detected by 3´LIFE suffer little from such false 
positives. First, 73% of the top hits detected by 3´LIFE contain canonical miRNA target 
sites, a significant enrichment compared to the remainder of the library (~17%) (Figure 
3.13). Second, among the non-canonical putative target genes, we have experimentally 
validated direct targeting of two genes by deletion analysis (Figure 3.17), suggesting that 
3´LIFE can identify direct repression of genes targeted via non-canonical sites. Lastly, we 
observe relative conservation of the canonical seed elements, both predicted and 
unpredicted, within our top hits, suggesting that these are evolutionarily maintained 
functional target sites (Figure 3.17). While false positives due to indirect regulatory 
interactions are certainly plausible events, the above evidence suggests that the top hits 
from 3´LIFE are bona fide direct miRNA targets.  
The second scenario yielding false positives, where miRNA overexpression 
results in specific and direct regulatory interactions that only occur at supraphysiological 
levels, is a primary concern in generalizing results from experiments that rely on miRNA 
overexpression. The relative abundance between miRNAs and their target mRNA can 
influence the degree of repression, as well as the phenotypic consequences of miRNA 
targeting, thus experimental approaches that mimic physiological miRNA/mRNA levels 
may yield less such false positives. To address this concern we screened a portion of the 
3´UTR library with miRNAs driven by a relatively weak promoter that drives both the 
luciferase reporter and miRNA genes (Figure 3.14). The weak promoter repressed 10 of 
the 13 top hits identified by the strong promoter, albeit to a lesser extent. Interestingly, 
there were also three genes that were significantly repressed by the weak promoter and 
not the strong promoter (Figure 3.14). Of these three genes, two contain perfect seed 
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matches, and the third a perfect seed shifted one nucleotide outside of the canonical 
position. 
This data suggests that while the majority of 3´UTRs are consistently repressed 
regardless of the degree of overexpression in the 3´LIFE assay, miRNA overexpression 
may yield both false positive and false negative results. In conclusion, the context, i.e. 
cell lines, used to identify miRNA targets is typically dependent on the biological 
questions being asked, therefore caution must be taken when generalizing results across 
cellular contexts.  
 
MiRNAs target multiple genes within biological pathways 
The effect of miRNA targeting on protein production is generally understood to 
result in modest translational repression [126, 161], and can be influenced by several 
factors. These factors include the number of target sites in the mRNA, target site 
characteristics, with interactions guided by canonical seeds and high degrees of 
complementarity in the 3´ end of the miRNA resulting in stronger repression, and 
position in the 3´UTR relative to the polyadenylation site, with more distal target sites 
generally showing stronger repression [161]. These observations led to the hypothesis 
that a primary effect of gene regulation via miRNAs serves not as a switch, turning 
protein production on or off, but instead functions as a mechanism to fine-tune protein 
output, protect against aberrant levels of gene expression, and provide robustness to cell 
specific programs [224, 441]. Thus, the discrepancy between the modest impact a 
miRNA has on any single message and the powerful role specific miRNAs have in 
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diverse biological processes, suggests that miRNAs must target multiple genes at various 
nodes in these networks in order to obtain more vigorous regulation. For the emergence 
of such a multi-faceted mechanism, miRNAs and/or their targets would require a high 
degree of evolvability. In support of this notion is the observation that in metazoan 
genomes miRNAs have undergone three major expansions in recent evolutionary history, 
with the number of miRNAs correlating with organismal complexity [59]. These 
expansions are driven primarily by the duplication and divergence of miRNAs, resulting 
in miRNA families, members of which are distinguished by only a few nucleotides in the 
mature miRNA. Furthermore, the small size and degenerate nature of miRNA target 
elements, combined with the relatively rapid evolutionary flexibility of 3´UTRs [442], 
suggests that miRNAs are capable of readily evolving novel targets [286]. Consistent 
with these hypotheses, the 3´LIFE assay identified an enrichment of specific pathways 
among the top hits targeted by each miRNA, including central members, upstream 
regulators, and downstream effectors of RAS signaling for let-7c, and the retinoic acid 
signaling pathway for miR-10b. 
 
let-7c targets multiple genes within the RAS signaling pathway 
Loss of let-7 family members correlates with poor survival rates in many cancers 
[254, 309-311], in part by inhibiting the RAS signaling pathway by targeting several 
elements within the 3´UTRs of KRAS and NRAS [253, 314, 443]. Consistent with the 
hypothesis that miRNAs function by targeting multiple members of the same pathway, 
the top hits for let-7c identified by 3´LIFE were enriched for multiple genes within the 
RAS signaling pathway. Among these genes were two small GTPases within the RAS 
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superfamily (RhoB, RhoV). RhoB has conflicting reports of its role in tumorigenesis 
dependent on tumor type [330, 331, 444]. let-7c targets RhoB at a single non-canonical 
target site (Figure 3.18). Recent evidence also suggests that RhoV overexpression may 
contribute to tumorigenesis [445]. In addition to these central signaling components, 
3´LIFE also identified several downstream effectors of the RAS signal (ID1, HSF1, 
CRK, DNMT1, ARID3A, EZH2). Inhibitor of differentiation 1 (ID1) regulates the 
activity of several transcription factors, is positively correlated with tumor progression, is 
transcriptionally activated in a KRAS dependent manner in culture [341], is a 
downstream effector or RAS signaling in fibrosarcomas [342], and cooperates with RAS 
in metastatic breast tumors in vivo [343]. Heat shock factor 1 (HSF1) is a transcription 
factor and downstream effector of RAS signaling, and is required for malignant 
transformation induced by oncogenic RAS [353-356, 446]. V-CRK avian sarcoma virus 
oncogene (CRK) is an adaptor protein that binds to several tyrosine-phosphorylated 
proteins, and by interacting with multiple signaling pathways suppresses call adhesion 
and contributes to transformation in the presence of oncogenic RAS [447] [448]. AT-rich 
interacting domain 3A (ARID3A) is a transcription factor that has been shown to rescue 
RAS-induced senescence, promoting cell survival and immortalization [377, 449]. DNA 
methyltransferase 1 (DNMT1) is overexpressed in a variety of tumors and is required for 
RAS-dependent epigenetic silencing of several tumor suppressors [373, 374, 450]. 
Enhancer of zeste homolog 2 (EZH2) is a member of the polycomb family of 
transcriptional repressor proteins, its expression is an initiating event a variety of tumors 
is induced by oncogenic RAS, and results in a wide range of downstream effects 
including transformation and metastasis [451];Cai, 2012 #40085;Min, 2010 #40077}. 
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Among these eight let-7c target genes, ARID3A and EZH2 are the only bioinformatically 
predicted targets (Figure 3.12), while CRK, ARID3A, EZH2, and HSF1 contain 
canonical seed elements within their 3´UTRs (Figure 3.15).  
 
miR-10b targets are enriched for multiple genes within the retinoic acid (RA) signaling 
pathway 
Recent studies link the miR-10 family to the retinoic acid signaling pathway, yet 
report conflicting roles of these miRNAs in tumor progression. In neuroblastoma miR-
10a and miR-10b positively regulate the activity of retinoic acid (RA) signaling and 
promote differentiation [316], while the ability of miR-10a to promote metastasis in 
pancreatic ductal adenocarcinoma is inhibited by RA treatment [452]. While context is 
critical in relation to the response of a cell to retinoic acid signaling, the overexpression 
of miR-10 in various late stage tumors and its induction of invasion and migration is well 
documented [453, 454]. In line with these observations, 3´LIFE confirmed three 
previously validated targets (SDC1, NCOR2, HOXD10) and identified seven novel 
targets of miR-10b with various roles in the RA signaling pathway. These include 
upstream regulatory effectors of the RA response (RARG, NCOA6, NCOR2, ASCL2), as 
well as downstream transcriptional targets (HOXD1, HOXD10, HOXD11, SDC1, 
STAT6, MYF5).  
The effectors of the retinoic acid response, the retinoic acid receptors (RARs), are 
ligand dependent transcription factors that are central regulators of a wide range of 
biological processes. RA is a potent inhibitor of tumorigenesis by activating networks of 
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genes via RARs [455], and generally promotes differentiation in various contexts [456]. 
The retinoic acid receptor gamma (RARG) was a top hit in 3´LIFE, and has been linked 
to conflicting aspects of tumorigenesis. RARG promotes differentiation and cell cycle 
arrest in keratinocytes [406] and neuroblastoma [407], and differentiation, apoptosis 
[457], and inhibition of invasiveness in melanomas [408]. Conversely, RARG has been 
shown to have oncogenic properties in carcinomas by activating the Akt/NF-kβ and 
Wnt/β-catenin pathways [409, 410]. NCOR2/SMRT and NCOA6/ASC2 are both nuclear 
receptor cofactors which physically interact with the RARs. NCOR2/SMRT has 
conflicting reports of its contribution to tumorigenesis dependent on tumor type, but is 
responsible for integrating estrogen and retinoic acid receptor signals by recruiting 
chromatin remodeling complexes that repress target gene transcription in the absence of 
the ligand hormone [458]. In contrast, NCOA6/ASC2 is a nuclear receptor coactivator 
that outcompetes nuclear corepressors in binding nuclear receptors in the presence of 
retinoic acid, resulting in transcriptional activation of RAR target genes. NCOA6/ASC2 
is also frequently up-regulated in various tumors [423, 459]. ASCL2 is a transcription 
factor that is critical in the maintenance of adult intestinal stem cells, and interacts with 
RARs via direct interaction with NCOA6 [460]. 
Interestingly, we also identified several downstream transcriptional targets of 
retinoic acid signaling, including, HOXD1, HOXD10, and HOXD11, whose genomic 
locus also contains the miR-10b gene itself. The entire HOXD gene cluster responds to 
RA treatment by sequentially activating the transcription of the HOXD genes, generally 
promoting the differentiation of a variety of tissues [461, 462]. HOXD10 is the only 
bioinformatically predicted member of the HOXD cluster and was the first 
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experimentally validated target of miR-10b, yet we identify three members of this cluster 
as targets of miR-10b, and demonstrate that miR-10b targets HOXD11 by a single non-
canonical target site (Figure 3C). SDC1/CD138 is a cell surface proteoglycan which 
plays a role in adhesion to the extracellular matrix [403], is frequently downregulated in 
multiple myelomas [463] and other cancers, and is up-regulated in response to RA 
treatment [464, 465]. STAT6 is a transcription factor that is a key effector of IL4 
mediated signaling, and promotes growth inhibition, apoptosis, and differentiation in 
breast tumors [429, 466]. STAT6 is also transcriptionally activated in response to RA 
treatment in T-helper cells [466], and requires interaction with a nuclear receptor 
coactivator (NCOA1) to enact the IL4 response in hepatocytes [467]. Lastly, MYF5, a 
transcription factor central to skeletal muscle differentiation, is also activated in response 
to retinoic acid in the developing limb bud [468]. Among these ten targets of miR-10b, 
NCOR2, NCOA6, HOXD10, and SDC1 are the only bioinformatically predicted targets 
(Figure 3.12), and RARG, NCOR2, NCOA6, HOXD1, HOXD10, SDC1, and STAT6 
contain canonical seed elements within their 3´UTRs (Figure 3.15).  
The identification of target genes associated with RAS signaling (let-7c) and 
retinoic acid signaling (miR-10b) by 3´LIFE, is consistent with the known roles of these 
miRNAs as either negative or positive regulators of tumorigenesis, respectively, and 
potentially broadens the scope by which they target these pathways. Furthermore, the 
novel, non-canonical, and unpredicted targets within these pathways suggests that 
unbiased, high-throughput approach to identify miRNA targets is a productive approach 
to identify regulatory networks targeted by miRNAs. 
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In conclusion, our study suggests that 3´LIFE is a powerful method to identify 
novel and non-canonical miRNA targets, and identify mechanisms by which miRNAs 
contribute to biological processes that conveys several advantages over current methods. 
First, 3´LIFE is a comprehensive screen because it utilizes all functional elements present 
in each 3´UTR that are targeted by the query miRNA. Second, 3´LIFE is unbiased, since 
it probes one interaction at a time and does not rely on prior assumptions about target 
genes. Third, the detection of a miRNA target requires direct translational inhibition of 
the 3´UTR in the presence of the miRNA, providing a functional measure of targeting. 
Fourth, the sensitivity of the assay is greatly improved by its high-throughput nature, 
revealing subtle targeting of multiple genes within regulatory networks. Lastly, 3´LIFE is 
flexible in that it can be adapted to detect other functional elements in 3´UTRs targeted 
by non-coding RNAs and RNA binding proteins. While the biological relevance of 
miRNA targets identified by 3´LIFE cannot be assigned, this assay provides rapid 
detection and initial validation of direct miRNA/3´UTR target interaction at a scale not 
possible with current methods.  
 
Experimental 
MiRNA target analysis of target prediction software:  
 We have extracted the predicted targets and their prediction scores for the miRNAs 
let-7c, miR-10b, miR-125a, miR-138 and miR-22 from the TargetScan [183], PicTar 
[181], and Diana-microT [321] websites. The target score for each gene was normalized 
using the mean target score per miRNA. The list of the validated targets was compiled 
using Tarbase [469], miRTarBase [319] and a manual literature search using the gene 
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name and all aliases listed in NCBI gene database. A gene was assigned as a validated 
target if it had at least two distinct experimental methods demonstrating direct miRNA 
regulation.  
 
pLIFE-3´UTR Vector Construction:  
The original luciferase vector T7 DLP was kindly provided by Dr. John Chaput. 
The SV40 3´UTR was amplified from the pcDNA3.1/V5-his vector, and introduced 
downstream of the Renilla luciferase open reading frame by introducing the restriction 
sites for NsiI and XmaJI ( Figure 2A). The IRES was replaced with the PGK promoter by 
introducing a PstI restriction site and ligating using BamHI and PstI restriction sites 
upstream of Firefly luciferase. The P2R-P3 Gateway cassette was amplified from the 
pDONR P2R-P3 (Invitrogen), and cloned downstream of Firefly luciferase gene by 
introducing BglII and NheI restriction sites. MS2 repeats were amplified from pSL-MS2-
6x (AddGene Clone ID: 27118). Four MS2 repeats were cloned downstream of Firefly 
luciferase using BglII and ApaI restriction sites for use in downstream RNA isolation 
protocols. This vector is available through DNASU (http://dnasu.org Clone 
ID EvNO00601503) [324]. 
 
pLIFE-miRNA Vector Construction:  
The miRNA expression vector (pLIFE-miRNA) was adapted from the pCAG-
RFP-miRint plasmid [322]. The CAG promoter was replaced with the CMV promoter by 
introducing SpeI and SacI restriction sites upstream of the DSRed2 open reading frame 
using QuickChange site-directed mutagenesis (Agilent). let-7c and miR-10b genomic 
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DNA sequences were amplified from human genomic DNA and cloned into the pLIFE-
miR vector using the AsiSI and NotI restriction sites. We included ~200 nucleotides 
upstream and downstream from the surrounding genomic locus to replicate endogenous 
miRNA processing. We also created a Gateway compatible miRNA expression plasmid, 
which contains the L2R3 Gateway cassette cloned into AsiSI and MluI Restriction sites 
(Supplemental Figure 2B). This vector is available through DNASU (http://dnasu.org, 
Clone ID EvNO00601504) [324]. To prepare the pLIFE-PGK miRNA expression vector, 
which produces low expression level for the test miRNAs, we amplified the PGK 
promoter from the pLIFE-3´UTR plasmid and ligated it into the pLIFE-miRNA plasmid 
using SpeI and XhoI Restriction sites. 
 
Test 3´UTR Library Preparation:  
We designed primers to amplify 384 3´UTRs from various protein-coding genes 
based on the RefSeq annotation (HG19), and custom Perl scripts [172]. Forward primers 
were anchored to the 3´ end of the terminal exon. Reverse primers anchor ~150 
nucleotides beyond the end of the longest annotated 3´UTR to include putative elements 
important for mRNA processing [470]. The attB2 and attB3 Gateway cloning elements 
were added to the ends for the forward and reverse primers, respectively. Primers were 
arrayed based on annealing temperature and expected amplicon size. Genomic DNA was 
isolated from HEK293T cells using DNAzol (Invitrogen), per manufacturer’s protocol. 
Touchdown-PCR (TDPCR) from genomic DNA was conducted using Taq polymerase 
(Invitrogen) in 96 well plates with 100ng genomic DNA per PCR reaction. Cycling 
conditions were based on manufacturers protocol, with the addition of ~15 touchdown 
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cycles, where the annealing temperature started at 14 degrees above the lowest primer 
Tm on each plate, and decreasing 1 degree per cycle for 15 cycles. Remaining cycles 
were carried out at 55 degrees. Amplicons were then recombined into the pLIFE-3´UTR 
vector using BP Clonase reactions (Invitrogen) per manufacturer's protocol. Cloning 
reactions were incubated overnight at room temperature, and 1 µL of the cloning reaction 
was transformed into DH5-α bacteria cells and plated on 48 well LB-amp agar plates. We 
initially picked one colony per well, and individual colonies were screened for correct 
size using universal primers that flank the P2R-P3 cassette in colony PCR experiments. 
20% were randomly picked and sequence verified. Clones that passed these tests were 
further used in the 3´LIFE assay. In our positive and negative control experiments, we 
recombined the SV40 3´UTR into the pLIFE-3´UTR vector using BP Clonase 
(Invitrogen), and introducing control miRNA targets for let-7c, 
(AACCATACAACCTACTACCTCA), and miR-10b 
(ACAAATTCGGTTCTACAGGGTA) using QuickChange site-directed mutagenesis 
(Agilent). Putative miRNA seeds in RhoB and HOXD11 were deleted from the 3´UTR 
luciferase reporter plasmids using QuickChange site-directed mutagenesis. 
 
Plasmid DNA Preparation:  
pLIFE-miRNA plasmids were prepared using Maxi Preps (Promega) and the 
recovered DNA was resuspended to a concentration of 500 ng/µL. Bacterial stocks of 
pLIFE-3´UTR plasmids were arrayed in 96-well 2mL blocks and grown for ~16 hours in 
1.3 mL Terrific Broth. Plasmids were purified using the Nucleospin 96-well mini-prep kit 
(Macherey-Nagel) and the Biomek FX (Beckman Coulter) liquid handling robot 
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according to manufacturers protocol. DNA was eluted in 50 µL of nuclease-free water. 
DNA concentrations were then normalized to ~100 ng/µL using the Biomek FX liquid 
handling robot. To facilitate the assay in high-throughput we have also optimized this 
step using an in-house HighRes Biosolutions fully automated DNA miniprep systems that 
includes three Liconic automated 800RPM/37C incubators, one automated Liconic 
automated -20°C freezer, three Denso fully articulated robotic arms, two Heraus robotic 
centrifuges, two Thermo Wellmate bulk dispensers, one Thermo combi bulk dispenser, 
two KBio Wasp automated plate sealers, one Nexus automated plate pealer, one 
Molecular Devices DTX880 Plate Reader, one Beckman Biomek FX dual arm 96/SPAN 
8 liquid Handler, one EL405 plate washer, and two ambient automated plate storage 
hotels. 
 
Cell Culture 
HEK293T cells were kindly provided by Dr. Josh LaBaer. Cells were cultured in 
Dulbecco's Modified Eagle Medium (DMEM) (Sigma), supplemented with 10% fetal 
bovine serum (FBS) (Fisher) and 1% penicillin/streptomycin (Fisher).  
 
Nucleofection Buffer Test  
A significant cost associated with high-throughput cell based assays is 
consumable reagents associated with transfection, thus we tested a panel of buffers for 
efficient transfection and cell survival using the 96-well Shuttle Device by Lonza. An 
initial panel of 11 buffers and the SF cell line solution (Lonza), was used to transfect 
1x105 HEK293T cells with 100 ng pmaxGFP plasmid (Lonza). Each buffer was tested 
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using several different nucleofection pulse codes. As the conditions of these pulse codes 
are proprietary, exact pulse conditions are unknown. The pulse codes tested were ER100, 
CU123, CM102, EO115, DT130, FF120, CN114, CM130, CB150, DS150, CA123, and 
DS138. We tested the following buffer solutions: PBS (pH 7.4), PBS + 10% HEPES (pH 
7.0), PBS + 10% HEPES (pH 7.4), PBS + 5% HEPES (pH 7.0), PBS + 1.5% HEPES (pH 
7.0), HEPES Buffered Saline (HBS), 50% PBS/50% HBS, BD Perm Wash, 
Electroporation Buffer, and Phosphate buffered Sucrose. HBS solution contains 140 mM 
NaCl + 1.5 mM Na2HPO4•2H2O + 50 mM HEPES. Electroporation buffer contains 
15mM potassium phosphate + 1mM MgCl2 + 250 mM sucrose + 10mM HEPES adjusted 
to pH 7.3 using concentrated HCl. Phosphate buffered sucrose solution contains 272 mM 
sucrose + 7 mM K2HPO4 and is pH adjusted to 7.4 with phosphoric acid. HBS and PBS 
HEPES consistently produced high transfection efficiency and/or cell survival, so we 
performed secondary experiments using permutations of pH and buffer composition. 
75%PBS/25%HBS, 50%PBS/50% HBS, 25%PBS/75% HBS, PBS 1% HEPES (pH 7.0), 
PBS 1.5% HEPES (pH 7.0), PBS 1.5% HEPES (pH 6.4), PBS 1.5% HEPES (pH 7.4), 
and PBS 2% HEPES (pH 7.0). Because PBS 1.5% HEPES (pH 7.0) in combination with 
the FF120 pulse code yielded relatively few nucleofection errors, had high transfection 
efficiency, and relatively high cell survival with HEK293T cells, this protocol was used 
for all subsequent experiments. 
 
Nucleofection Protocol 
A detailed 3´LIFE protocol is available at www.mangonelab.com. In brief, cells 
were grown to ~90% confluency and passaged between 24 and 48 hours prior to 
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transfection to be in logarithmic growth phase at time of transfection. Cells were removed 
from 145mm parent culture plate with .25% trypsin (Fisher) for 3 minutes, washed with 
an equal volume of media, and spun for 5 minutes at 300g. Media/trypsin was eluted, and 
cell pellet was resuspended to a density of ~3.0x107 cells/ml. For each well, 100,000 cells 
were pelleted and resuspended in 20 µL of nucleofection buffer/plasmid solution, in 
presence of no more than 2 µL of plasmid DNA (10% total volume). Each well contained 
a plasmid solution composed of 500 ng of pLIFE-miRNA, and 100 ng of pLIFE-3´UTR. 
Cell/buffer solution was loaded into a 96-well shuttle plate, and transfected via 
nucleofection using the 96-well Shuttle System according to manufacturer's conditions 
(Lonza). Immediately following nucleofection, 80 µL of pre-warmed complete media 
was added into each well. Transfected cells were then transferred to a 96-well culture 
plate to total volume of 200 µL media. Each plate containing human 3´UTRs cloned into 
pLIFE-3´UTR vector was transfected in quadruplicate, with each replicate co-transfected 
with either the empty miRNA vector control, pLIFE-miR let-7c or miR-10b. Transfected 
cells were for 48-72 hours post transfection to minimize non-specific effects caused by 
cascades of changing gene expression due to exogenous miRNAs. Cell are then imaged 
using fluorescence microscopy and dsRed2 protein to identify wells with failed 
transfections, and subjected to the luciferase assay.  
 
Luciferase assay 
Prior to luciferase assay, the media was removed, and cells were lysed for 30 
minutes in presence of 26 µL of passive lysis buffer (Promega) and gentle rocking. 25 µL 
of total lysate was removed from the culture plate and transfered to opaque white 96-well 
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plates and used in the luminescence assay. The non-commercial dual-luciferase buffer 
was prepared as previously described [306]. Coelentarazine (Promega) was resuspended 
in 5mM acidified methanol and stored at -80°C. Beetle luciferin (Promega) was 
resuspended in nuclease-free water and stored at -80°C. Individual buffer components 
were prepared and stored at 10X concentration. Buffers were prepared fresh with stored 
reagents prior to each luciferase assay. Luminescence was measured using the Glomax 96 
Microplate Luminometer with dual injectors (Promega). 100 µL of Firefly luciferase and 
Renilla buffers were injected sequentially, followed by a 5 second delay and a 10 second 
measurement time. 
Statistical Analysis of Luciferase Assay 
Raw data from Firefly and Renilla luciferase luminescence assay was recorded for 
each well. We calculated the ratio between Firefly and Renilla using the relative light 
units (RLU) obtained for each well, to control for variation in DNA concentrations, cell 
number, and transfection efficiency. The ratio of the Firefly and Renilla luciferase values 
between the negative miRNA control and its correspondent miRNA experiment were 
then used to calculate the absolute repression (A) for each well using the following 
formula (1). 
 
 
The mean absolute repression of each plate was calculated by averaging the 
repression of each well in across a plate, and used to normalize each well to obtain the 
normalized repression value (N) (2). 
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This transformation measures repression as a function of all the 3´UTRs on each 
plate and allows the comparison of replicates of the experiment, removing fluctuations in 
raw FLuc/Ren ratios caused by subtle variation in the luciferase buffers and 
luminometers. Each plate is performed in quadruplicate on different days, and normalized 
repression ratios for each well are averaged to obtain miRNA Repression index (RI) (3).  
 
 
We then rank the results based on the RI value, and putative hits are defined as 
3´UTRs with an RI<0.80, and obtain a statistically significant repression (p-value<0.05) 
using student’s t-test.  
 
pLIFE-PGK Secondary Screen 
To quantify PGK expression levels, pmiRNA-LIFE or pmiRNA-LIFE-PGK were 
cotransfected with the pmaxGFP plasmid (Lonza). Fluorescent images for RFP and GFP 
were obtained, and expression levels were calculated using ImageJ (NIH) with standard 
parameters. To test the effect of miRNA overexpression on positive hits, one plate 
containing 87 3´UTRs were screened for targeting by let-7c and miR-10b driven by the 
PGK promoter. Experiments were performed with four replicates. Results were analyzed 
as above.  
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MiRNA Target Literature Review 
The genes with an RI score<0.8 and p-value<0.05 were analyzed in a literature 
search for potential contributions to tumorigenesis. In the case of a gene having roles in 
tumors of different origins, emphasis was placed on tumors originating in breast tissues 
due to the relevance of let-7c and miR-10b to breast cancer progression. Criteria for 
placing each gene into a category as either a positive or negative driver of tumorigenesis 
included evidence of over expression or down regulation, if its role was classified in at 
least two publications, and was associated with a defined mechanism of action. Cases 
where a gene has opposing roles in distinct tissues of origin are noted with dual color 
annotation. References used in this analysis are provided in Table 3.1. 
 
MiRNA Target Alignment  
The 3´UTRs of top putative hits were analyzed for potential miRNA target sites 
using ClustalW [471]. To identify both canonical and likely non-canonical targets, 
individual alignments were attempted for nucleotides 2-7,1-9,10-22, and the entirety of 
the miRNA, against each 3´UTR. The gap open and gap extension parameters were 
adjusted between 10-25 and .5-5, respectively, to obtain the best alignment in terms of 
seed binding and 3´ compensatory complementarity. To create the miRNA binding 
footprint we used the WebLogo software [302]. Gaps in the binding footprint 
corresponding to loops in the mRNA were removed leaving only the nucleotides that 
interact with the miRNA. G:U wobbles were accounted for by first running the software 
with all normal sequences. Second, we temporarily replacing all U’s in mRNA sequence 
with C if the interacting miRNA nucleotide corresponded with a G, and replaced all G’s 
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with A if the corresponding miRNA nucleotide was a U. Third, we reran the software, 
measuring the height of the combined wobble peaks, and fourth, corrected the original 
WebLogo with the heights corresponding to the number of bits expected if G:U wobbles 
are accounted for.  
 
Comparison with AGO-HITS-CLIP CLASH dataset from Helwak, et al. 
The complete supplemental dataset from Helwak, et al. [206] was downloaded 
from http://www.cell.com/cell/abstract/S0092-8674%2813%2900439-X. Chimeric reads 
from all let-7 and miR-10 family members were searched for genes that were also present 
in the 3´LIFE library. Genes whose reads mapped to regions other than the 3´UTR were 
binned separately. Genes with chimeric reads in the 3´UTR were compared against the 
scores from the 3´LIFE assay. 
 
Analysis of 3´UTR conservation using PhyloP 
For each hit in the 3´LIFE assay that contained a canonical seed, defined as 
perfect complementarity with no G:U wobbles in nucleotides 2-7 of the miRNA, 
conservation scores were identified using the 100 vertebrates Basewise Conservation by 
PhyloP track [472] in the UCSC genome browser. For each gene conservation scores for 
three loci were obtained: the six nucleotide seed, 200 nucleotides flanking the seed (score 
includes seed site), and up to 200 nucleotides of the terminal exon.  
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CHAPTER 4  
MICRORNAS REPRESS GENES WITHIN REGULATORY NETWORKS  
AT CONTEXT DEPENDENT TARGET SITES 
 
Publication Note 
The research reported in this chapter is in press in Genome Research by Justin M. 
Wolter, Hoai Huang Thi Le, Alexander Linse, Victoria A. Godlove, Thuy-Duyen 
Nguyen, Kasuen Kotagama, Alissa Lynch, Alan Rawls, and Marco Mangone. 
Evolutionary Principles of Metazoan microRNAs Reveal Targeting Principles in the 
Human let-7 and miR-10 families. Genome Research. 2016 (in press). All co-authors 
have granted permission for this work to be included in this dissertation. 
 
Overview 
MiRNAs alone have no biochemical function; instead their sequence serves to 
guide the RISC to target sites on 3´UTRs. The interaction between the RISC and the 
mRNA leads to a reduction of the protein expression of the target mRNA. The repression 
of the miRNA target is what effects cell behavior and morphology. Thus, identifying 
target genes is a central goal of miRNA research, and is critical to gain an understanding 
of how each miRNA contributes to specific biological processes. Chapter 3 detailed the 
pros and cons of several high-throughput approaches to identify miRNA targets, the most 
common of which couples miRNA overexpression/depletion followed with the 
quantification of mRNA levels by RNA-seq. However, as a reduction in protein level is 
the most biologically relevant result of miRNA targeting, protein focused approaches 
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may reveal novel information about general miRNA targeting principles not attainable by 
measuring RNA abundance alone. The proof-of-principle experiments in Chapter 3 
demonstrate the value of combining a protein-centered approach with high-throughput 
screening. The resulting assay, called Luminescent identification of functional elements 
in 3´UTRS (3´LIFE), can be used to address key questions about miRNA targeting and 
function. Below is a discussion of three specific hypotheses we test using the 3´LIFE 
assay. 
First, the general model of miRNA target recognition suggests that the central 
region of the miRNA does not play a substantial role in target recognition or repression 
strength (see Figure 1.10 and discussion in Chapter 2). This model is based on previous 
data using conservation, RNA-seq, and biochemical approaches. However, none of these 
approaches directly measure the functional output of miRNA targeting at the protein 
level. It is unclear if these conclusions will be upheld when looking at a more relevant 
measure of miRNA targeting. Furthermore, because the majority of the evolutionary 
hotspots that we identified in Chapter 2 fall within the central region of the miRNA (see 
Figure 2.8, 2.11), addressing this question has clear relevance for the function of 
nucleotide changes between highly similar miRNA family members.  
Second, in the proof-of-principle 3´LIFE experiments, we identified many 
canonical miRNA targets that did not grant functional repression. Surprisingly, while we 
validated the majority of previously identified targets in our screen (see Figure 3.12), 
there were several that did not grant functional repression. This observation also held true 
for bioinformatic predictions, which greatly overestimated the number of functional 
canonical target sites (see Figure 3.12). However, the conclusions that we can draw about 
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features of target sites that contribute to repression is limited by the low numbers of 
genes tested in our proof-of-principle experiments in Chapter 3. We will address these 
questions by expanding the 3´UTR library, and performing an unbiased screen of ~1,400 
full length human 3´UTRs. 
Lastly, the modest effect of miRNA targeting on individual protein expression 
suggests that miRNAs may productively impact cell fate by targeting multiple 
components of regulatory networks. This has been previously demonstrated 
experimentally by measuring mRNA abundance following miRNA perturbations [473], 
bioinformatically using multiple features of target sites and pathway annotations [474], 
and by high-throughput screening for direct miRNA targets [167]. We hypothesize that 
each miRNA targets a large number of genes with cooperative function in specific 
regulatory networks. However, the prediction and detection of bona fide miRNA targets 
using traditional approaches is difficult because of the complexity of targeting principles 
and the multiple mechanisms of translational repression. For example, RNA-seq or 
quantitative proteomics approaches may capture only a subset of the mechanisms by 
which miRNAs repress target genes [128]. Furthermore, extracting targets from gene lists 
is complicated by the high frequency of non-canonical targeting mechanisms [167]. 
3´LIFE assay overcomes many of these limitations, and can be used to discover 
cooperative networks of genes that are targeted by each miRNA.   
To address these three questions, we applied the 3´LIFE assay to a panel of 1,407 
full-length human 3´UTRs and two diseases relevant miRNAs. This library was 
generated using the same cloning pipeline described in Chapter 3, but greatly expands the 
capabilities of the 3´LIFE screen. The library was selectively enriched for factors that 
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play key regulatory roles in cells, such as transcription factors, RNA-binding proteins, 
kinases, and other genes with known regulatory functions [475]. To our knowledge, this 
screen represents the largest scale use of luciferase assays for the detection of miRNA 
targets performed to date. Our results suggest that 1) individual miRNAs recognize 
distinct features of target sites, 2) the context of the target site in the 3´UTR significantly 
impacts the degree of repression, and 3) miRNAs preferentially regulate a large number 
of genes within biological pathways.  
 
 
Figure 4.1. The human 3´UTR Clone Library v1. Pictured are 16 96-well agarose 
gels, with each well corresponding to one 3´UTR cloned into the pLIFE-3´UTR 
expression plasmid. The library was enriched for 3´UTRs belonging to genes with key 
regulatory functions, such as transcription factors, RNA binding proteins, and kinases. 
The table represents the number of proteins in the humane genome in each of these 
classes, and the number that were cloned in the library. Figure adapted from Kotagama 
et al. (2015) BMC Genomics. 
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Results 
Different miRNAs employ distinct targeting footprints 
Evidence from diverse approaches suggests that the central region of miRNAs 
does not substantially contribute to target recognition. These experiments include 
measurements of target site conservation, target mRNA abundance [160], and in vitro 
binding affinities [159]. However, as mRNA abundance and binding strength may not be 
 
 
Figure 4.2. 3´LIFE assay identifies 3´UTRs repressed by let-7c and miR-10b. 
1,407 3´UTRs tested in triplicate for targeting by each miRNA in cotransfection 
experiments in HEK293T cells. A 3´UTR was considered a putative target if it 
exhibited >20% repression and p<0.05. Top 30 repressed genes for each miRNA are 
listed adjacent to each heat map, with the type(s) of miRNA target site. Predicted 
targets, both conserved and poorly conserved, were identified using TargetScan 7.0. 
We found that these miRNAs represses a large number of genes (>10% of the library). 
However, the majority of 3´UTRs are subtly repressed, suggesting that miRNAs may 
more effectively impact cell fate by targeting a large number of genes within 
regulatory networks.   
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directly indicative of a miRNAs effect on protein levels [56, 57], we wondered if similar 
patterns would be obtained when measuring protein output directly. To test this, we 
employed the 3´LIFE assay using an expanded target library composed of 1,407 full-
length human 3´UTRs (h3´UTRome v1) (Figure 4.1) [167, 475]. We tested these 3´UTRs 
for targeting by two deeply conserved human miRNAs: let-7c and miR-10b. Overall, we 
obtained 334 genes that exhibited at least 20% repression and p<0.05 (Figure 4.2, 
Appendix B). 77% of the top 30 hits, and 49% of all targeted 3´UTRs contained at least 
one canonical target site for the targeting miRNA, suggesting an enrichment for 
canonical targets amongst repressed 3´UTRs (Figure 4.2, 4.3). When we looked for the 
presence of targets with a p6 wobble, we did not observe enrichment within the let-7c or 
miR-10b targets (Figure 4.3), suggesting that while these miRNAs may be capable of 
utilizing this motif (see Figure 2.7), it is not preferred.  
 
 
Figure 4.3. Characteristics of miRNA target sites in 3´UTR library. 3´UTRs were 
sorted based on targeting score in the 3´LIFE screen, and then searched for canonical 
seed targets (left) or p6 wobble base pairs (right). We found an enrichment for 
canonical target sites amongst our hits for both miRNAs. However, we did not identify 
a preference for targets with a p6 wobble for either miRNA.   
  
125 
  
 
Figure 4.4. Each miRNA recognizes distinct features of target site. We extracted 
the top 50 canonical target sites for each miRNA, and measured the frequency of base 
paring at each position using alignment software. We found that each miRNA has 
distinct targeting footprints.  let-7c strongly favors p1 and p8 binding, which is in line 
with the current understanding of ‘strong’ miRNA target sites.  Conversely, miR-10b 
strongly favors the central nucleotides, and does not favor positions p1 and p8. miR-
34a and miR-125b also have distinct target footprints. Asterisks represent statistically 
significant nucleotides (p<0.05, Chi-square).  
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In order to identify which nucleotide positions cooperate with canonical seeds in 
granting functional repression, we analyzed the sequence downstream of the seed site 
from the top 50 canonical target sites 
for each miRNA (Figure 4.4). 
Interestingly, the functional targeting 
footprints of let-7c and miR-10b 
exhibit distinct patterns. Consistent 
with the classic model of miRNA 
targeting [160], let-7c strongly 
favors 7mers and 8mers (Figure 
4.4A). The position with the least 
complementarity, p12, is the site 
with the most heterogeneity in the 
human let-7 miRNAs (see Figure 
2.8), suggesting that other family 
members may utilize this position in 
these targets. In stark contrast, miR-
10b rarely utilizes positions 1 and 8 
for targeting; relying more heavily 
on positions 12,13, and 15 (Figure 
4.4B). To further characterize 
miRNA binding preferences, we  
  
   
Figure 4.5. miR-34a and miR-125b targets 
identified in the 3´LIFE screen. We 
performed a targeted screen for targets of miR-
34a and miR-125b, with the library enriched 
for targets that possess a canonical target site 
for either miRNA.   
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Figure 4.6. Functional miRNA targets tend to cluster at the 3´ end of mRNAs. 
We hypothesized that distance to the polyA tail may be a critical factor in 
determining if a miRNA target site was functional.  To test this, we filtered the 
3´UTRs in our screen that have one canonical miRNA target site, one canonical 
polyadenylation sequence element (AAUAAA), and/or one annotated 3´UTR 
isoform (Refseq).  (A) We find that the canonical target sites that lead to function 
repression tend to cluster at the 3´ end, while sites that do not grant function 
repression tend to cluster closer to stop codon. (B) When we measured the 
absolute distance to the polyA tail we find that if a target site is in the last 200 
nucleotides of the 3´UTR it is used the majority of the time. 
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performed a targeted screen for two additional deeply conserved miRNAs, miR-34a and 
miR-125b (Figure 4.5), finding that each of these miRNAs exhibits distinct targeting 
footpr	ints (Figure 4.4C-D). In agreement with this, a recent study using AGO2 CLIP-Seq 
also found that individual miRNAs have preferred binding footprints [168]. Together, 
this suggests that individual miRNAs may 
utilize distinct features of target sites for 
the recognition and repression of canonical 
seed targets. 
Of the 773 genes in the 3´LIFE 
screen that contain a canonical target site 
for either miRNA, only 163 (21%) show 
any measure of repression, suggesting that 
features besides the seed are critical for 
repression (Figure 4.3) [160]. To test how 
the position of miRNA targets in the 
3´UTR impacts the strength of repression, 
we measured the relative distance between 
the miRNA target site and the 3´UTR end 
(Figure 4.6). This analysis revealed that 
functional target sites tend to cluster 
toward the 3´ end of the mRNA (Figure 
4.6A). When looking at absolute distance 
 
Figure 4.7. Gene ontology analysis of let-7c 
target genes. GO term analysis of genes 
repressed by let-7c revealed a functional 
enrichment for genes implicated in cell cycle 
checkpoint progression, DNA synthesis, and 
several steps of mitosis. repression > 20%, 
p<0.05. p-value noted in parentheses.  
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to the polyA tail, we find that when a canonical target site is located in the last 200 
nucleotides of an mRNA, it will lead to functional repression the majority of the time 
(Figure 4.6B). However, beyond this distance, additional factors may influence the ability 
of a miRNA to functionally repress a target mRNA. 
 
 
 
Figure 4.8. let-7c targets multiple genes involved in cell cycle progression. then 
identified at what points of the cell cycle are these genes implicated, and found that 
let-7c regulates genes at nearly all key checkpoints and transitions in the cell cycle. All 
genes listed were identified as targets by the 3´LIFE screen (repression > 20%, 
p<0.05). p-value noted in parentheses.  
  
130 
let-7c and miR-10b target 
multiple genes in regulatory 
networks 
To identify networks 
targeted by these miRNAs, we 
performed a gene ontology (GO) 
analysis of the hits obtained in 
our screen. In line with our 
hypothesis, we found that each 
miRNA repressed multiple genes 
with cooperative function in 
specific biological pathways. let-
7c targeted multiple members of 
the general transcription 
machinery (splicing, mediator 
complex, and general 
transcription factors), as well as 
many key proteins involved in 
cell cycle checkpoints, DNA 
replication, and mitosis  
  
 
Figure 4.9. miR-10b targets multiple genes 
involved in the retinoic acid signaling pathway. 
GO term analysis of miR-10b targets, showing that 
most enriched term for miR-10b targets was genes 
implicated in the retinoic acid signaling pathway. 
p-value noted in parenthesis. 
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(Figure 4.7) [476]. We also identified many additional components of the RAS signaling 
pathway, which expands upon our previous findings (see Chapter 3). However, we also 
found a substantial enrichment of genes that function during multiple stages of mitosis, 
 
Figure 4.10. miR-10b targets multiple genes involved in the retinoic acid signaling 
pathway. All listed genes were those that were found as targets of miR-10b in the 
3´LIFE screen. Genes with experimental evidence for physical association are adjacent 
to each other. miR-10b regulates several key components of the pathway, including 
extracellular transport and delivery of the retinoic acid precursor retinol (Rol), the 
conversion of retinaldehyde (Ral) to retinoic acid (RA), cytoplasmic to nuclear 
transport of RA, nuclear hormone receptors, one of the three nuclear RA receptors 
(RARG), multiple effectors of RA induced transcription, and many downstream genes 
that are transcriptionally activated by RA.   
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and particularly at key cell-cycle checkpoints (Figure 4.8). These genes include a helicase 
essential for DNA replication (MCM4), an activator of histone translation at the initiation 
of S-phase (LSM11), genes central to kinetochore formation and function (GSG2/haspin, 
CENPP), a gene required for metaphase spindle anchoring (PAK4), key effectors of cell 
cycle checkpoint progression (E2F5, EZH2, CDC25A), and a protein that suppresses 
checkpoint genes via miRNA networks (TRIM71). These findings support the hypothesis 
that a single miRNA may more effectively impede cell division by regulating mRNAs at 
multiple stages during mitosis. 
GO term analysis	 for miR-10b targets 
identified multiple ephrin receptors, mediator 
subunits, and genes implicated in apoptosis (Figure 
4.9). We also found that miR-10b targeted genes at 
nearly all levels of the retinoic acid (RA) signaling 
pathway [291, 316], including a nuclear RA receptor 
(RARG), RA-metabolite transport proteins (RBP4, 
CRABP2), a rate limiting enzyme in RA synthesis 
(ALDH1A3), several RA receptor cofactors, and  
  
 
Figure 4.11. miR-10b targets multiple Hox genes. 
The 3´LIFE screen identified many genes expressed 
from the Hox cluster that were targeted by miR-10b.  
Specifically the HoxA and HoxD clusters were 
particularly enriched for targets. miR-10a is located in 
the HoxA cluster between HoxA4 and HoxA5 (grey 
boxes), and miR-10b is located between HoxD4 and 
HoxD8. 
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downstream effectors of the RA response (Figure 4.10). Interestingly, we also found that 
miR-10b targets many of the Hox genes, specifically those in the HoxA and HoxD 
clusters (Figure 4.11). The expression of specific Hox genes imparts cells with positional 
identity in the organism, largely by activating the transcription of genes that are important 
 
Figure 4.12. miR-10 sponge induction leads to deregulation of key retinoic acid 
genes. (A) Inducible miR-10 sponge design. (B) Fluorescence microscopy showing 
induction of RFP and GFP three days post 5 uM doxycycline treatment (5uM) in 
HEK293T cells. GFP images taken at 1s exposure to detect any leaky sponge 
expression. (C) RT-qPCR for mature miR-10a and miR-10b 72 hrs after dox treatment. 
Specificity of the qPCR primers for miR-10 family members is demonstrated in Fig. 
7C. (B) mRNA levels of four genes in the RA pathway identified in 3´LIFE screen, as 
well as two RA responsive genes that were not targeted by miR-10. mRNA levels of 
target genes increase following doxycycline, while non-targets do not.  All data 
normalized to ACTB, n=3.   
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for the function of cells in specific tissues. Together, the combined repression of genes 
that activate the RA signaling pathway with downstream targets of the pathway suggests 
that miR-10 may function as a potent negative regulator of differentiation, directing cells 
towards a less differentiated state. 
To further validate endogenous targeting of several of these genes, we depleted 
miR-10 in HEK293T cells using a doxycycline inducible miRNA sponge (Figure 4.12) 
[154, 425]. We observed using RT-qPCR that as levels of miR-10 family members 
decreases, mRNA levels of target genes increase (Figure 4.12). One of these genes, 
RARG, possesses two canonical target sites, but deletion analysis revealed that only the 
most distal site was functional (Figure 4.13). Combined with the modest repression we 
observe for the majority of targets, the striking convergence of targets into cooperative 
networks provides further evidence that miRNAs effectively impact cell fate by targeting 
multiple components of regulatory networks.  
 
Figure 4.13. miR-10b directly targets RARG via only one canonical target site. 
(A) RARG 3´UTR, showing position of two putative target sites for miR-10b. (B) 
Deletion analysis of putative miR-10b target sites in RARG 3´UTR. HEK293T cells 
were cotransfected with miR-10b and luciferase::3´UTR, and normalized to luciferase 
ratio of a no miRNA control (dashed line) (n=4). 
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Discussion 
Individual miRNAs utilize distinct targeting footprints 
Our experiments to identify functional miRNA targets found that each miRNA 
exhibits distinct targeting footprints surrounding canonical target sites. This suggests that 
individual miRNAs may identify distinct features of target sites, complicating the use of 
generic target site principles for predictive purposes. To explain this disparity, we 
speculate that differences in the nucleotide composition of specific miRNAs may subtly 
impact Argonaute structure, and thus targeting preferences. For example, miR-99a 
contains an atypical nucleotide at the first position, which facilitates miRNA loading into 
Argonaute proteins [119]. Because Argonautes specifically interact with the first position 
of the miRNA, it is conceivable an unfavorable first nucleotide may alter Argonaute 
structure and influence the preferred targeting motif. Furthermore, Argonautes interact 
with the 5´ and 3´ ends of miRNAs, leaving the middle regions of the miRNA disordered 
[118] and allowing miRNAs of subtly different lengths (20-24 nt) to be incorporated into 
Argonaute. Given our findings with let-7c (~22 nt), miR-10b (~23 nt) and miR-125a (~24 
nt), it is interesting to speculate how miRNA length may affect targeting footprints. 
However, further experiments are needed to explore the precise impact of nucleotide 
content and miRNA length on targeting preference.  
 
miRNA target sites cluster close to the polyA tail 
 Target site identification is a major challenge in miRNA studies, especially given 
evidence that miRNAs target hundreds of genes. Our studies find that functional miRNA 
target sites tend to cluster toward the 3´ end of the transcript, while non-functional sites 
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tend to be relatively closer to the stop codon. This suggests that context plays a major 
role in determining if a miRNA target leads to a decrease in protein production. We find 
that functional repression will occur the majority of the time when a target site is in the 
last 200 nucleotides of the mRNA. Beyond 200 nucleotides we observe functional and 
non-functional targets, suggesting that additional factors may be required to enable 
repression at this distance. Mechanistically, our findings are in agreement with evidence 
that one key function of the RISC is deadenylation of target mRNAs; the closer the RISC 
is to its substrate, the more effective it may be at degrading the polyA tail. This context 
dependent effect may also be due to inhibition of translation initiation via the EIF4 
proteins. Although the exact mechanism behind our observation requires further 
investigation, this knowledge may be especially informative when looking for functional 
non-canonical target sites, which are typically not as effective at repressing translation or 
enabling mRNA decay as canonical target sites. 
Currently, the most efficient approach for high-throughput target detection is 
miRNA expression followed RNA-sequencing to obtain a list of candidate targets. While 
sequencing is a rapid and effective approach, it does not identify targeting events that do 
not lead to mRNA degradation. To overcome this, a recent RNA-seq approach using 
Argonaute immunoprecipitation combined with a ligation of the miRNA and target 
(CLASH) was established to identify miRNA targets in an unbiased manner [168, 207]. 
These approaches identify miRNA/target binding, yet it is unclear to what extent these 
target sites lead to functional repression. In line with this, there is no mention of target 
site context or distance to the polyA tail in recent papers that employ the CLASH 
technique [168, 207].  This suggests that miRNA targeting does not necessarily cause a 
137 
reduction in protein expression, and supports the use of protein-based measures to 
identify biologically relevant miRNA targets. 
 
miRNAs target genes within regulatory networks 
Our findings from this 3´LIFE screen revealed a striking convergence of miRNA 
targets in specific regulatory networks. These interactions typically resulted in a 20-30% 
decrease in target protein expression. However, due to our reliance on exogenous 
constructs to drive expression of both the miRNA and 3´UTR, it is unclear if this degree 
of repression is relevant in vivo. Yet the identity of these targets suggests a context in 
which these miRNAs are likely to function. For example, previous reports have shown 
that miR-10b functions as a positive regulator of retinoic acid induced differentiation in 
neuroblastoma cells via regulation of NCOR2, a negative regulator of retinoic acid (RA) 
signaling [291, 316], which we also identify in the 3´LIFE screen. However, the GO term 
analysis of miR-10b targets suggested an enrichment of positive regulators of RA, 
including key metabolic enzymes involved in RA synthesis, and many downstream 
targets of the pathway. This conflicting evidence raises two relevant questions. First, is 
the effect of miR-10b on RA signaling context dependent? In tissues where NCOR2 is not 
the dominant repressor of RA signaling, does miR-10b have a repressive effect on the 
pathway? It is intriguing that miR-10b, which is a transcriptional target of retinoic acid 
signaling, may have opposite effects based on the cellular context and coexpression of 
specific sets of target genes in the RA pathway. Second, all-trans retinoic acid (ATRA) is 
the functional signaling molecule in the RA pathway, and is synthesized from the 
precursors retinol and retinaldehyde, which are transported throughout the body. While 
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the ability of a cell to respond to RA signaling depends on the expression of key 
metabolic enzymes, most experiments bypass processing and use ATRA directly. We 
found that miR-10b strongly repressed ALDH1A3, a rate-limiting enzyme in RA 
synthesis. Thus, it is unclear if the net effect of miR-10b will be consistent when using 
different RA precursors, and the form of RA used in experiments may drastically impact 
the outcome. By combining our miRNA sponge system in different cell types with 
different RA precursors we can explore the potentially context dependent effects of miR-
10b on retinoic acid signaling.  
 
Conclusion 
The experiments presented in this chapter identified many novel miRNA targets, 
both canonical and non-canonical, that fall into key regulatory pathways. These studies 
demonstrate the unique capabilities of the 3´LIFE screen in discriminating between 
functional and non-functional canonical target sites. Furthermore, this suggests the 
importance of expanding the capabilities the 3´LIFE assay by increasing the target library 
size, and screening for targets of miRNAs that are misexpressed in specific disease 
contexts.  
 
Experimental 
MiRNA and 3´UTR Cloning 
3´UTRs and MiRNAs were cloned as previously described [167, 475]. In brief, 
~200 nucleotides upstream and downstream of the pre-miRNA were cloned into an intron 
in the pLIFE:miRNA plasmid by Gateway recombination reactions. MiRNA target sites 
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were cloned in the SV40 3´UTR using a simultaneous restriction digest ligation reaction 
using two BbsI cut sites. All mutagenesis experiments were performed using site directed 
mutagenesis (Stratagene). 
 
3´LIFE Assay 
The 3´LIFE assay was performed as previously described [167]. In brief, each 
miRNA was tested against each 3´UTR with either five (miR-10, let-7, and miR-125 
family screens), or three replicates (miR-10b and let-7c screen) by transient transfection 
in HEK293T cells. For the analysis in Figure 4.2 we used the complete human 
3´UTRome v1, consisting in 1,407 3´UTRs not enriched with targets for any specific 
miRNA [475]. Repression of a 3´UTR by a miRNA was measured by calculating the 
Firefly/Renilla ratios compared to a negative control, and normalized to the mean of each 
96 well plate. Putative hits were called as those that had a repression index <0.80, and a 
p<0.05. Differences in repression between miRNA family members were calculated by 
determining the standard error the 3´LIFE assay (~0.04), and differences between 
miRNAs greater than 2x the SE were considered divergent. 
 
Target site distance analysis 
We identified all the 3´UTR s in the 3´LIFE library that contain only one 
canonical miRNA target site, and filtered to keep 3´UTRs with one annotated 3´UTR 
based on Refseq annotation. We then calculated the distance to the end of the transcript 
and the distance to the miRNA target site. 
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GO Term analysis 
Analysis of GO terms was performed using the ToppGene software [477]. 
Because the 3´LIFE library was created using predefined criteria, we removed common 
results between both miRNAs. 
 
miRNA sponge plasmid construction 
We replaced eGFP with dsRed2 in pLVCT-tTR-KRAB [154] via ligation to 
create pLVCT-RFP-KRAB. We then cloned d2eGFP::miR-10 sponge from [425] into 
pLenti CMV/tet puro dest [478] via Gateway cloning. We first integrated pLVCT-RFP-
KRAB into the genome of HEK293T cells using lentivirus, picked a single cell, and 
clonally expanded the population. We then infected this line with lentivirus containing 
the CMV/tet::d2eGFP::miR-10 sponge, and selected for positive transgenics with 
puromycin (Sigma). 
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CHAPTER 5: 
HIGHLY SIMILAR MICRORNA FAMILY MEMBERS  
HAVE DISTINCT FUNCTIONS 
 
Publication Note 
The research reported in this chapter is in press in Genome Research by Justin M. 
Wolter, Hoai Huang Thi Le, Alexander Linse, Victoria A. Godlove, Thuy-Duyen 
Nguyen, Kasuen Kotagama, Alissa Lynch, Alan Rawls, and Marco Mangone. 
Evolutionary Principles of Metazoan microRNAs Reveal Targeting Principles in the 
Human let-7 and miR-10 families. Genome Research. 2016 (in press). All co-authors 
have granted permission for this work to be included in this dissertation. 
 
Overview 
MiRNAs are known to play key roles in development, and are frequently 
misregulated in diseases. Identifying miRNAs that contribute to these processes has been 
greatly simplified by the development of high-throughput sequencing technologies that 
can discriminate between highly similar family members. Owing to their highly similar 
sequences, it is largely assumed that miRNA family members target largely, if not 
completely, overlapping sets of genes. However, sequencing approaches often find that 
individual family members are expressed in one context, while other family members are 
not.  For example, while miR-10a/b share many targets with overlapping functions, these 
miRNAs have been implicated in specific processes independent of each other. miR-10a 
plays a role in several aspects of blood cell differentiation and leukocyte interactions with 
142 
endothelial cells [479-481], and is differentially expressed in cell lines and serum from 
patients with relapsed acute and chronic myelogenous leukemia [482, 483]. miR-10b has 
been implicated in the progression of tumors of diverse origin, including breast [243] and 
glioblastoma [291], while miR-10a is not associated with these tumor types. It is 
currently unclear if these expression differences merely reflect changes at the promoter 
level, or if the nucleotide changes between miRNA family members grants enhanced 
targeting capabilities in specific tissues.   
Increasingly, circulating miRNAs are being used as disease biomarkers due to 
their high stability in the bloodstream [484-487]. MiRNAs isolated from patient serum 
have demonstrated disease specific signatures from individual tumor types [488-490], 
Alzheimer’s disease, [491], and diabetes [492], and individual miRNA family members 
are often associated with specific diseases [493]. A common assumption in the 
biomedical community is that miRNA family members are largely redundant, and targets 
for one miRNA can generally be applied to other family members. While this assumption 
is often true, any functional distinction between family members has clear relevance for 
diseases that specifically express subsets of family members. However, this has not been 
systematically tested, and it is currently unclear to what extent family members possess 
distinct targeting preferences. 
Our analysis of evolutionary trends in miRNA families revealed a strong 
connection between the emergence of miRNA families and sequence changes in the 
mature miRNA. This lead us to hypothesize that these sequence changes grant distinct 
targeting preferences to highly similar miRNA family members. To address this question, 
we combine the 3´LIFE assay with various experimental and bioinformatic approaches to 
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assess targeting and expression differences between miRNA family members. We find 
striking targeting differences within all of the miRNA families we tested. We further 
demonstrate that the single nucleotide change in the miR-10 family grants distinct 
targeting preferences, and experimentally mutate these miRNAs to reverse target 
preference. We then explore miRNA family member expression using a wide range of 
experimental and bioinformatic approaches, and observe substantial differences in 
expression patterns. Together, our data suggests that miRNA family members possess 
specific targeting preferences, which may correlate with distinct expression patterns and 
coexpression of preferentially targeted genes. 
Figure 5.1. Sequences of the miR-10, miR-99, let-7, and miR-125 families. Shown 
are the sequences of miRNA family members that we used in our studies.  Unique 
nucleotides are marked in gold.  
  
144 
Results 
Nucleotide changes at evolutionary hotspots in several human miRNA families modulate 
targeting preferences 
In order to test if the hotspots within miRNA families impact targeting specificity, 
we studied the targeting preferences of three intertwined human miRNA families (let-7, 
miR-10 and miR-125). The miR-10 family is composed of five miRNAs (Figure 5.1). 
miR-10a and miR-10b differ by a single nucleotide at p12 which occurred at the base of 
the vertebrate lineage, and is maintained in all subsequent species (see Figure 2.9). This 
family also includes miR-99a/b and miR-100, which differ from miR-10a/b primarily by a 
 
 
Figure 5.2. Genomic loci of miRNAs used in this study. Members of the miR-10 
family are located within the Hox clusters, which have undergone two rounds of 
duplications in vertebrate genomes. miR-10b is located upstream of HoxD4, while 
miR-10a is located upstream of HoxB4. The first validated target of miR-10b, 
HoxD10, is noted with a dark arrow. The let-7c/miR-99a/miR-125b cluster is located 
on chromosome 21, and is transcribed from two transcription start sites, marked with 
arrows. These miRNAs are also within an intron of a lncRNA (LINC00478). 
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single nucleotide deletion in the seed (Figure 5.1). In contrast, miR-125a/b differs by a 
two-nucleotide insertion that arose at the base of the vertebrate lineage (see Figure 2.10). 
miR-99a/b, miR-100, and miR-125a/b are located within miRNA clusters alongside let-
7c/e/a (Figure 5.2). 
To test the specificity of miRNA family members, we cloned perfectly 
complementary target sites for miR-10 and let-7 family members into a minimal 3´UTR,  
  
 
 
Figure 5.3. Targeting specificity of miR-10 and let-7 family members. To test the 
specificity of miRNA family members we cloned perfectly complementary target sites 
into the SV40 3´UTR, and tested each miRNA against each target. We find that while 
miR-10a and miR-10b repress each other’s targets, the single sequence change at p12 
greatly reduces targeting strength. The single nucleotide deletion in miR-99a grants 
complete targeting specificity. We see similar discrimination for let-7f compared to let-
7a/c, which also differ at p12.  However, let-7a and let-7c, which differ at p19, equally 
repress each others targets. This data suggests that in cases of perfect complementarity, 
different regions of the miRNA grant distinct target discrimination. Results are 
represented as percentage of luciferase signal normalized to a negative miRNA 
control.     
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and used luciferase assays to test the ability of these miRNAs to repress common targets 
(Figure 5.3). While miR-10a and miR-10b were capable of cross-repression, the single 
nucleotide mismatch at p12 disrupted ~50% of the repression by each miRNA, and the 
 
 
 
Figure 5.4. 3´LIFE assay target 
specificity of miR-99a, miR-10a, and 
miR-10b. (A) We screened 375 3´UTRs 
for targeting by miR-99a, miR-10a, and 
miR-10b (n=5). Heatmap of 3´UTRs 
with repression (rep.<0.8, p<0.05) by 
any one of the three miRNAs. 
Arrowheads denote genes further 
discussed in this study. Results show a 
substantial overlap between miR-10a/b 
and a surprising overlap with miR-99a. 
Arrowheads represent genes that are 
discussed further in this text. (B) Venn 
diagram of genes exhibiting any degree 
of repression, regardless of strength of 
repression.   
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seed deletion in miR-99a granted complete targeting specificity (Figure 5.3). Let-7a and 
let-7c, which differ by a single nucleotide at p19, equally repressed each other’s targets. 
In contrast, let-7f, which differs at p12 from the other family members, was not able to 
fully repress the targets of let-7a and let-7c. This confirms that in cases of perfect 
complementarity that lead to slicing [155], there 
are positional differences in the effect of 
mismatched base pairing on miRNA targeting 
(Figure 5.3).  
 
miRNA family members preferentially target 
distinct sets of genes 
Because endogenous miRNA target sites 
rarely utilize perfect complementarity, we next 
characterized the extent to which miR-10a/b/99a 
regulate full-length human 3´UTRs. Using the 
3´LIFE assay we screened a panel of 374 
3´UTRs from the h3´UTRome v1 [475], which 
correspond to the first four plates in the library. 
We identified 35 genes repressed by miR-10a, 
39 by miR-10b, and 29 by miR-99a (Figure 
5.4A). When comparing the identity of target 
genes without considering strength of  
  
 
 
Figure 5.5. Commonly regulated 
genes between clustered miRNAs. 
We looked at common targeting by 
genomically clustered (miR-99a/let-
7c) and non-clustered miRNAs 
(miR-10/let-7c). In comparison to a 
random set of 3´UTRs from the 
3´LIFE library, we find that 
clustered miRNAs share a relatively 
larger fraction of targets compared 
to non-clustered miRNAs. 
  
148 
  
Figure 5.6. Bioinformatic prediction of miRNA family members. Predictions for 
miR-99, miR-10, and let-7 family members with Diana microT-CDS, which makes 
independent predictions for each miRNA family member. Percentage represents the 
overlap of predictions for each family member. Of note is the larger fraction of 
overlap, and the relatively small number of predictions for the miR-99 family. 
Circles are drawn to scale. 
  
Figure 5.7. miR-
10a/b and miR-
99a target distinct 
sites in the 
HOXD10 3´UTR. 
Mutagenesis 
experiments for 
HOXD10, a top 
target for both 
miR-10a/b and 
miR-99a. Deletion 
of the miR-10 
target site does not 
rescue repression 
by miR-99a.  
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repression, we find that the majority of genes were commonly regulated by both miR-10a 
and miR-10b, and uniquely regulated by miR-99a as expected (Figure 5.4B). We also 
found that miR-99a and let-7c commonly repress 28% of target genes, and that miR-10 
and let-7c are depleted for common targets compared to a random dataset, suggesting 
cooperativity between the clustered miRNAs (Figure 5.5).  
We also observed a significant overlap between the miR-10a/b and miR-99a target 
genes, which was surprising given that target predictions for these miRNAs are 
completely non-overlapping (Figure 5.6). We were unable to identify a direct target site 
for miR-99 in the HOXD10 3´UTR by deletion analysis (not shown), but deletion of the 
target site for miR-10 suggests that these miRNAs target different sites in this 3´UTR 
(Figure 5.7). We also found 
only 20% of miR-99 predicted 
targets were repressed in our 
screen, and >90% of targets 
were not predicted (Figure 5.8). 
When we looked for canonical 
miR-99 target sites in repressed 
3´UTRs, we found a depletion 
of seed sites (9%) (Figure 5.9), 
which is consistent with the 
small number of predicted 
targets (Figure 5.6) and an 
 
 
Figure 5.8. Target prediction softwares perform 
poorly in predicted miR-99 targets. Predictions for 
miR-99a by three prominent target prediction 
softwares. Conservation of targets predicted by 
TargetScan is noted. TargetScan predictions for miR-
99a have 11% overlap with 3´LIFE hits compared to 
35% for miR-10b and let-7c, suggesting that false 
negative rates for target prediction softwares may 
depend on the miRNA of interest.  
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overall depletion of the seed sequence in human 3´UTRs (data not shown). However, we 
did find enrichment for target sites with a wobble base pair in p6 (Figure 5.9), and 
validated the direct targeting of one of these sites in HOXD1, which is also repressed by 
let-7c (Figure 5.10). Together, this data suggests that miR-99a has a preferred targeting 
mechanism that utilizes non-canonical base pairing in the seed, making it distinct from all 
other miRNAs in our analysis. 
We next focused on targeting differences between miR-10a and miR-10b, and 
unexpectedly found that 51% of genes were differentially repressed more than two times 
 
Figure 5.9. Occurrence of miR-99 seed in repressed genes. We investigated the 
prevalence of canonical miR-99a target sites among repressed genes. #1: Frequency of 
miR-10b seed among genes repressed by miR-10b (for reference). #2: Scrambled 
permutation of the miR-10/miR-99 seed among miR-99 hits. Canonical miR-99 (#3) 
and miR-99* seed (#4). #5-#7: miR-99 seeds with wobbles allowed in indicated 
positions.  
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the standard error of our screen 
(>8% relative repression) (Figure 
5.11). Only four genes  
were repressed more by miR-10a, 
while 17 were repressed more by 
miR-10b (Figure 5.12). 
Importantly, alignments for miR-
10a or miR-10b targets with a 
canonical seed revealed that all the 
targets favored by miR-10a and the 
majority of miR-10b targets  
  
 
Figure 5.10. Direct targeting of the HOXD1 
3´UTR at a non-canonical p6w site by miR-
99a. Deletion analysis of the p6 wobble seed 
motif targeted by miR-99a in the 3´UTR of 
HOXD1 (nucleotides 577-599 from stop codon) 
rescues repression by miR-99a, but not let-7c, 
which also targets this 3´UTR (n=4). 
 
 
 
Figure 5.11. miR-10 family members regulate target genes with variable strength. 
Heat map of miR-10a and miR-10b targets showing hits that exhibit repression >2 
times the standard error of the 3´LIFE assay. Genes targeted more strongly by miR-10a 
or miR-10b are listed on the left or right, respectively. Alignment of top genes with 
canonical target sites shows nucleotides in position 12 favors the respective miRNA. 
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contain a complementary nucleotide at p12 (Figure 5.11). Because the single nucleotide 
difference between miR-10a/b occurs at p12, we were interested if other miRNA families 
with changes in different positions would exhibit a similar trend. To do this, we focused 
on two let-7 family members that differ at p19, and two miR-125 family members, which 
differ by a two-nucleotide insertion between p13-14. Using a small library enriched for 
targets of these miRNAs, we found that each miRNA preferentially repressed a large 
portion of these genes (Figure 5.13A,B). Strikingly, when we performed alignments for 
the let-7 targets, we found that all of the target sites favored by one family member 
contain the complementary nucleotide to the favored miRNA (Figure 5.13C). Together, 
this data suggests that evolutionary hotspots may provide distinct target preferences, 
regardless of where in the miRNA the hotspot occurs. 
We then sought to determine experimentally if the single nucleotide change 
between miR-10a/b effects target preference. We reciprocally mutated p12 of each 
miRNA, and tested for target specificity of the mutant and wild-type miRNAs (Figure 
5.14). Both miR-10a and miR-10b switched targeting preferences for a fully 
complementary target. Conversely, ALDH1A3, which was equally repressed by both 
miRNAs, was not affected by these mutations. Because miR-10b preferentially targeted 
more genes than miR-10a, we then focused on three targets favored by miR-10b. We 
identified the direct target site for miR-10a/b in these 3´UTRs by deletion analysis, and 
found that these genes reversed miRNA preference with the mutant miRNAs (Figure 
5.15). Taken together, these results suggest that a single nucleotide change at p12 in the 
miR-10 family can have a significant impact on the strength of silencing by otherwise 
identical miRNAs. 
153 
  
Figure 5.12.  Count of genes with 
differential silencing activity between miR-
10 family members. Differential silencing 
is defined as those with repression 
differences between the miR-10a and miR-
10b >2x the standard error of the screen 
(0.08). 
   
  
 
Figure 5.13. let-7 and miR-125 family members exhibit distinct target preferences. 
We performed an additional targeted screen for (A) miR-125 and (B) let-7 family 
members, finding that these additional family members also exhibit distinct targeting 
preferences. (C) Alignments for the let-7a/c preferred targets revealed that in 3´UTRs 
that contain a canonical target site, the nucleotide that corresponds to the favored 
miRNA was always complementary to that family member.   
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Figure 5.14. Mutant miR-10 family members reverse target preference. We 
reciprocally mutated p12 of each miRNA, and tested for the target preference of 
specific genes with luciferase assays in HEK293T cells (n=4). Repression of the 
perfectly complementary sequence in each SV40 3´UTR shows switching of target 
preference. ALDH1A3, which contains multiple miR-10 target sites and was not 
favored by either miRNA in our screen, was not affected by these mutations. Results 
normalized to a negative control miRNA (dashed line). 
 
 
Figure 5.15. A single nucleotide change between miR-10a/b grants distinct 
targeting preferences in full length 3´UTRs. Luciferase assay showing genes 
favored by miR-10b switch target preference by mutant miRNAs (n=4). 3´UTR ∆ 
refers to a deletion analysis of the miR-10 target site in each 3´UTR, confirming a 
single functional target site in these 3´UTRs. The alignments of these target sites are 
shown below, demonstrating that each 3´UTR contains the complementary nucleotide 
to miR-10b. 
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miRNA Family Members Exhibit Tissue Specific Expression 
 
We hypothesized that the appearance of hotspots may accompany novel 
expression patterns, allowing the enhanced repression of target genes expressed in novel 
contexts. To address this we studied the expression patterns of the miR-10 family during 
embryogenesis in 9.5 and 10.5 day old mouse embryos using LNA probes (Figure 5.16, 
Table 5.1). miR-99a is ubiquitously expressed at both stages, while miR-10a and miR-10b 
share largely overlapping expression patterns along the dorsal aspect of the embryos 
(neural tube, paraxial mesoderm and lateral plate mesoderm) extending from the  
 
 
Figure 5.16. Expression of miR-10 family members have divergent expression 
patterns during mouse embryogenesis. Whole mount in situ hybridizations of 
mouse embryos at 9.5 and 10.5 days post coitus (dpc), using locked nucleic acid-based 
probes to detect the expression pattern of mature miR-10a, miR-10b, miR-99a. Data 
representative of 3 embryos. We note the specificity of the probes to detect specific 
family members by the differences in expression in the heart (arrowheads). We 
observe that while miR-10a and miR-10b have largely overlapping expression patterns, 
miR-10a has extended anterior expression. 
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midthoracic region to the tailbud (Figure 5.17). Interestingly, the highest expression is 
inhe region of the tailbud where RA signaling is repressed [494]. However, miR-10a is 
more broadly expressed anteriorly, including in the branchial arches and developing brain 
(Figure 5.16, Table 5.1). These divergent expression patterns are in agreement with miR-
10a/b expression in adult mouse tissues [226]. This difference could be the result of 
changes in the composition of the miRNA promoters, or be influenced indirectly by 
expression of the Hox clusters to which these miRNAs belong. To test these hypotheses  
 
 
Figure 5.17. Dorsal 
expression of miR-10b. miR-
10b expression is strongest in 
the extending tailbud, where 
retinoic acid signaling is 
repressed. miR-10b is also 
lowly expressed along dorsal 
region of the neural tube. 
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we isolated ~2,000 base pairs upstream of each miRNA, and tested their ability to drive 
GFP expression in HEK293T cells. We found the miR-10a promoter is significantly more 
active than the miR-10b promoter in these cells (Figure 5.18). This was mirrored by 
differential expression of the mature 
miRNAs (Figure 5.19). Despite the 
deep conservation and overlapping 
expression of these two miRNAs, the 
composition of their promoters are 
very different and we were unable to 
identify any elements that could justify 
either the overlap or differences in 
expression levels (data not shown). We  
	
Figure 5.18. The promoters of 
miR-10 family members have 
different activity levels in 
cultured cells. We cloned the 
promoter regions (~2,000 bp) of 
miR-10a and miR-10b, and tested 
their ability to drive GFP 
expression by transient transfection 
in HEK293T cells. CMV promoter 
used as a positive control to 
indicate transfection efficiency. 
Fluorescence quantified by flow 
cytometry (n=2, 10,000 cells 
analyzed per sample. Side scatter 
(SSC) and GFP intensity of cells in 
each sample, and representative 
fluorescent images of cells. Insets 
are bright field images. 
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then studied the 
expression dynamics of 
these two miRNAs in 
response to RA in a 
breast ductal 
adenocarcinoma cell 
line (MCF-7) (Figure 
5.20). After 48 hours of 
treatment, the  
Figure 5.19. qRT-PCR of 
mature miR-10a and miR-
10b levels in HEK293T 
cells. We extracted total 
RNA from HEK293T cells 
and performed qRT-PCR 
using primers specific for 
each miR-10 family 
member. Results are in 
agreement with the previous 
figure, suggesting that 
differences in promoter 
activity result in differential 
expression of the mature 
miRNA. Results normalized 
to ACTB (n=3). 
 
Figure 5.20. Expression dynamics of mature miR-10a and miR-10b following 
retinoic acid treatment. We treated the breast cancer cell line MCF-7 with 10 uM 
retinoic acid (RA), and measured the expression dynamics of miR-10 family members 
over time (n=3). Results demonstrate that while both promoters respond to RA, their 
dynamics are not identical. 
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expression of both mature miRNAs increases dramatically. However, their expression 
levels are not identical, suggesting that the dynamics of the response to RA is not equal. 
Taken together, this data suggests that although the mature miR-10a and miR-10b 
 
 
Figure 5.21. let-7 family members have differential expression patterns in tissues. 
To investigate the degree of overlap of specific miRNAs in normal human tissues, we 
downloaded expression levels for let-7 family from miRGator v3.0 [495], which is a 
compilation of high-throughput sequencing data from GEO, SRA, and TCGA. 
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sequences are nearly identical, their expression dynamics and localization patterns are 
not, and that variation in their promoter composition could explain this diversity. 
To expand on these observations, we explored the expression patterns for the let-
7, miR-10, and miR-99 families in normal human tissues using miRGator, a curated 
  
 
Figure 5.22. miR-10 family members have differential expression patterns in 
normal tissues. The degree of overlap of specific miRNAs in normal human tissues, we 
downloaded expression levels for miR-10 (A) and miR-99 (B) families from miRgator 
v3.0 [495]. 
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miRNA expression database which compiles TCGA, GEO, and SRA datasets [495] 
(Figure 5.21, 5.22). The expression patterns of individual family members were 
surprisingly distinct,	with many tissues favoring expression of only one family member. 
Interestingly, in the let-7 family, the expression patterns of members that have undergone 
duplications without sequence divergence (let-7a, let-7f) are more similar to each other 
than other family members. Together, the difference in target preference and expression 
patterns between family members suggests a connection between the functional 
divergence of miRNA family members with the coexpression of novel target genes.  
 
Discussion 
The majority of genes regulated by members of the same miRNA family vary in the 
strength of repression 
The expansion of miRNA families in higher metazoans has been suggested to 
provide robustness to gene regulatory networks, and it is commonly assumed family 
members target completely overlapping sets of genes. In line with this, our results 
confirm the overlap between targets of miR-10a/b, let-7a/c, and miR-125a/b, but we also 
find that the majority of the genes exhibit different degrees of repression. Our 
evolutionary analysis also found a strong connection between duplications and sequence 
divergence, providing additional evidence of selective pressure for sequence changes to 
duplicated miRNAs. Given that a single nucleotide change in the miR-10 family has the 
ability to modulate target specificity, we speculate that multiple changes, like those in the 
let-7 family, may exaggerate the targeting differences between family members. In 
tissues where multiple miRNA family members are coexpressed, miRNA sequence 
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changes that enhance the repression of specific genes may allow a given miRNA family 
to fortify its biological function via regulation of a broader target set of genes. The 
emergence of novel expression patterns may also shape miRNA sequence evolution 
through coexpression with novel targets. In support of this hypothesis, we observe clear 
differences in expression patterns of family members. However, it is difficult to infer 
individual relationships from this anecdotal evidence because bona fide miRNA targets 
have been observed in both cases of coexpression and mutually exclusive expression 
[224].  
 
miR-99a preferentially utilizes a non-canonical targeting mechanism 
 Despite numerous examples of non-canonical miRNA targets, it is controversial 
to what extent such targets are biologically relevant [165, 166, 196-201, 305]. One reason 
for this is that no general pattern has emerged from these examples. Without a model to 
guide predictions, the degenerate nature of miRNA target sites complicates the accurate 
prediction of non-canonical targets. In spite of these difficulties, a large proportion of 
miRNA target sites may be non-canonical, as suggested by approaches such as 3´LIFE 
and CLASH that do not rely on target predictions [165, 168]. Yet the discovery of 
canonical seed based targeting has far outpaced discovery of non-canonical targets, 
largely due to the ease with which canonical targets are predicted. In this way, a 
significant question in the field is to what extent non-canonical targets are biologically 
relevant, and if there are consistent trends in non-canonical target sites. 
Unexpectedly, we found that miR-99a target genes were depleted for canonical 
seed targets, which was mirrored by depletion in both the human 3´UTRome and in the 
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number of predicted targets.  Instead, we found an enrichment of targets that possess a 
wobble base pair at p6. Our evolutionary analysis in Chapter 1 suggested that p6 may 
uniquely tolerate wobble pairing, and we experimentally demonstrated this tolerance 
using artificial miRNA targets.  However, we did not find an enrichment of p6 wobble 
targets in our screen for let-7c and miR-10b. It is unclear why miR-10b does not 
preferentially utilize this target motif, despite being capable of doing so, and why miR-
99a prefers the p6 wobble motif, while it is also capable of utilizing canonical targets 
(mTOR, FOXA1). However, we cannot rule out that miR-10b does target a relatively 
small number of targets with p6 wobbles, similar to how miR-99a utilizes some canonical 
sites. 
An interesting observation is the depletion of the miR-99a target site in the human 
3´UTRome.  The miR-10 seed target sequence (CAGGGT) and the miR-99 target 
sequence (ACGGGT) are highly similar, so it is surprising that the miR-99 sequence 
occurs approximately six times less often. It is unclear if there is some selective 
disadvantage for the miR-99 target, yet the result is that it is less likely for miR-99 to 
utilize canonical sites. This depletion may provide a clue as to why miR-99 prefers the p6 
wobble, but does not provide any suggestion as to the mechanism by which this 
preference occurs. In comparing these two miRNAs, the most striking difference is the 
identity of the nucleotide in the first position. Because the first position plays an 
important role in Argonaute incorporation, it is conceivable that an unfavorable first 
nucleotide could direct a miRNA to have preference for a different Argonaute protein. 
There is conflicting evidence for the preference of specific miRNAs by Argonaute 
proteins [119, 135], and future experiments aimed at the mechanism of Argonaute 
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preference may reveal why different miRNAs utilize different targeting principles. The 
identification of a specific, conserved non-canonical targeting motif would be of broad 
interest to the miRNA community, and may be used to expand the criteria for miRNA 
target predictions.   
 
Clustered miRNAs repress common sets of genes 
An intuitive finding from our screen was that miRNAs that cluster together 
cooperatively target a greater proportion of genes than is expected by chance alone.  
Given that let-7/miR-99/miR-125 clusters have formed independently at least three times 
in evolutionary history [228], it is not surprising that there is selective pressure for these 
miRNAs to be expressed from the same promoter and target complementary sets of 
genes. However, one interesting question is the processing of these clusters of miRNAs.  
It is frequently observed in RNA-seq experiments that one member of the cluster will be 
highly expressed relative to the others, despite sharing a promoter.  Furthermore, these 
expression differences seem to be context dependent.  There are examples of RNA-
binding proteins that facilitate this preference [496-498], although these examples are 
only described in the context of the miR-17-92a cluster. It would be interesting to connect 
the regulation of these RNA-binding proteins with the preferential processing of clustered 
miRNAs, and use the 3´LIFE assay to assess how differential of miRNA processing 
affects gene regulation.   
 
 
‘ 
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Conclusion 
These experiments demonstrate that highly similar miRNA family members have 
distinct preferences for target genes.  This is in contrast to what is currently assumed in 
the field, and has implications for our understanding of how miRNA family members 
uniquely contribute to development and disease. We also find a conserved, non-canonical 
targeting mechanism that is preferred by miR-99a. While both these observations require 
follow up experiments to assess their biological relevance in vivo, these experiments 
provide important first steps that will be especially relevant for the development of 
synthetic antisense oligonucleotide therapeutics based on natural miRNAs [499].  
 
Experimental 
3´LIFE Assay 
 Artificial SV40 miRNA target cloning experiments were performed as previously 
described (Chapter 2). 3´LIFE assays were performed as previously described (Chapter 
4). One notable exception was, when screening for differential targeting of miRNA 
family members, we performed five replicates instead of three of each plate to achieve 
statistical confidence in the results. For the analysis in Figure 5.4 we used 375 3´UTRs 
enriched for targets of miR-10 and miR-99, and for the analysis in Figures 5.13 we used 
189 3´UTRs enriched with genes containing canonical a seed for let-7 and miR-125. 
 
Generation of random gene/seed target sets for Figure 5.5 and Figure 5.9 
 To generate random lists for either the sets of genes or scrambled permutation of 
the miR-10/99 target sequence, a random data generator was used with either the library 
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of genes, or the hexameric seed sequence. Random permutations were generated 10 times 
for each, and each permutation was compared against our actual results. Quantification of 
the random set was the average of these 10 comparisons. 
 
MiRNA target site deletions 
 Putative target sites within the 3´UTRs of HOXD10, HOXD1, GATA3, FXR2, 
RB1CC1, and the miRNAs miR-10a and miR-10b were performed using site directed 
mutagenesis. 
 
In situ hybridizations 
To detect miRNA expression patterns during mouse embryogenesis, we used 
miRCURY LNA probes, which are specific for miRNA family members (Exiqon). E9.5 
CD1 embryos were placed in MeOH and added into columns in an Intavis AG Insitu Pro. 
Pre-hybridization was performed at 61˚C for 6hrs and hybridization was performed at 
61˚C for 10hrs. Following completion in the Insitu Pro, embryos were removed and 
washed with Ab buffer (1M pH9.5 Tris, 1M MgCl, 5M NaCl). Substrate was added and 
embryos were allowed to sit overnight at 4˚C. The color reaction proceeded at room 
temperature until desired colored was achieved. If color reaction required additional time, 
the substrate was removed and embryos were washed with Ab buffer. Ab buffer was then 
replaced with either a lower pH buffer (50mM pH7.5 Tris, 150mM NaCl, 0.1% Triton-
X100) or KTBT buffer (50mM pH7.5 Tris, 150mM NaCl, 10mM KCl, 1% Tween-20) 
and placed at 4˚C overnight. Buffer was then removed and replaced with fresh substrate 
and embryos were allowed to resume staining at room temperature. When desired 
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staining was achieved, substrate was replaced with PBS and embryos were stored at 4˚C. 
 
Drug treatments and qPCR from cell lines 
All cell lines were cultured in DMEM (Invitrogen), supplemented with 10% FBS 
(Sigma) and 1% penicillin/streptomycin. MCF-7 cells were treated with 10 uM ATRA 
resuspended in DMSO (Sigma). HEK293T-miR-10 sponge lines were treated with 5 uM 
doxycycline for 72 hours. Total RNA was extracted from cell lines using Trizol 
(Invitrogen). To quantify miRNA expression, we used Taqman probes for miR-10a and 
miR-10b (Invitrogen). For mRNAs, we performed a first strand reaction using 
SuperScriptIII (Invitrogen) and polydT primer. For qPCR we designed primers spanning 
the terminal intron, and quantified using SYBR Green MM (Invitrogen). ΔΔCt method 
was used for quantification, with normalization to ACTB. 
 
Promoter cloning and transfection 
The miR-10a/b promoters were amplified from genomic DNA from the Encode 
Tier 1 cell line GM12878 and cloned into Gateway donor plasmid P4P1R using the 
following primers: 
miR-10a promoter F TGGGCGGTGAAGGGGAGAGGC 
miR-10a promoter R GCCCAGAAATTTTCCAGTTCTCC 
miR-10b promoter F CCTCTGCTTCTCTGTAACTGCAG 
miR-10b promoter R GGTCCCACCCAGAGTGAGGTAC 
Promoters were recombined with the reading frame from eGFP and the SV40 3´UTR 
using LR Clonase 2+ (Invitrogen). Cell lines were transfected with Lipofectamine 3000 
(ThermoFisher) per manufacturers protocol. Cells were counted 48 hours post 
transfection, capturing 10,000 events, using the Attune flow cytometer. 
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CHAPTER 6 
CONCLUSION 
 
The research presented in this thesis provides compelling evidence for the 
importance of miRNA duplications in higher metazoans, and supports the roles of 
miRNAs as an evolutionarily flexible mode of post-transcriptional gene regulation.  The 
pronounced expansion of miRNA families at the base of the vertebrate lineage suggests 
 
 
Figure 6.1.  A model for the function of miRNA families. Over evolutionary time 
miRNAs evolve to regulate specific mRNAs within pathways. Following a miRNA 
duplication event, there is frequent sequence divergence between paralogous 
miRNAs, along with the emergence of novel in miRNA expression patterns. The 
sequence of target genes expressed in these novel contexts may influence specific 
nucleotide changes to facilitate more efficient repression by the duplicated miRNA. 
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this may be especially relevant during the development of higher metazoans. Nucleotide 
changes at specific hotspots allow each family member to specialize and preferentially 
regulate a specific set of genes, which may be driven by novel expression patterns of 
duplicated miRNAs. This suggests that the ability of a miRNA to regulate a large set of 
genes is enhanced by membership in a larger miRNA family. Furthermore, our data 
demonstrates that miRNAs exhibit surprising plasticity in recognizing specific features of 
target sites, underscoring the complexity of miRNA targeting principles. This evidence 
informs a model on the function of miRNA duplications (Figure 6.1). The following 
discussion reiterates some of these key findings, and places emphasis on future 
experimental directions. 
 
Why so many? 
 In the prologue of this thesis, this simple question was posed as the driving 
interest behind the experiments presented here. Our work built upon previous research 
investigating the function of miRNAs in higher metazoans, specifically in the light of 
miRNA families. We observe a clear trend in the acquisition of miRNAs in higher 
metazoans, and in this light, the expanded miRNA repertoire has a clear evolutionary 
advantage. However, the question remains, how exactly do these duplicated miRNAs 
contribute to the fitness of complex organisms? A predominant view in the field is that 
miRNA families provide robustness to the complex genetic landscape of higher 
metazoans, buffering against random transcriptional fluctuations. In this view, duplicated 
miRNAs afford an additional layer of robustness to the system, providing a contingency 
against mutation, misregulation, or loss of any one family member. Below is a discussion 
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of this hypothesis in light of our findings, and concludes that robustness alone does not 
account for the trends we observe.   
 Robustness is a key feature of complex genetic systems, and is a trait that is 
frequently selected for over evolutionary time [500]. Robustness provides resistance to 
random fluctuations in the environment, both internal and external, and is largely 
manifested by redundancies in the genetic components that make up a regulatory 
program. In this way, if miRNAs are a key part of regulatory networks, duplications 
certainly provide a contingency against random mutations to the miRNA. However, our 
findings suggest selective pressure to not only maintain these miRNAs, but also for them 
accumulate subtle sequence changes immediately following duplications. We find that 
without duplications, sequence changes are rare, and sequence changes almost invariantly 
follow duplication events. This striking trend strongly suggests that these sequence 
changes impart a selective advantage only following duplication.  For protein coding 
genes, the relevance of such a trend is dubious, as genetic drift will cause random 
sequence changes over time in less relevant regions of the protein.  However, the small 
size of miRNAs grants each nucleotide with functional significance, whether it be in 
processing or target identification. In our analysis of sequence changes, we observe 
conserved trends throughout metazoan evolution that reflect both processing and 
targeting constraints. We coin the term evolutionary hotspots to describe sequence 
changes that are evolutionarily conserved. We observe that these hotspots frequently 
occur in the center of the miRNA, which has been suggested to not play a substantial role 
in miRNA target identification.  However, using an unbiased high-throughput screening 
approach, we identified hundreds of novel miRNA targets, and use this data set to assess 
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the contribution of the central region to targeting.  In contrast to the current model of 
miRNA targeting, we find that the central region does in fact have functional 
significance, and in the case of some miRNAs, is even the most statistically relevant 
region for target recognition. Furthermore, we demonstrate in three different miRNA 
families that these evolutionary hotspots, wherever they occur, grant family members 
with distinct targeting preferences. While the observed differences in targeting are not 
absolute, they do suggest that different family members regulate the same genes with 
varying strength. This is in agreement with the hypothesis that duplicated miRNAs 
provide robustness by targeting an overlapping set of genes.  However, it also adds an 
important element of specificity, suggesting the emergence of novel regulatory 
interactions is a critical component of the miRNA duplications in higher metazoans.   
To our knowledge, this is the first set of experiments that systematically tests the 
targeting preferences of miRNA family members in an unbiased and high-throughput 
manner. While our systematic approach was made possible by the 3´LIFE assay, the use 
of exogenous reporter constructs limits the strength of our conclusions. Therefore, 
experiments that assess the relative contribution of endogenous family members to 
various biological processes will be an important corroboration of our findings.  
Historically, manipulating levels of individual miRNA family members was difficult 
because most knockdown approaches could not discriminate between highly similar 
miRNAs.  However, the emergence of precise genome engineering tools, such as 
CRISPR, should facilitate the functional exploration of individual family members.   
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The 3´LIFE assay is a powerful tool to study the mechanisms and outcomes of miRNA 
regulation 
 Our experiments using the 3´LIFE assay revealed several novel findings relating 
to general miRNA targeting principles, and support the use of this unique tool for future 
studies. Yet, for the experiments described below, it is important to stress a multi-
pronged approach to address important questions on miRNA targeting.  Similar to how 
sequencing based approaches have inherent strengths and limitations, so it is with 
reporter assays such as 3´LIFE.  By directly comparing the similarities and differences in 
results obtained with these complementary approaches, we can hope to achieve a more 
accurate understanding of the biological function of miRNAs. Below are two important 
questions to be addressed in the future with the 3´LIFE assay as it currently exists. 
First, it is still poorly understood why some targeting interactions lead primarily 
to mRNA decay, while others lead to translational repression without changes in mRNA 
abundance. By comparing 3´LIFE and RNA-seq data, we can identify a large pool of 
genes that fall into each mechanistic category. Identifying distinct features of target sites 
that direct the fate of the mRNA one way or the other can greatly strengthen target 
prediction softwares, and facilitate more representative and accurate searches for 
biologically relevant miRNA targets. Furthermore, because the majority of canonical 
miRNA targets eventually lead to mRNA decay, identification of target features that do 
not lead to mRNA decay may reveal novel insights into the prevalence and relevance of 
non-canonical miRNA targets. The 3´LIFE assay is the only method currently available 
that can provide high-throughput data for such a comparison. 
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 Second, a highly relevant question that 3´LIFE can address is the biological 
function of alternative polyadenylation (APA), which is a pervasive feature of most 
animal transcriptomes. Despite the conceptual importance of APA, there are surprisingly 
few examples where APA results in clear phenotypic consequences. This has dampened a 
broader interest in APA as a critical regulator of post-transcriptional gene regulation. The 
3´LIFE assay can be combined with recent advances in the accurate mapping of the 3´ 
ends of mRNAs, to discover sets of genes that are specifically influenced by APA.  For 
example, there are significant numbers of evolutionarily conserved and bioinformatically 
predicted target sites in the 3´LIFE screens presented here that were not targeted by the 
miRNAs of interest. Combining this list with 3´ end mapping experiments (either 
3´RACE or RNA-seq) will achieve a high confidence list of genes that escape miRNA 
regulation through APA. This data could then direct downstream experiments in 
biologically relevant contexts, such as cell lines or developmental models, where the 
choice of polyadenylation site can be manipulated genetically. Importantly, these 
experiments aim to expand specific examples of biologically relevant alternative 
polyadenylation, and more generally assess its contribution to development and disease. 
 
The future of 3´LIFE 
 Much of the research presented in this thesis was proof-of-principle experiments 
for the 3´LIFE assay, which demonstrate the effectiveness of this screening approach to 
identify miRNA targets. While the 3´UTR library generated for these experiments 
(h3´UTRome v1) is a unique resource, it only covers ~8% of the human 3´UTRome.  As 
such, future 3´LIFE studies should include efforts to expand this library, with a long-term 
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goal of creating a comprehensive human 3´UTRome.  While cloning some 3´UTRs may 
present technical challenges due to their size, there is still a substantial portion of the 
3´UTRome that falls within the 2.5kb window used in our preliminary cloning efforts. To 
focus future cloning efforts, choosing 3´UTR targets based on transcriptome data from a 
specific biological context may be an effective approach. For example, in experiments 
aimed at studying a miRNA that contributes to Alzheimer’s disease, an efficient approach 
would be to characterize the transcriptome of CNS neurons both before and after disease 
detection, and focus cloning efforts on 3´UTRs expressed in this tissue. This context 
driven approach would reduce the number of 3´UTRs required for screening, and greatly 
streamline the discovery of biologically relevant miRNA targets.   
 There are many additional questions that the 3´LIFE assay can be used to address, 
but which fall outside the scope of this thesis.  However, two of these warrant 
mentioning, as they reflect high impact questions.  First, it is well established that many 
pathogens and parasites have their own genomically encoded miRNAs; there are over 
200 experimentally validated viral miRNAs. In some cases these miRNAs have 
complementarity to host genes, but in many cases they do not. It is completely unclear 
what role these miRNAs play in pathogenesis, yet their continued existence in rapidly 
changing viral genomes hints at their importance [501]. Furthermore, at least one 
intriguing example suggests that miRNAs of parasitic nematodes may suppress an 
immune response by targeting mRNAs in the intestinal endothelial cells of the host [502]. 
The 3´LIFE assay can provide an unbiased tool to identify the functional targets of these 
unconventional miRNAs, and explore a novel aspect of the pathogen/host relationship.  
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Second, it is clear that RNA-binding proteins play a key role in nearly all 
biological processes, yet most approaches focus on the protein, and not individual RNA 
targets.  The pLIFE-3´UTR plasmid possesses MS2 structural elements that can be used 
to isolate a single 3´UTR of interest with immunoprecipitation approaches. When 
combined with mass-spectrometry or other protein detection methods, this RNA-focused 
approach may yield insights into the collective regulation of a single 3´UTR by multiple 
RNA-binding proteins. 
 
“What is the mutant phenotype?” 
This is perhaps the most revealing question in classical genetic studies, yet 
attempting to answer this question has yielded surprisingly little information on the 
function of miRNAs. The most intuitive answer is genetic compensation; other family 
members will compensate for the loss of any one miRNA. Yet C. elegans miRNAs, 
which often stand alone in the genome, typically do not produce a knockout phenotype. 
Perhaps more unsettling, is what the compensation argument means for one major finding 
in this thesis, that miRNA family members have distinct targeting preferences.  If 
miRNA family members demonstrate such preference in vivo, miRNAs should not be 
able to compensate for each other. So, as has been suggested by the challenging parties, 
this evidence leads to the logical conclusion that the majority of miRNAs may not play 
critical roles in normal biological (or at least developmental) processes. However, there is 
substantial evidence from disease models that individual miRNAs can in fact exert 
powerful influence on cellular phenotypes and behavior. The reconciliation of these two 
conflicting observations is critical to gain a more complete understanding of miRNA 
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function in development and disease. Below are suggestions of specific experiments to 
test these ideas.   
The first experiments propose below are aimed at assessing the accuracy of the 
claim that miRNA knockouts lack of overt phenotypes.  Historically, miRNA knockout 
experiments cast a wide net by knocking out the miRNA, and then looking for any 
obvious phenotypic changes.  While this was effective for the discovery and 
characterization of lin-4 and let-7, it has not been effective for the majority of metazoan 
miRNAs. Instead, a hypothesis-based approach may be more productive in identifying 
distinct functions of miRNAs, and possibly individual family members.  For example, 
our data suggest that members of the miR-10 family target multiple components of the 
retinoic acid signaling pathway, and that expression of individual miR-10 family 
members may be restricted to specific tissues. We also find target preferences by specific 
family members. By combining this knowledge a priori, we can design specific 
experiments in the context of miR-10 knockouts to assess what effect the knockout of one 
family member has in tissues where it is uniquely expressed. It may be especially 
important to assess the molecular phenotype of miRNA knockouts in these contexts, i.e. 
what are the effects on specific target proteins, and more broadly, what is the effect on 
responses to stimuli such as retinoic acid treatment, environmental stresses, or specific 
genetic backgrounds. Without a clear hypothesis about the function of a given miRNA, it 
may be difficult to observe any subtle phenotypes that result from knocking the miRNA 
out.  
Furthermore, emerging evidence suggests that miRNA knockout phenotypes may 
be especially pronounced in altered environmental or genetic backgrounds, as 
177 
demonstrated by miR-10 knockouts in worms [225] and mice [226]. This evidence 
suggests that in times of cellular stress, miRNAs provide a mechanism of enabling an 
effective cellular response to an aversive stimulus. In this light, our observation of the 
large number of miRNA targets with cooperative function, each subtly repressed, 
suggests that miRNAs may only stimulate a cellular response in a stressful environment. 
In normal conditions, the net effect of miRNA targeting may be difficult to detect. 
Hypothesis based testing should guide experimental parameters such as the genetic 
background, morphological location, and the nature of the aversive or stressful stimulus.  
My second question addresses the degree of genetic redundancy between family 
members. While it is the case that miRNA family members have overlapping target sets, 
we find distinct target preferences within all the families we examined. Because C. 
elegans has only one copy of most miRNAs, the worm may be useful in addressing this 
question. For example, C. elegans has one homologue of miR-10, called miR-57.  MiR-57 
mutants have rare tail defects, and a certain frequency of larval developmental arrest in 
stressful environmental conditions [225]. Importantly, these defects can be rescued by 
reintroduced an exogenous copy of miR-57. An informative experiment would be to 
quantify the extent to which mutant versions of the miRNA, which reflect the single 
nucleotide changes observed throughout the course of vertebrate development, also 
rescue these phenotypes.  Because miRNAs target a large of number of genes, not all 
versions may equally rescue the mutant phenotype, and this could in turn be connected to 
preferential targeting by these mutant miRNAs. Of course, conclusions drawn from this 
approach rely on identifying the target genes of miR-57, and tissue specific miRNA and 
mRNA profiles using Argonaute immunoprecipitation and RNA-seq will be key 
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experiments toward this end. 
 
Conclusion 
 MiRNAs are a powerful component of the zoo of non-coding RNAs. The 
ubiquitous nature of miRNAs has generated incredible interest in this form of post-
transcriptional gene regulation, yet for the majority of miRNAs few, if any, target genes 
have been identified. The work presented here provides a conceptual basis for exploring 
the function of individual miRNA family members in development and disease, and 
establishes the 3´LIFE assay as an effective high-throughput tool to identify miRNA 
targets. In conclusion, two features of these tiny RNAs warrant emphasis, as highlighted 
by the experiments in this thesis. First are the broad capabilities of miRNAs as a 
mechanism of post-transcriptional regulation: miRNAs employ a complex collection of 
targeting principles to regulate a large number of targets in a wide range of biological 
processes. Second, miRNAs demonstrate surprising flexibility in how readily they adapt 
throughout the course of evolution to regulate targets with cooperative function. 
Together, these two features of miRNAs speak to their complexity, and provide a wealth 
of questions to be explored in the future. The research presented in this thesis provides a 
theoretical and experimental foundation from which to investigate the function of these 
important genetic regulators. 
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APPENDIX A 
ALIGNMENTS OF TARGET SITES FOR LET-7C AND MIR-10B 
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APPENDIX B 
LET-7C AND MIR-10B TARGET GENES IDENTIFIED IN THE 3´LIFE SCREEN 
  
223  
let-7c 
Rank Gene 
Repression 
Index 
79 CNNM2 0.73 
80 USF2 0.73 
81 FYN 0.73 
82 OLFM4 0.73 
83 MED31 0.73 
84 MGMT 0.73 
85 PA2G4 0.73 
86 ALX1 0.73 
87 ZNF655 0.73 
88 DNMT1 0.73 
89 ZC3H4 0.74 
90 ZNF526 0.74 
91 MED7 0.74 
92 SMAD6 0.74 
93 ZNF343 0.74 
94 CSTF2T 0.74 
95 MED24 0.74 
96 TBX10 0.75 
97 ZNF530 0.75 
98 ETNK2 0.75 
99 CREB3 0.75 
100 GMNN 0.75 
101 SSX4 0.75 
102 DBX2 0.75 
103 ZNF189 0.75 
104 ARID3A 0.75 
105 DND1 0.75 
106 ZNF287 0.75 
107 LOC93349 0.75 
108 PDK3 0.75 
109 KIT 0.75 
110 EZH2 0.75 
111 NR1I2 0.76 
112 PKN3 0.76 
113 RSF1 0.76 
114 ZMAT5 0.76 
115 GABPB2 0.76 
116 HHAT 0.76 
117 CHD4 0.76 
118 ZNF253 0.76 
119 PAK3 0.76 
120 VPS72 0.76 
121 MYCL 0.76 
let-7c 
Rank Gene 
Repression 
Index 
122 SPDEF 0.77 
123 EN2 0.77 
124 ZNF736 0.77 
125 PKNOX2 0.78 
126 DGKQ 0.78 
127 CHD6 0.78 
128 HOXC11 0.78 
129 SOX17 0.78 
130 DHX57 0.78 
131 TTF1 0.78 
132 RBM38 0.78 
133 RNF7 0.78 
134 NES 0.78 
135 THRA 0.79 
136 ZNF571 0.79 
137 LOC91461 0.79 
138 ZNF202 0.79 
139 HNRNPF 0.79 
140 HES5 0.79 
141 CSRP2 0.79 
142 ZNF44 0.79 
143 ZNF416 0.79 
144 ZNF687 0.79 
145 BAZ1B 0.79 
146 KAT5 0.79 
147 MYT1 0.79 
148 ZNF552 0.79 
149 TAB2 0.79 
150 KLF10 0.79 
151 DYRK1B 0.79 
152 HOXB7 0.79 
153 WDR77 0.79 
154 RIOK2 0.80 
155 LRRK1 0.80 
156 KLF1 0.80 
157 ZNF501 0.80 
158 TBK1 0.80 
159 NCOR1 0.80 
160 ZNF19 0.80 
161 TBP 0.80 
162 E2F6 0.80 
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 miR-10b 
Rank Gene 
Repression 
Index 
1 MAP4K5 0.38 
2 L3MBTL3 0.39 
3 ERCC3 0.44 
4 SCML2 0.45 
5 SMARCD2 0.49 
6 RBBP7 0.50 
7 ALDH1A3 0.51 
8 KLF10 0.52 
9 ALDH1A3 0.52 
10 ADRB2 0.54 
11 ZMYND11 0.54 
12 CBFB 0.55 
13 ZNF766 0.56 
14 THAP9 0.56 
15 FOXF2 0.56 
16 SDC1 0.57 
17 MKRN2 0.57 
18 HOXD10 0.58 
19 HDAC8 0.58 
20 BAZ1B 0.59 
21 TAF5L 0.59 
22 KIT 0.59 
23 EPHB2 0.60 
24 TFAP2C 0.60 
25 CHD1 0.61 
26 DAZAP1 0.61 
27 ZNF879 0.62 
28 PNPT1 0.62 
29 TSC22D4 0.62 
30 RB1CC1 0.62 
31 MED27 0.63 
32 DAPK1 0.63 
33 ZNF333 0.64 
34 WWP1 0.64 
35 SSB 0.64 
36 ZSWIM4 0.64 
37 PCBD1 0.65 
38 ZC3H4 0.65 
39 MYT1 0.66 
40 BCL6B 0.66 
miR-10b 
Rank Gene 
Repression 
Index 
41 SMARCC2 0.66 
42 HNRNPH3 0.66 
43 KMT5A 0.66 
44 SIAH2 0.66 
45 TP63 0.66 
46 RARG 0.67 
47 STK16 0.67 
48 HTATIP2 0.67 
49 ARID4B 0.67 
50 HNRNPR 0.68 
51 ANXA7 0.68 
52 ZNF90 0.68 
53 DMTF1 0.68 
54 CHD6 0.68 
55 HOXD1 0.69 
56 TCF15 0.69 
57 ZNF184 0.69 
58 ZFP62 0.69 
59 PSIP1 0.69 
60 DKC1 0.69 
61 KMT2D 0.69 
62 PTF1A 0.69 
63 KDM3B 0.70 
64 TBK1 0.70 
65 ZNF479 0.70 
66 APTX 0.70 
67 ZNF580 0.71 
68 PKD1 0.71 
69 ZKSCAN4 0.71 
70 TRIM71 0.71 
71 ZNF521 0.71 
72 ZNF732 0.71 
73 ZNF202 0.71 
74 PNO1 0.72 
75 SRC 0.72 
76 NEK6 0.72 
77 ALX1 0.72 
78 MED17 0.72 
79 GLIS2 0.72 
80 HOXB2 0.72 
225  
miR-10b 
Rank Gene 
Repression 
Index 
81 MED14 0.72 
82 LRRK2 0.72 
83 ORC2 0.72 
84 GABPB2 0.72 
85 CDIP1 0.72 
86 FOXR2 0.72 
87 BRD2 0.73 
88 MAP2K3 0.73 
89 ZNF626 0.73 
90 SOX17 0.73 
91 ZNF689 0.73 
92 ZNF721 0.73 
93 ZNF215 0.73 
94 MAP4K2 0.74 
95 MBD3 0.74 
96 DCAF6 0.74 
97 DDX5 0.74 
98 ZNF644 0.74 
99 GCM2 0.74 
100 NCOR2 0.74 
101 NCOA1 0.74 
102 EPHB1 0.74 
103 MED7 0.74 
104 RPS6KA1 0.74 
105 NR2E3 0.75 
106 ZSCAN32 0.75 
107 TRIB2 0.75 
108 RBP4 0.75 
109 NCOA6 0.75 
110 TAF1A 0.75 
111 ZFP42 0.75 
112 LRRK1 0.76 
113 ZFP36 0.76 
114 CRABP2 0.76 
115 GFI1 0.76 
116 ZNF749 0.76 
117 ZNF135 0.76 
118 TCF7 0.76 
119 ZNF345 0.76 
120 SRCAP 0.76 
miR-10b 
Rank Gene 
Repression 
Index 
121 TCF19 0.76 
122 PATZ1 0.76 
123 GRHL1 0.77 
124 EWSR1 0.77 
125 RBM7 0.77 
126 SIAH1 0.77 
127 NPR1 0.77 
128 NCOA5 0.77 
129 NES 0.77 
130 BRD8 0.77 
131 NIP7 0.77 
132 HOXA5 0.77 
133 CTBP2 0.77 
134 EPHA6 0.77 
135 SPI1 0.77 
136 PSMD9 0.77 
137 ZNF823 0.77 
138 PIM3 0.77 
139 TRIB3 0.77 
140 MELK 0.77 
141 ZNF626 0.77 
142 TRIO 0.77 
143 OSR2 0.77 
144 LOC93349 0.78 
145 RPS6KA5 0.78 
146 ZFYVE1 0.78 
147 ZNF596 0.78 
148 FXR2 0.78 
149 BRSK1 0.78 
150 AKT1 0.78 
151 HOXD11 0.79 
152 NOVA1 0.79 
153 RCOR3 0.79 
154 T 0.79 
155 NCOR1 0.79 
156 PBX3 0.79 
157 NR0B2 0.79 
158 SMAD6 0.79 
159 PTBP1 0.79 
160 ASXL1 0.79 
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miR-10b 
Rank Gene 
Repression 
Index 
161 ROCK1 0.79 
162 PRKCD 0.79 
163 CHD3 0.80 
164 ICAM1 0.80 
165 SNX4 0.80 
166 ZNF343 0.80 
167 HNRNPAB 0.80 
168 ZNF461 0.80 
169 BNC1 0.80 
170 ZNF532 0.80 
171 NCOR1 0.80 
172 CBX4 0.80 
